BCM Neurology
Click on the 
sign to list the poster and platform presentations by year. Then click on the link to view that presentation.
2023
- Dichotomy of basket cell recruitment during seizures.
[Oral Presentation]
- Age at onset and therapeutic efficacy of primidone in essential tremor.
- Risk factors of sleep disordered breathing in Veterans with Parkinson's disease.
- Endocannabinoid signaling at GABAergic synapses in behaving animals.
[Oral Presentation]
- Early-life social determinants of SCA6 age at onset, severity, and progression.
- Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.
- Parental leave experience for academic neurology faculty at 19 academic centers.
- Spinocerebellar ataxia 21 and phenotypic variability within a single family.
- Systemic inflammatory response syndrome deteriorates the outcomes of mechanical thrombectomy in acute stroke.
- Data-driven phenotypic clustering of Parkinson's disease patients seeking deep brain stimulation.
- Gambling associated risk-taking decision in cerebellar ataxia.
- Instrumental Activities of Daily Living (IADL) as a digital biomarker of cognitive decline in older adults.
- Apathy and Parkinson's disease motor phenotypes: A preliminary study.
- Respiratory impairment in multiple sclerosis: A single-center study in 371 people with MS.
- Impact of gender and race on academic achievements for neurology faculty.
- Cognitive function remains associated with global functional impairment in profound dementia due to Alzheimer's disease and dementia with Lewy bodies.
- Precision neurology for dementia.
- Strokes averted by intravenous thrombolysis: A secondary analysis of the BEST-MSU trial.
- A patient-level data Euclidean-matched analysis of reperfusion therapies in acute ischemic stroke from the Latin American Stroke Registry (LASE).
- Stroke survivors experience during the COVID-19 pandemic: A phenomenological investigation.
- Acute stroke treatment in patients with pre-exiting disability: A secondary analysis of the BEST-MSU trial.
[Oral Presentation]
- Favorable mechanical thrombectomy outcomes from the Latin American Stroke Registry (LASE) and resilient trial compared to a 90-day functional and mortality predictive model.
[Oral Presentation]
- Predictors of occlusion after flow diversion of aneurysms in the internal carotid artery: Pooled analysis of 2 large studies.
- Enhancing exploration platforms and analog definition intracranial pressure.
- SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt bed rest.
- The long-term consequences of spaceflight on brain and eye health (SANS LTH).
- Initial analysis of pre- and post-flight refractive error changes in commercial spaceflight participants.
[Oral Presentation]
- Machine learning for the automation of optic nerve sheath diameter measurement: Current progress and future implications for crew autonomy.
- Uncovering methodological inconsistencies in ultrasonographic optic nerve sheath diameter measurement and a path forward using expert consensus.
- Investigating long-term structural and functional changes to the eye and brain after spaceflight.
- BRAIN-SANS: Brain-related assessments for investigating the neurophysiology of SANS - 2023 update.
[Oral Presentation]
- Zero G and ICP: Invasive and noninvasive ICP monitoring and sans biomarker identification.
- B complex: A nutraceutical SANS countermeasure.
[Oral Presentation]
- Exploring endothelial function risk factors and optic disc edema during strict 6° head-down tilt bed rest.
[Oral Presentation]
Park City Epilepsy Meeting
Park City, Utah (Oct. 15-17, 2023)
Movement Disorder Society (MDS)
27th International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark (Aug. 27-31, 2023)
Gordon Research Conferences (GRC)
Cannabinoid Function in the CNS Conference in Barcelona, Spain (July 16-21, 2023)
American Academy of Neurology (AAN)
75th Annual Meeting in Boston, Mass. (April 22-28, 2023)
American Stroke Association
2023 International Stroke Conference in Dallas, Texas (Feb. 8-10, 2023)
National Aeronautics and Space Administration (NASA)
2023 Human Research Program Investigators' Workshop in Galveston, Texas (Feb. 7-9, 2023)
International Neuropsychological Society (INS)
51st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023)
2022
- A Bayesian switching linear dynamical system for modeling seizure cycles.
- Surgical outcomes in post-traumatic epilepsy: A metanalysis.
- The VA EEG Utilization Project: A national VA operations and quality improvement initiative.
- Assessment of mindfulness in the epilepsy monitoring unit.
- Encephalopathy in kv1.1 KO mice is associated with hippocampal BDNF and EGR3.
- Nonlinear dysregulation of glutamate and neural activity facilitates glioma-induced epilepsy.
- A digenic mechanism for absence epilepsy.
- Emx1-Cre is expressed in peripheral neurons that regulate cardiorespiratory tone.
- mTOR complexes in epilepsy and seizure disorders.
- Diagnostic utility of video alone in differentiation of epileptic seizures from paroxysmal non-epileptic events in children.
- Disparities in morbidity and mortality in adults with status epilepticus in the USA: 2010-2019.
- Pathogenic germline mutations in glioma patients.
- Dissecting the role of mTOR complexes in epilepsy and seizure disorders.
- Layer- and cell type- specific cortical circuit deficits underlying the absence epilepsy.
- Transcriptional dysregulation of thalamic t-type calcium channel gene precedes seizure onset in childhood absence epilepsy mouse model tottering.
- Actigraphic correlates of psychiatric disability in patients with focal epilepsy.
- Patient and cost-benefit of utilizing checklists in the Neurocritical Care Unit.
- Methodological inconsistencies in optic nerve sheath diameter measurement using bedside ultrasound - A systematic review of literature.
- A multimodal noninvasive approach to predict radiographic DCI in high grade aneurysmal SAH.
- Orthostatic differences in transcranial Doppler in severe COVID-19.
- Critical care provider's perspective of multimodal monitoring in patients with acute brain injury.
- Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis subtype of cervical dystonia.
- Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with retrocollis subtype of cervical dystonia.
- Spinocerebellar ataxia 21 and phenotypic variability within a family.
- Racial differences in essential tremor.
- Neuroanatomical underpinnings of apathy in Parkinson's disease.
- Chronotype and cognition in veterans with Parkinson's disease.
- How does head tremor in cervical dystonia change with head position?
- Time to EEG connection after status epilepticus in the neurocritical care unit - A pilot study.
- Neurophysiologic competency certification module for ancillary test reporting in determination of death by neurological criteria — EEG, brainstem and somatosensory evoked potentials.
[Oral Presentation]
- Cell type-specific recruitment of hippocampal perisomatic inhibition during seizures in vivo.
- Dichotomy of basket cell recruitment during seizures.
[Oral Presentation]
- "Hablemos de Alzheimer": Words Mexican Americans use to talk about Alzheimer's disease genetic testing. Implications for precision medicine education.
- A matrisomal proteomics network modulates tau and amyloid-beta toxicity in fly AD models.
- Reduced vascular disease mortality associated with improved 5-year survival in an AD cohort followed for 25 years.
[Platform Presentation]
- Cell-specific responses to Tau pathology in the aging brain.
- Retromer subunit, VPS29, regulates vacuolar-type ATPase and lysosomal acidification in the aging brain.
- Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.
- Forensic grand rounds: Practical considerations in the evaluation of non-native English speakers.
- Experience of stroke survivors during the COVID-19 pandemic (ESS-COV): A phenomenological
investigation.
[Oral Presentation]
- Comparative adherence trajectories across oral disease-modifying agents in multiple sclerosis.
- Factors associated with prescribing of teriflunomide and dimethyl fumarate versus fingolimod in multiple sclerosis.
- Clinical and demographic characteristics associated with poor posterior circulation stroke outcomes: Greater Cincinnati/Northern Kentucky stroke study.
- The American Academy of Neurology Residents as Educators Workgroup Initiative: Nurturing future neurology educators.
[Oral Presentation]
- Erdheim-Chester disease with isolated CNS involvement: A case report and systematic review of literature.
- Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
[Previously Presented]
- A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
- Determinants of disparate disability accumulation in Black, Hispanic, and White patients with multiple sclerosis.
- NeuroLytes: Developing clinical reasoning for medical students on the neurology clerkship.
- Steroid-responsive ecchordosis physaliphora diagnosed as CLIPPERS: A systematic review of literature and case report.
- Responsive neurostimulation vs. vagus nerve stimulation in epilepsy.
- Implementation of systematic safety checklists in a neurointensive care unit: A quality and improvement study.
[Oral Presentation]
- Investigation of neuroplasticity with the responsive neurostimulation (RNS) system during battery failure.
- Seizure control during COVID-19: A study using the responsive neurostimulation system (RNS).
- Gender discrepancies in neurologist compensation.
- Impaired large fiber sensory exam with normal NCS.
[Oral Presentation]
- Utility of routine inpatient echocardiography in acute ischemic stroke patients with established stroke etiology: A population study.
- Temporal trends in stroke patients who had prior transient ischemic attack and did not present to the emergency room: A population study.
- Trends in the clinical phenotype of infective endocarditis related stroke from 2005-2015: A population-based study of the Greater Cincinnati/Northern Kentucky region.
- Mobile health technology is feasible and effective for self-management support among underserved stroke survivors.
[Oral Presentation]
- CADRE: Commercial astronaut data repository.
[Oral Presentation]
- SPACE-CENT: Studying the physiological and anatomical cerebral effects of centrifugation and head down tile bed rest: 2021 update.
- A review of optic nerve sheath diameter use in spaceflight and analogues with qualitative analysis and future directions.
- Governance and institutional review board challenges for the Inspiration4 mission?s crew health research program (MESH -i4 and CADRE).
[Oral Presentation]
- BRAIN-SANS: Brain-related assessments for investigating the neurophysiology of SANS.
[Oral Presentation]
- Zero G and ICP: Invasive and noninvasive ICP monitoring and SANS biomarker identification.
- Exploring endothelial function risk factors and optic disc edema changes during strict 6° head-down tilt bed rest.
- The electroencephalogram of the developing brain.
[Herbert H. Jasper Award Lecture]
American Epilepsy Society (AES)
76th Annual Meeting in Nashville, Tenn. (Dec. 2-6, 2022)
Society of Neuro-Oncology (SNO)
27th Annual Scientific Meeting and Education Day in Tampa, Fla. (Nov. 16-20, 2022)
Society for Neuroscience (SFN)
52nd Annual Meeting in San Diego, Calif. (Nov. 12-16, 2022)
American Neurological Association (ANA)
147th Annual Meeting in Chicago, Ill. (Oct. 22-25, 2022)
Neurocritical Care Society (NCS)
20th Annual Meeting in San Antonio, Texas (Oct. 17-21, 2022)
Movement Disorder Society (MDS)
26th International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain (Sept. 15-18, 2022)
32nd International Congress of Clinical Neurophysiology (ICCN)
Geneva, Switzerland (Sept. 4-8, 2022)
Gordon Research Conferences (GRC)
Mechanisms of Epilepsy and Neuronal Synchronization Conference in Barcelona, Spain (July 31 - Aug. 5, 2022)
2022 Alzheimer's Association International Conference (AAIC)
San Diego, Calif. (July 30 - Aug. 4, 2022)
International Neurotoxin Association (INA)
Toxins 2022 6th International Conference in New Orleans, La. (July 27-30, 2022)
American Academy of Clinical Neuropsychology (AACN)
20th Annual Meeting in Minneapolis, Minn. (June 22-25, 2022)
ISI Committee on Risk Analysis (ISI-CRA) of the International Statistical Institute (ISI)
9th International Conference on Risk Analysis (ICRA9) in Perugia, Italy (May 25-27, 2022)
Professional Society for Health Economics and Outcomes Research (ISPOR)
2022 Annual Meeting in Washington, DC (May 15-18, 2022)
American Academy of Neurology (AAN)
74th Annual Meeting in Seattle, Wash. (April 2-7, 2022)
Texas Scottish Rite Hospital for Children
44th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 24-25, 2022)
American Stroke Association
2022 International Stroke Conference in New Orleans, La. (Feb. 9-11, 2022)
American Stroke Association
2022 Stroke Nursing Symposia in New Orleans, La. (Feb. 8, 2022)
National Aeronautics and Space Administration (NASA)
Virtual 2022 Human Research Program Investigators' Workshop (Feb. 7-10, 2022)
American Clinical Neurophysiology Society (ACNS)
2022 Annual Meeting in Orlando, Fla. (Jan. 26-30, 2022)
American Society of Neuroimaging / NeuroNet Pro (ASN/NNP)
Joint Annual Meeting 2022 in Scottsdale, Ariz. (Jan. 13-16, 2022)
2021
- A more generalizable DNN based automatic segmentation of brain tumors from multimodal low-resolution 2D MRI.
- The Neuropsychology of SARS-CoV2.
[Oral Presentation]
- KCNQ2 G256W, a "moderate severity" developmental encephalopathy allele, modeled in silico, in vitro, and in knockin mice.
- Spontaneous cortical spreading depolarization in a SCN1A deficient Dravet syndrome mouse model.
- System xc: Friend or foe in KCNA1-null mice?
- Predictive value of magnetoencephalography to guide intracranial implant strategy.
- Opposite recruitment of hippocampal PV- and CCK-expressing interneurons in epilepsy.
- Mortality and access to comprehensive epilepsy care among U.S. veterans.
- COVID-19 and epilepsy: Data from Responsive Neurostimulation System (RNS).
- On the mental status of Stargazer mice.
- Actigraphic correlates of disability in patients with focal epilepsy.
- Genetic labeling of CCK-expressing interneurons in a chronic mouse model of temporal lobe epilepsy.
- On the digital psychopharmacology of antiseizure medications.
- Making absence epilepsy by combining two epilepsy genes.
- Multi-scale investigation of the pathological nature of interictal spikes.
- Fenfluramine directly inhibits cortical spreading depolarization&emdash;A pathophysiologic process linked to SUDEP.
- Provider experience with ketamine for refractory status epilepticus.
- Transcriptional dysregulation of thalamic T-type calcium channel CACNA1G gene precedes seizure onset in childhood absence epilepsy mouse model tottering.
- The effect of sensory deprivation and mutant gene dosage on seizures and background oscillations in a mouse model of absence epilepsy.
- An innovative virtual multi-institutional, multidisciplinary neuro-oncology tumor board: The NIH-NOB experience during the COVID-19 pandemic.
- Dural arteriovenous fistula and implications in aneurysmal genesis.
- Impact of systemic inflammatory response syndrome on acute ischemic stroke patients treated with mechanical thrombectomy.
- Covered stent placement for treatment of a dural arteriovenous fistula: Case report and literature review.
- Functional validation of the cytoskeletal protein Plectin in Alzheimer's disease.
- Alzheimer's disease risk gene CD2AP modulates synaptic structure and plasticity.
- Layer- and pathway-specific disruption of perisomatic inhibition in the somatosensory cortex of the stargazer model of absence epilepsy.
- Hippocampal GABAergic cell type selectively controlling local and extra-hippocampal interneurons during sharp-wave ripples.
- Retrograde endocannabinoid signaling at perisomatic GABAergic synapses during behavior.
[Oral Presentation]
- The use of point of care compression ultrasound as a screening tool for lower extremity deep vein thrombosis in the neurocritical care unit.
- Spontaneous spinal subarachnoid hemorrhage with simultaneous intracranial subarachnoid hemorrhage: A case report.
- The implication of pyramidal signs in multiple system atrophy.
[Previously Presented]
- Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.
- Distinct impulsive traits in cerebellar ataxia and Parkinson's disease.
- A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
- The implication of pyramidal signs in multiple system atrophy.
- Tourette syndrome and driving.
- Deep brain stimulation surgery and clinical characteristics of essential tremor in a cohort of veterans.
- Whole-exome sequencing in a movement disorders clinic.
- The MJFF global genetic Parkinson's disease research resource.
- A qualitative approach to evaluate post stroke telehealth (VAST) services in Texas.
[Oral Presentation]
- U.S. POINTER: Lessons learned about delivery of a multi-domain lifestyle intervention during the COVID-19 pandemic.
- Integrating multimodal data to support Alzheimer's disease target prioritization.
- The Alzheimer's disease risk gene CD2AP modulates mammalian synaptic structure and plasticity.
- Elucidiating cellular contributions to tau-mediated neurodegeneration using Drosophila and single cell transcriptomics.
- Strict aspects cutoffs in endovascular therapy selection paradigms may harm patient outcomes.
- Alternating recruitment and opposed scaling of distinct hippocampal inhibitory modules during behavior.
- Psychiatric and military history do not differentiate psychogenic non-epileptic seizures and epileptic seizures among veterans.
- Multiple sclerosis in a multi-ethnic population in Houston, Texas: A retrospective analysis, 2019-2020.
- Effects of narcolepsy during pregnancy on adverse maternal-fetal outcomes.
- Effect of different variance estimation methods with inverse probability treatment weights (IPTW) on comparative effectiveness measure in multiple sclerosis.
- Factors associated with prescribing of disease-modifying agents among older adults with multiple sclerosis: A real-world analysis of electronic medical records.
- Optic disc edema and chorioretinal folds develop during strict head-down tilt bedrest with and without artificial gravity.
- Diagnostic outcome of genetic testing on neuromuscular disorders in a tertiary center.
- The RIKEE database: Genotype-phenotype patterns in KCNQ channel related disease, based on 784 individuals and pedigrees.
- Acute bilateral optic neuritis due to Borrelia Burgdorferi in a patient with multiple sclerosis on ocrelizumab.
- Adverse neurological events amongst patients undergoing Extracorporeal Membrane Oxygenation (ECMO).
- Age of onset and deep brain stimulation in a cohort of essential tremor.
- A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
- A paradoxical phenomenon: Seizure exacerbation following administration of anti-seizure drugs.
- Patient reported baseline measures in RAD-PD reveal marked heterogeneity in a DBS cohort.
- Patient preference in virtual versus in-person visits in neuromuscular clinical practice, a multicenter survey.
- The implication of upper motor neuron burden in multiple system atrophy.
- Cerebellar Impulsivity-Compulsivity Assessment (CIA): A scale to measure impulsive and compulsive behaviors in cerebellar disorders.
- Corticobasal degeneration and auditory hallucination.
- NeuroLytes as a novel, virtual, case-based didactics targeted at medical students undergoing Neurology clerkship.
- Ten year clinical outcomes of subthalamic nucleus versus pallidal deep brain stimulation for Parkinson's disease: VA/NINDS CSP #468F.
- Candida parapsilosis mastoiditis causing Gradenigo's and Vernet's syndrome: a case report in an older adult.
- Sociodemographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS Registry).
- Spontaneous intracranial hypotension presenting as postural headache and cranial VI palsy: A case report.
- EEG findings in patients undergoing extracorporeal membrane oxygenation (ECMO).
- North American survey on the effects of the COVID-19 pandemic shutdown on DBS care.
- Resident lumbar puncture clinic at Geisinger Health System: A single program needs assessment for quality improvement.
- Machine learning algorithm for differentiating epileptic and non-epileptic seizures.
- COVID-19 survey of clinical neurophysiology/epilepsy program directors and fellow trainees in the United States.
- ADHD Comorbidity in patients with epilepsy and psychogenic non-epileptic seizures in the Epilepsy Monitoring Unit.
- Racial disparities in blood pressure at time of acute ischemic stroke emergency department presentation within a population.
- Google Auto ML based prediction of outcomes in intracerebral hemorrhage - Bringing machine learning to clinicians.
- Outcomes after thrombolysis for ischemic stroke in Costa Rica compare favorably with international cohorts.
- The reality of MS epidemiology in LATAM.
[Oral Presentation]
- Outcomes in neuromuscular genetic testing.
- Clinicians preference of virtual vs. physical visit.
[Oral Presentation]
- The utility of additional depth or subdural electrodes following stereotactic EEG evaluation.
- SALUD Strutt MacDonald Equitable Healthcare Model: A comprehensive approach to addressing healthcare disparity in the field of neuropsychology.
- Predictive utility of MMPI-2-RF in differentiating psychogenic non-epileptic events and epilepsy in a largely male veteran sample.
- SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt — Updated results.
[Oral Presentation]
- Cerebral oxygen delivery and dynamic autoregulation are maintained following 60 days strict head down tilt.
- Saccade metrics and visual reaction times are not negatively affected by head down tilt bedrest with or without artificial gravity.
- Effects of repetitive, successive oculometric testing on saccades, smooth pursuit, and visual reaction times for future head down tilt bed rest study applications.
- MRI-based quantification of posterior globe flattening in head-down tilt bedrest subjects, and the effect of centrifugation.
- Fluid shifts during short-arm centrifugation: The AGBRESA Study (SPACE-CENT).
- Hemodynamic fluid shifts during orthostatic tilt — Can NIRS detect impending pre-syncope? The AGBRESA Study (SPACE-CENT).
- Brain related assessments for investigating the neurophysiology of SANS (BRAIN-SANS).
- Zero G and ICP: Invasive and non-invasive ICP monitoring and SANS biomarker identification.
- Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
- A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.
- Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naive subjects: Results from a phase III study.
Institute of Electrical and Electronics Engineers (IEEE)
2021 IEEE 18th India Council International Conference (INDICON) in Guwahati, India (Dec. 19-21, 2021)
Baylor College of Medicine (BCM)
Virtual Neuropsychology Grand Rounds in Houston, Texas (Dec. 9, 2021)
American Epilepsy Society (AES)
75th Annual Meeting in Chicago, Ill. (Dec. 3-7, 2021)
Society of Neuro-Oncology (SNO)
26th Annual Scientific Meeting and Education Day in Boston, Mass. (Nov. 18-21, 2021)
Society of Vascular and Interventional Neurology (SVIN)
Hybrid Annual Meeting in Phoenix, Ariz. (Nov. 17-20, 2021)
Society for Neuroscience (SFN)
Virtual Annual Meeting (Nov. 8-11, 2021)
Association of American Medical Colleges (AAMC)
Learn Serve Lead 2021: The Virtual Experience (Nov. 8-10, 2021)
Gordon Research Conferences (GRC)
Cannabinoid Function in the CNS Conference in Ventura, Calif. (Nov. 6-7, 2021)
Neurocritical Care Society (NCS)
19th Annual Meeting in Chicago, Ill. (Oct. 26-29, 2021)
American Neurological Association (ANA)
146th Annual Virtual Meeting (Oct. 14-19, 2021)
Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 17-22, 2021)
17th International Conference of Computational Methods in Sciences and Engineering (ICCMSE)
Crete, Greece (Sept. 4-7, 2021)
2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)
Society of NeuroInterventional Surgery (SNIS)
18th Annual Meeting in Colorado Springs, Colo. (July 26-29, 2021)
Human Brain Project (HBP)
Brain Initiative Meeting (virtual) (June 15-17, 2021)
American Academy of Clinical Neuropsychology (AACN)
Virtual 19th Annual Meeting (June 9-12, 2021)
Baylor College of Medicine (BCM)
4th Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (May 20, 2021)
Professional Society for Health Economics and Outcomes Research (ISPOR)
Virtual 2021 Annual Meeting (May 17-20, 2021)
Association for Research in Vision and Ophthalmology (ARVO)
Virtual 2021 Annual Meeting (May 1-7, 2021)
American Academy of Neurology (AAN)
Virtual 2021 Annual Meeting (April 17-22, 2021)
Baylor College of Medicine (BCM)
Henry J.N. Taub and James K. Alexander Medical Student Research Symposium in Houston, Texas (March 25, 2021)
American Stroke Association
Virtual 2021 International Stroke Conference (March 17-19, 2021)
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Virtual 2021 Annual Meeting (Feb. 25-27, 2021)
Texas Scottish Rite Hospital for Children
43rd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 18-19, 2021)
American Clinical Neurophysiology Society (ACNS)
Virtual 2021 Annual Meeting (Feb. 10-14, 2021)
International Neuropsychological Society (INS)
Virtual 49th Annual Meeting (Feb. 2-5, 2021)
National Aeronautics and Space Administration (NASA)
Virtual 2021 Human Research Program Investigators' Workshop (Feb. 1-3, 2021)
International Neurotoxin Association (INA)
Virtual Conference (Jan. 16-17, 2021)
<2020
- Actigraphic correlates of disability in patients with focal epilepsy.
- Machine learning can model visual EEG analysis for epileptic and non-epileptic seizure classification.
- EEG education in neurology residency &emdash; EEG knowledge before and after lecture-based didactics.
- Outpatient smartphone video prediction of epileptic vs. non-epileptic seizures in U.S. veterans.
- Epileptic encephalopathy in KCNA1 KO mice disrupts active state organization.
- Deficits in 5-HT2C receptor signaling coordinately impact seizure risk and behavioral activity.
- On the digital psychopharmacology of valproic acid in mice: Adult and prenatal exposure.
- Neuromonitoring at the height of a pandemic: EEG findings in patients with COVID-19.
- Right-lateralized posterior parietal theta-gamma coupling during sustained attention in mice.
- IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
- Predictors of functional outcome in post-mechanical thrombectomy patients.
- Clinical description of post-mechanical thrombectomy patients treated at a comprehensive stroke center.
- Cell count ratios as outcome predictors in acute ischemic stroke patients treated with mechanical thrombectomy.
- Functional outcome in very elderly acute ischemic stroke patients after IV thrombolysis: Single center experience.
- Reducing door-to-needle times for acute ischemic stroke in a public hospital in Costa Rica.
- Pulse pressure variability is associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial.
- Response to thrombolysis in Costa Rican patients compared with NINDS and CLOTBUST-ER cohorts.
- Moderators of the efficacy of sonothrombolysis in acute ischaemic stroke patients with large vessel occlusion: A systematic review and international collaborative individual patient data meta-analysis.
- Blood pressure excursions are associated with unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis in a phase III randomized-controlled clinical trial.
- Disparities in global cognition between lower and higher SES older adults.
- Long-term effects of daily sensory neuromodulation on gait function in persons with peripheral neuropathy using a wearable neuroprosthesis.
- Epileptic encephalopathy in Kcna1 KO mice disrupts active state organization.
- Neurosarcoidosis related vision loss mimicking idiopathic intracranial hypertension.
- Variations in regional and hospital level factors in relation to clinical outcomes of subarachnoid hemorrhage in the United States.
- Clinically measured scalp EEG activity and detection of cortical spreading depolarizations.
- Is door-to-needle time an adequate surrogate in predicting function outcome after IV thrombolysis in acute ischemic stroke?
- Predictors of functional outcome in patients with acute ischemic stroke treated with IV thrombolysis, in a public hospital in Costa Rica.
- Early systolic blood pressure variability and hyponatremia are associated with cerebral vasospasm in aSAH patients.
- Early systolic blood pressure variability is associated with a poor neurological outcome at discharge in aSAH patients.
- Positive fluid balance during NICU stay is associated with decreased survival after aSAH.
- Goal attainment measures for stroke survivors self-management support interventions: A systematic review.
[Invited Presentation]
- Comparative treatment effectiveness of oral fingolimod and injectable disease modifying agents in multiple sclerosis.
- Impulsivity in cerebellar ataxias: Testing the cerebellar reward hypothesis in humans.
[Previously Presented]
- Cognitive differences between men and women with progressive supranuclear palsy.
- Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: Results from a Phase III study.
- Is chronotype a biomarker for depression in military veterans with Parkinson's disease?
- Use of botulinum toxin: Experience in a cohort of essential tremor patients.
- Socio-demographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS registry).
- US-POINTER (USA).
[Platform Presentation]
- A consensus proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
- Different profiles of cognitive deficits predict progression rate in probable AD.
- Neuropsychological assessment for primarily Portuguese-speaking Brazilians living in the United States.
- Working with culturally diverse populations: Development of a Farsi-speaking battery.
- Comparative adherence trajectories of oral fingolimod and injectable disease modifying agents in multiple sclerosis.
- Factors associated with prescribing of oral fingolimod in multiple sclerosis.
- Neurological symptoms in patients with zinc deficiency: A case series with documented blood levels.
- Impulsivity in cerebellar ataxias: Testing the cerebellar reward hypothesis in humans.
- Clinical and neuropsychological correlates of the TETRAS score in DBS patients.
- Evaluation of the association between the age of onset and duration of epilepsy, and the neuropsychological and developmental performance, in patients with refractory epilepsy, at the Costa Rica National Children's Hospital Epilepsy Monitoring Unit: a 13-year hospital-based retrospective cohort.
- Postpartum relapse after first on-study pregnancy in RRMS patients treated with alemtuzumab in the phase 2 and 3 clinical development program over 8 years.
- The use of dual therapy vs. triple therapy in patients with atrial fibrillation and acute coronary syndrome: A network meta-analysis of randomized clinical trials.
- Inpatient complications and mortality of stroke in Costa Rica: A seven-year hospital-based acute stroke registry of 1319 patients.
- Utilization of systematic safety checklists to improve length-of-stay, infection rates, preventable complications and mortality at the Neurointensive Care Unit of the Baylor Saint Luke's Medical Center: A quality improvement study.
- Improving learning with a neurology question of the day.
- Addressing challenges of clinical comprehensive genetic testing in Parkinson's disease.
- Treatment strategies for glioblastoma in older patients: Age is just a number.
- Examining the impact of isocitrate dehydrogenase (IDH) gene status on the development of venous thromboembolism in glioma patients.
- EEG education in neurology residency &emdash; Baseline EEG knowledge and resident perception.
- A wearable sensory neuroprosthesis to improve gait and balance function in persons with sensory peripheral neuropathy &emdash; the walk2Wellness Trial .
- Treatment patterns in patients with essential tremor.
- Multiple watershed infarcts confirming the existence of a vascular steal phenomenon established around a brain arteriovenous malformation.
- Synergistic impact of pain interference and depression on quality of life and function of the stroke patients.
- Integrating service learning opportunities into traditional geropsychology curriculum.
- Sjogren's associated with inclusion body myositis.
- Post-acute stroke experience survey: Development and pilot testing.
- Cerebellar infarction presentations: A population-based study from the Greater Cincinnati/Northern Kentucky Stroke Study.
- Behavioral change intervention and predictors of self-management blood pressure control in underserved post-stroke population.
- No improvement in emergency medical services use by stroke patients from 1999-2015: A population-based study.
- High accuracy of predictive models for SAH using different machine learning approaches.
- Diffusion weighted imaging lesions in patients with acute intracerebral hemorrhage: A pooled analysis of individual patient data from MISTIE-III, ATACH-II, I-DEF, and ERICH.
- Safety and efficacy of sonothrombolysis in acute ischemic stroke patients with large vessel occlusion: International collaborative individual patient data meta-analysis.
- Self-reported sleep quality and cortical thickness at 3-months post-mild traumatic brain injury.
- Predictive utility of MMPI-2-RF in differentiating psychogenic non-epileptic events and epilepsy in a largely male Veteran sample.
- Neuropsychological and non-motor assessment baseline characteristics of the RAD-PD cohort.
- Addressing health disparities in specialty care: Strutt MacDonald Service Model for Equitable Healthcare.
[Platform Presentation]
- SPACE-CENT: Studying the physiological and anatomical effects of centrifugation and head down tilt - preliminary results.
[Platform Presentation]
- Intracranial effects of artificial gravity: A flow study at 3T.
[Platform Presentation]
- Optic disc edema develops during bed rest in subjects not exposed to elevated ambient CO2.
[Platform Presentation]
- Successful implementation of oculometric assessment during head down tilt bed rest: Technical considerations.
- Evolution of eye examinations during bed rest studies: Maintaining ocular health in space and on Earth.
- Changes in refraction during 60 days of -6° headdown tilt bed rest.
[Platform Presentation]
- Physiological monitoring of fluid shifts during orthostatic tilt.
[Platform Presentation]
- Zero G and ICP: Invasive and noninvasive ICP monitoring and sans biomarker identification.
- High yield of screening for ADHD in the epilepsy monitoring unit.
- KB-3061 is a potent activator of wild type KCNQ channels and restores current to KCNQ2 encephalopathy variants in vitro.
- Mice lacking 5-HT2C receptors have a lowered spreading depolarization threshold compared to wildtype littermates.
- Local disinhibition via tetanus toxin injection reshapes neural activity and EEG patterns in mouse neocortex.
- 17th Annual Judith Hoyer Lecture in Epilepsy: Advances in diagnosis and management of neonatal seizures.
[Invited Lecture]
- Arx mouse model of x-linked infantile spasms shows augmented wave of early cortical apoptosis without evidence of cellular inflammation.
- Pregnancy-related complications and risk of post-partum readmission for seizures.
- Posterior parietal theta-gamma phase-amplitude coupling as a biomarker for sustained attention in mice.
- Radiology 101 for nurses and respiratory therapists.
- How to prevent older adults from falling? Effectiveness of technological innovations and clinical approaches.
- Neurodegenerative disease NG and geriatric rehabilitation NG mentorship round table discussion.
- Patient engagement approaches for improving research and clinical care in Parkinson's disease.
- Cav3.1 and 3.2 T-type Ca2+ channels collectively contribute to oscillatory excitation of nucleus ambiguus neurons.
- A genetic cross between Gad2-Cre and loxTB Htr2c mouse strains does not prevent seizures and death in a 5-HT2C-null SUDEP mouse model.
- Progression of cortical hypersynchrony and epileptogenesis induced by brain tumors.
[Platform Presentation]
- Mice with adult-onset P/Q calcium channel deletion recapitulates childhood absence epilepsy.
- Investigating the role of CD2AP, an Alzheimer's disease susceptibility gene, in mammalian synaptic structure and function.
- Nodes of DMN involved in general intelligence.
- Incorporation of electrodiagnostic case reviews to the morning report in a neurology residency program.
- Characteristics of Patients with Deep Venous Thrombosis after Intracerebral Hemorrhage.
- Rates of Infections and Clinical Outcomes after Intracerebral Hemorrhage.
- Low serum calcium levels are associated with a worse clinical outcome in ICH.
- Clinical seizures associated with a worse clinical outcome at hospital discharge in ICH patients.
- Clinical seizures associated with a worse clinical outcomes at hospital discharge in aSAH patients.
- Factors Affecting the Development of Acute Renal Failure after Intracerebral Hemorrhage.
- A multimodal non-invasive approach for intracranial hypertension detection: A single-center prospective study.
- A consensus Alzheimer's disease brain protein co-expression network identifies robust biological alterations associated with early- and late-stage disease.
- Biological alterations associated with early- and late-stage disease.
- Parkinson's disease susceptibility in carriers of lysosomal storage disorder genes.
- Progressive autoimmune cerebellar degeneration in a young healthy man: Not your typical vertigo.
- Norovirus: An unusual case of infantile encephalopathy and status epilepticus.
- Posterior parietal theta-gamma phase-amplitude coupling as a biomarker for sustained attention in mice.
- The influence of sociodemographic factors on post-DBS impulse control symptom severity in Parkinson's disease.
- Age of onset and diagnosis of essential tremor.
- Design and implementation of a quality improvement registry for DBS in Parkinson's disease.
- Is sleep disordered breathing a risk factor for REM sleep behavior disorder in military Veterans with Parkinson's disease?
- Neuropsychiatric symptoms over the initial lustrum of Parkinson disease: Common, increasing, comorbid and varied.
- Tool that measures goal attainment in management of stroke risk factors.
- Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer's disease.
- Functional dissection of an Alzheimer's disease susceptibility gene network.
- Functional dissection of Alzheimer's disease brain gene expression signatures in humans and mouse models.
- Cholinesterase inhibitors have a disease modifying effect in AD relative to CHRFAM7A genotype suggesting an a7NAChR dependent mechanism.
- Recruitment of interneuron classes during spontaneous behavior: CCK cells fill the gaps.
[Oral Presentation]
- Temporal dichotomy of the activity of parvalbumin- and cholecystokinin-containing hippocampal interneurons during locomotion and immobility.
- Spanish/cross-cultural fellowship in neuropsychology: A response to the needs of the Houston Hispanic community.
- Developing culturally competent foreign language neuropsychological assessments: Vietnamese-speaking patients with suspected dementia.
- Geopolitical considerations of working with medically complex patients: An Urdu speaking case illustration.
- CCACTUS - Cross-cultural consortium on aging and cognition in Texas, U.S.: The development of a neuropsychology data repository.
- BCM Cerebro: Neuropsychology outpatient clinic specializing in the care of Spanish-speakers.
- Development of a cross cultural neuropsychology outpatient clinic at Baylor College of Medicine.
- The evaluation of non-motor symptoms in the registry for DBS in Parkinson's disease (RAD-PD).
- Patient engagement in the development of OUR DBS: A global patient registry addressing outcomes and unanswered questions for DBS.
- Endovascular equipoise shift during a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke.
- Constitution (Prakriti) as defined by traditional Indian medicine is a risk factor for stroke.
- Machine learning to predict subarachnoid hemorrhage outcomes.
- Factors associated with prescribing of oral disease modifying agents in multiple sclerosis.
- Healthcare expenditure burden in multiple sclerosis: Marginal costs based on national level data.
- Conditioned fear extinction, neuropsychological, and psychological aspects of OCD in Latinos.
- Symptomatic cerebrovascular manifestations as presenting symptom for neurosarcoidosis.
- Genome-wide association study meta-analysis for Parkinson disease motor subtypes.
[Platform Presentation]
- Leprosy in two patients with relapsing remitting multiple sclerosis (RRMS) treated with fingolimod.
- Immunogenicity of daxibotulinumtoxinA for injection in adults with cervical dystonia from a phase 2 dose-escalation multicenter study.
- When Occam's razor fails: A McArdle disease diagnosis following idiopathic transverse myelitis.
- RECLAIM-DCP: A randomized, double-blind, placebo-controlled study of deutetrabenazine for the treatment of dyskinesia in cerebral palsy in children and adolescents.
- Fingolimod related cryptococcal meningitis and immune reconstitution inflammatory syndrome in two patients with multiple sclerosis.
- Student satisfaction and NBME outcomes with team based learning on the neurology clerkship, a pilot study.
- A case of hepatocellular carcinoma presenting with myasthenia gravis.
- Capturing Parkinson's disease heterogeneity with quantitative mobility measures.
[Platform Presentation]
- Vitamin D assessment in veterans with Parkinson's disease.
- Using a quality improvement framework to examine deep brain stimulation in Parkinson's disease: The RAD-PD initiative.
- Consistently large amyloid reductions in patients with and without ARIA-E in the gantenerumab SCarlet RoAD and Marguerite RoAD open-label extension studies.
[Platform Presentation]
- Bradykinesia, mitochondrial myopathy and progressive ophthalmoplegia associated with a novel DNM1L mutation.
- The potential role of estrogen in moderating symptom severity in women with RYR1-related myopathy.
- Baseline characteristics from a phase III trial of crenezumab in early (prodromal-to-mild) Alzheimer's disease (CREAD).
- Anti-GAD65 antibody: A possible link to encephalopathy, aphasia, seizures and lateralized weakness.
- Feasibility of virtual reality-based video-oculography to detect neurologic deterioration in the intensive care unit.
- Design and implementation of a quality improvement registry for DBS in Parkinson's disease.
- Temporal trends in mortality in an AD clinical cohort.
- Substantia nigra hyperintensities leads to diagnosis of Leber's hereditary optic neuropathy.
- Nuclear gene mutation producing muscle weakness.
[Oral Presentation]
- Cognition and psychological symptomatology in Tourette's syndrome following deep brain stimulation.
- Cognitive and neuropsychiatric correlates of impulse control disorder symptom severity in Parkinson's disease.
- An examination of the relationship between frustration tolerance and objective executive function performance in a weight loss sample.
- Mobile health (mHealth) for secondary stroke prevention is feasible and effective.
- Effects of VA National Telestroke Program implementation training.
- Racial differences in left atrial size among patients with ischemic stroke.
- Racial differences in left atrial size among patients with ischemic stroke.
- The Goal Attainment Measure (GAM-S) for Secondary Stroke Risk Factors Management: Pilot test and psychometric analysis.
- Stroke in the young: preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
- Preliminary population-based temporal trends in stroke incidence: Racial disparity and stroke incidence from 1993-2015.
- Patient perceptions of remotely delivered acute stroke care.
- Development of outcome models for intracerebral hemorrhage using patient level data from ATACH-II and information theory to identify the best predictors.
- Veterans Administration National Telestroke Program: A distributed hub system of acute stroke care.
- Race and gender differences in mortality due to spontaneous subarachnoid hemorrhage.
- Predictors of neurological worsening among patients presenting with large vessel occlusions and mild symptoms.
- Regional variability in the care of subarachnoid hemorrhage (SAH) patients in the United States.
- Frequent flyers: Retrospective review of repeat stroke codes.
- Implementation of informal caregiver and veteran dyadic intervention: Acquiring new skills while enhancing remaining strengths.
- Effective communication and engagement cultivates teamwork among virtual telestroke providers.
- SPACE-CENT: studying the physiological and anatomical effects of centrifugation and head down tilt.
- Physiological monitoring of fluid shifts during centrifugation.
- Zero G and ICP: invasive and noninvasive ICP monitoring and SANS biomarker identification.
- The use of biofluids for biomarker discovery in SANS: RNAseq expression analysis on pilot ground biofluid samples.
- Tau loss modifies network excitability in brain tumor-related epilepsy.
- Functional involvement of periventricular nodular heterotopia.
- An objective description of PTZ kindling in a standardized instrumented home cage environment.
- Home cage monitoring reveals the presence of comorbid depression-related behavior in mice with deletions of Kcna1.
- Mice lacking 5-HT2C receptors display a novel adult-onset SUDEP phenotype and increased mortality in males.
- Conditional deletion of PQ-type calcium channels in kainate receptor4 (Grik4)-expressing hippocampal neurons leads to adult onset absence epilepsy.
- Pharmacodynamic dependence of retigabine on Kcnq2 expression in PV+ interneurons.
- Effect of health disparities on overall survival of patients with glioblastoma.
- Real world experience with novel VMAT2 inhibitors.
- Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
- Interictal dentate gyrus hyperexcitation in a mouse model of Dravet syndrome.
- Dysregulation of mTORC2, but not mTORC1, underlies the neurophysiological and behavior abnormalities in Pten-deficient mouse model of ASD and epilepsy.
- Tau loss modifies network excitability in brain tumor related epilepsy.
- β-spectrins maintain Na+ channels at axon initial segments and nodes of Ranvier.
- Sex specific Alzheimer's disease heterogeneity identified through cross study integrative analysis of RNA-seq data from the AMP-AD consortium.
- T-type calcium channel bursting in thalamic association pathways precedes sensory pathways and can be activated by GABAergic input during early postnatal development.
- cindr, the Drosophila homolog of CD2AP, plays a conserved role in synapse function and protein turnover.
- Deletion of KCNQ2/3 potassium channels from PV+ interneurons leads to homeostatic potentiation of excitatory transmission.
- A druggable genome screen identifies modifiers of α-synuclein levels via a tiered cross-species validation approach.
- Missense epilepsy mutations in neuronal KCNQ/Kv7 channels occur at hotspots within highly conserved functional domains of Kv7.2 and Kv7.3.
- Disseminated mycobacterium avium-intracellulare presenting with multiple cranial neuropathies.
- Constitution (Prakriti) as defined by traditional Indian medicine is a risk factor for stroke.
- Validation of the Triple Timed Up-and-Go Test for clinical assessment in Lambert-Eaton myasthenia patients.
- Improvement in patient perceived quality of life with daxibotulinumtoxinA for injection in adults with cervical dystonia.
- Predictors of alcohol responsiveness in dystonia.
- Consensus for the measurement of the camptocormia angle.
- Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease.
- Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson's disease?
- Accuracy of the International Parkinson Disease and Movement Disorder Society progressive supranuclear palsy diagnostic criteria (IPD-MDS-PSP).
- Genome-wide association study identifies common genetic variants associated with cervical dystonia.
- Erotophonophilia and severe impulse control disorder in a patient with Parkinson's disease.
- Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults.
- Loss of VPS29 disrupts retromer function and synaptic transmission, leading to neurodegeneration in Drosophila.
- Rates of reintubation in neurocritical care.
- Stroke without borders.
[Symposium]
- Hyponatremia precedes vasospasm after subarachnoid hemorrhage.
- Incidence of acute renal failure in patients with intracerebral hemorrhage.
- Full dose thrombolysis for a right middle cerebral artery stroke after an acute aortic dissection.
- Neuro-ECMO: Extracorporeal membrane oxygenation and cerebral blood flow.
- Seizure induced Takotsubo cardiomyopathy.
- Cerebral air embolism associated with transcatheter aortic valve replacement.
- Foster Kennedy syndrome secondary to cerebral fungal abscess in an immunocompetent patient.
- Renal injury in acute intracerebral hemorrhage.
- Wide variability of intracranial pressures measured in ventricular and parenchymal compartments warrant the use of separate terminology: A systematic review.
- Moral injury in relational context: Future directions in treatment model and intervention strategy.
- Update on the safety and tolerability of gantenerumab in the ongoing open-label extension (OLE) of the Marguerite Road Study in patients with mild Alzheimer's disease (AD) after approximately two years of study duration.
- Update on the safety and tolerability of gantenerumab in the ongoing open-label extension of the Scarlet Road Study in patients with prodromal Alzheimer's disease after approximately two years of study duration.
- Concord-AD: An international network of cohorts for better understanding of Alzheimer's disease.
- Twenty-four month amyloid PET results of the gantenerumab high dose open label extension studies.
- Baseline characteristics from a phase 3 trial of crenezumab in prodromal to mild Alzheimer's disease (CREAD).
- Cindr, the Drosophila homolog of CD2AP, affects synapse function and protein turnover.
- Twenty year trends in proportional mortality in a probable AD cohort.
- The effect of low doses of gantenerumab on amyloid and tau biomarkers in cerebrospinal fluid (CSF) in the Marguerite Road Study.
- Telestroke paradigms: What works and what doesn't.
[Symposium]
- IV tPA or not before thrombectomy for LVO?
[Symposium]
- Challenges in stroke certification: The process and recertification.
[Symposium]
- The grey matter of G: The structural neural correlates of general intelligence.
- Developing a comprehensive quality improvement registry for DBS in Parkinson's disease.
- Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma.
- Does random LDL accurately guide statin-based management compared to fasting LDL in patients with acute ischemic stroke or TIA.
- NIHSS is a better predictor of outcomes in ICH compared to GCS and hematoma volume. Information theory approaches applied to databases from India and U.S..
- Epidemiology of rural/urban stroke disparities in the Greater Cincinnati/Northern Kentucky Stroke Study.
- Serum anti-gliadin antibodies in cerebellar ataxias: A systematic review and meta-analysis.
[Previously Presented]
- Stand-alone ayurvedic treatment in acute ischaemic stroke: A pilot study.
- Telemedicine assessment of brain death examinations.
[Oral Presentation]
- Whole exome sequencing in essential tremor.
- Spectral analysis of dynamic functional connectivity between resting-state networks reveals information beyond static connectivity.
- TP73 is an amyotrophic lateral sclerosis candidate risk gene.
- Outcomes of week-24 completers and subjects who had follow-up beyond week 24 after a single treatment of daxibotulinumtoxinA for injection (RT002): Results of a phase 2, open-label (level II), dose escalating study in isolated cervical dystonia.
- RAD-PD: Registry for the advancement of DBS in Parkinson's disease.
- Higher dose gantenerumab leads to significant reduction in amyloid plaque burden - Results for the Marguerite and Scarlet Road open label extension studies.
- Why aren't you giving feedback?
- Weekly feedback comment card on neurology clerkship.
- Serum anti-gliadin antibodies in cerebellar ataxias: A systematic review and meta-analysis.
- Wernicke encephalopathy masquerading as a right middle cerebral artery territory infarction.
- Cervical dystonia and substance abuse.
- Effect of health disparities on overall survival of patients with glioblastoma.
- Unilateral versus bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.
[Platform Presentation]
- Spinal dural arteriovenous fistula and concomitant intramedullary spinal lesion.
- Phenomenology of leg stereotypy syndrome.
- Long-term outcomes of patients treated for idiopathic relapsing transverse myelitis.
- Is benign hereditary chorea really benign? Brain-lung-thyroid syndrome caused by NKX2-1 mutations.
- Validation of a pre-diagnostic progression rate used to predict post-diagnostic change on common Alzheimer's disease outcome measures.
- Integrated whole exome sequencing and chromosomal microarray in familial Parkinson's disease.
- Is excessive daytime sleepiness related to nocturnal sleep in Parkinson's disease?
- Levodopa induced dyskinesias in neurodegeneration with brain iron accumulation due to a heterozygous mutation in C19orf12.
- The danger of flying with acute otitis media, which may result in Gradenigo's syndrome.
- Impact of pre-existing dementia on intracerebral hemorrhage outcomes.
[Platform Presentation]
- Vision impairment and papilledema as the initial manifestation of neurosyphilis in a young immunocompetent patient.
- Evidence based treatments for anxiety in Puerto Rico after Hurricane María.
[Oral Presentation]
- Improving clinical outcomes in acutely ill neurology patients.
- Prevalence of undiagnosed risk factors in patients with first-ever ischemic stroke.
- Endovascular therapy eligibility in the advent of DAWN and DEFUSE-3 results.
- A nurse dyad model for collaborative action planning and goal attainment to support patient self-management of stroke risk factors.
- Potential impact of triage using non-contrast head CT and stroke severity on a regional stroke system of care: A population-based study.
- Acute ischemic stroke emergency department arrival times in the extended time window within a population.
- Sex differences in severity of stroke risk factors in the greater Cincinnati/northern Kentucky stroke study.
- Temporal trends of sex differences in transient ischemic attack incidence within a population.
- Prior antiplatelet use and baseline stroke severity: A population-based study.
- Systematic review identified some early phase promising therapeutics for subarachnoid hemorrhage.
[Oral Presentation]
- SPACE-CENT: Studying the physiological and anatomical cerebral effects of centrifugation and head down tilt.
- Quantitative magnetic resonance of cerebral blood flow hemodynamics in acute head down tilt.
- Assessment of artificial gravity as a countermeasure to cephalad fluid shifting.
- Mechanical countermeasures to cephalad fluid shifts.
[Oral Presentation]
- Zero G and ICP: Invasive and noninvasive ICP monitoring and VIIP biomarker identification.
- SANS/VIIP biomarker identification: RNA-SEQ technology and expression analysis on ground biofluid samples.
- Cognition — ayurveda and neuroimaging.
[Oral Presentation]
- Responsive neuro-stimulation (RNS) versus vagus nerve stimulation (VNS) in focal epilepsy.
- Tau loss modifies network excitability in glioma-associated epilepsy.
- Evidence for brainstem network disruption in focal epilepsy and sudden unexplained death in epilepsy: A first validation study.
- Kv7.2 as a therapeutic target in Dravet Syndrome.
- Autism with benzodiazepine-responsive electrical status epilepticus in sleep (ESES) caused by KCNQ3 gain-of-function variants.
- Infantile spasms: ACTH dose response relationships.
- mTORC2 dysfunction underlies the neuronal physiological and behavioral abnormalities in Pten-deficient mouse model of autism.
- Systems biology resource for Alzheimer's disease target prioritization: The AMP-AD Knowledge Portal.
- Tau-mediated disruption of the spliceosome in Alzheimer's disease models.
- Development of T-type calcium channel bursting in thalamic association pathway precedes sensory pathways.
- Adrenergic signaling promotes T-type Ca2+ channel mediated oscillatory discharges in nucleus ambiguus neurons.
- Outcomes of endovascular coiling versus surgical clipping of unruptured cerebral aneurysms in a large cohort.
- Executive function in adults with clinically significant weight loss via behavioral intervention.
- Education quality accounts for racial differences in executive function testing in weight management.
[Oral Presentation]
- No difference in decision making assessment by individuals maintaining or regaining weight loss.
- Comparison of performance-based and subjective reports of executive function in the context of weight management.
- Clinical utility of genetic testing in adults with epilepsy: 4-year experience of the Baylor Genetic Epilepsy Clinic.
- Review of GAD65 auto-antibodies in patients with ketosis prone diabetes and epilepsy (RAPIDE Study).
- Pulmonary embolism masquerading as ST elevations after spontaneous intracerebral hemorrhage.
- Causes of deterioration in neurological patients.
- Trends in refractory status epilepticus for adults in the United States.
- Rates of tract hemorrhages after external ventricular drain placement.
- Transcranial Doppler cerebral blood flow velocity characteristics in patients undergoing extracorporeal membrane oxygenation.
- Nonketotic hyperglycemia and unilateral neuro-imaging findings in the absence of a movement disorder.
- Identification of promising therapeutics for subarachnoid hemorrhage.
- A winter case of West Nile encephalitis with peculiar neuromuscular and neuroimaging findings.
- STORM super-resolution imaging of cannabinoid signaling.
[Oral Presentation]
- Eculizumab in refractory myasthenic crisis.
- Diurnal variation of potential ictal onsets detected by a responsive neurostimulation device.
- Classification of neonatal seizures: The results from a recent test of the ILAE commission on classification and terminology proposed neonatal seizure framework.
- Facing the invisible wounds of war: A holistic review of current moral injury research.
- Beyond combat veterans: Future directions in moral injury research with diverse populations.
- Predictors of atypical antipsychotic treatment in an AD clinical population.
- Cohort effects in progression rate in a clinical registry of Alzheimer's patients accrued from 1995-2010.
- Whole exome sequencing in essential tremor.
- Predictive ability of clinical timed tests for postural instability and gait difficulty in Parkinson's disease.
- A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
[Previously Presented]
- Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD probe study.
- Treatable rare movement disorders.
- A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome.
- Vitamin D and clinical phenotypes of Parkinson's disease in veterans.
- Results from a phase 1b multiple ascending-dose study of prx002, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson's disease.
- Leg stereotypy disorder: Phenomenology and prevalence.
- Emotion regulation and neuropsychological status in psychogenic subtypes.
- Hemidystonia associated with Alexander disease.
- Patient-reported overactive bladder in neuromyelitis optica spectrum disorder.
- Prevalence of self-reported sexual dysfunction in neuromyelitis optica spectrum disorder.
- Genetics, proteomics, metabolomics, and biomarkers unexpected conformational change of platelet glycoprotein IB (GPIB) receptor after rt-PA treatment of large vessel ischemic stroke.
- Intracerebral hemorrhage effect of untreated hypertension on in-hospital outcomes among intracerebral hemorrhage patients.
- SAH, aneurysms and vascular malformations identification of promising therapeutics for subarachnoid hemorrhage.
- Evaluating physiological, cognitive, and psychological measures in obsessive-compulsive disorder (OCD).
[Previously Presented]
- Improving health literacy in veterans with epilepsy.
- Oxidative toxicity and DNA damage in experimental hemorrhage models: targeting with a novel carbon nano-antioxidant.
[Oral Presentation]
- Testing treatments for intracranial hemorrhage compared to a pooled outcome model accounts for variability in baseline conditions and identifies potentially positive, neutral, and harmful interventions.
[Oral Presentation]
- Resumption of anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis.
- Primary angiitis of the central nervous system.
- Intrathecal NMDA receptor antibody reactivation due new ovarian teratoma in patient with previously resected ovarian teratoma for anti-NMDA receptor encephalitis.
- Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy.
- A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
- Mixed Curvularia and Klebsiella brain microabscesses in an immunocompromised patient.
- Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD Probe study.
- Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
[Platform Presentation]
- Presentation, diagnostic hurdles, and therapeutic measures in a case of isolated coccidioidomycosis meningitis in an immunocompetent individual.
- Leg discomfort and insomnia in Parkinson's disease.
- Discovery and systematic functional validation of Parkinson's disease genes from exome sequencing.
[Platform Presentation]
- Aphemia: A rare presentation of an acute infarct.
- Assessment of capacity to consent in a Huntington disease clinical trial: Implications for future clinical trial design in neurodegenerative disease populations.
- The predictability of smartphone video in distinguishing epileptic and nonepileptic seizures.
- Unexpected conformational change of platelet glycoprotein Ib (GPIb) receptor after rt-PA treatment of large vessel ischemic stroke.
- Incorporating biological variability in experimental stroke to better mimic human stroke.
- A novel catalytic antioxidant carbon nanoparticle improves outcome in hyperglycemic stroke in rats at clinically relevant recanalization times.
[Platform Presentation]
- Simulation training is a feasible implementation strategy for evidence based stroke swallowing screening.
- Ataxia: The first sign of breast cancer.
- Longitudinal cognitive asymmetry and decline in Alzheimer's disease patients.
- Performance on the Rey Auditory Verbal Learning Test (RAVLT) in neurologically intact Spanish-speaking older adults.
- Assessment of language fluency and confrontation naming in monolingual Spanish speaking older adults.
- A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
- Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: Results from the CD Probe study.
- Potential new uses of botulinum toxin injections in movement disorders.
- Predictors of onabotulinumtoxinA response in patients with cervical dystonia.
- Center for SUDEP Research: Brainstem atrophy in SUDEP.
- Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy.
- SUDEP rate in patients with medically intractable partial onset seizures treated with brain responsive neurostimulation.
- The role of tau in modulating hyper excitability in an emerging model of tumor associated epilepsy.
- Functional characterization of three de novo KCNQ2 encephalopathy variants in the pore helix and responses to SF0034 and ICA-069673.
- An informatics infrastructure for KCNQ2 encephalopathy research including a patient registry, database, curation platform, and website.
- Dynamics of gamma oscillations in a mouse model of absence epilepsy.
- Clinical utility of genetic testing in adults with epilepsy: Pilot experience of the Baylor genetic epilepsy clinic.
- Asynchronous suppression of superficial cortex during absence seizures.
[Platform Presentation]
- A survey of neurophysiology fellows in the United States.
- A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.
- Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
- Genotype-phenotype relationships In KCNQ2 related epilepsy and encephalopathy caused by variants in the pore region.
- Characterization of a polysynaptic microcircuit involved in sensory vagal afferent activation of dorsomotor vagal neurons in mouse.
- Effects of tau peptide aggregation inhibitor in human tau transgenic models.
- The role of tau in modulating hyper-excitability in an emerging model of tumor associated epilepsy.
- αII-spectrin-dependent cytoskeletons are essential for axon function, domain assembly and integrity.
- Early development of thalamic low-threshold T-type calcium current in the VPM of C57BL/6 mice.
- A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.
- Prevalence and character of severe epileptic encephalopathy in patients affected by MECP2 duplication syndrome.
- Dynamic participation patterns of superficial cortex during absence seizures.
- Hypothyroidism presenting with dysarthria and intermittent weakness of the extremities.
- Bilateral recurrent artery of Heubner infarction after extensive resection of a large olfactory groove meningioma.
- CNS post-transplant lymphoproliferative disorder presenting as de novo status epilepticus: Case report.
- Intravenous rt-PA use prior to endovascular thrombectomy increases probability of good outcome in acute ischemic stroke.
- Modeling outcome after intracerebral hemorrhage indicates no benefit and potential harm from aggressive blood pressure management.
[Platform Presentation]
- Novel noninvasive detection of increased intracranial blood volume induced by head-down tilt using volumetric induction phase-shift spectroscopy (VIPS).
- Chronic endurance exercise training in a mouse model of myotonic dystrophy type 1.
- Oculomotor and masticator muscle enhancement in a case of multiple cranial nerve palsies and internuclear ophthalmoplegia associated with herpes simplex virus infection.
- Evaluating physiological, cognitive, and psychological measures in obsessive-compulsive disorder (OCD).
- Advancing therapeutics for neuroinflammation in Alzheimer's disease: Clinical development considerations.
- Polysynaptic activation of dorsomotor vagal neurons by sensory afferent nerve.
- Evaluation of a non-invasive intracranial pressure meter (Vittamed) for spaceflight.
- Cerebrovascular and intracranial effects of 12 degree head-down tilt and hypercapnia: A preliminary study using phase-contrast, volumetric and diffusion tensor MR imaging.
- Cerebral blood pulsatility during head-down tilt and CO2 exposure.
- Understanding, predicting, and preventing falls in progressive supranuclear palsy.
- Objectives of the MDS rare movement disorders study group.
- A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.
- Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia.
- Apraclonidine in blepharospasm.
- Apraclonidine in the treatment of ptosis.
- Ayurvedic constitution type and disease susceptibility.
[Oral Presentation]
- Prevalence of dysphagia in multiple sclerosis and correlation with disability.
[Platform Presentation]
- Five-year outcomes of HALT-MS: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe relapsing-remitting multiple sclerosis.
[Platform Presentation]
- Irreversible electroporation-induced sciatic neuropathy observed with intraoperative somatosensory evoked potential monitoring.
- Sporadic Creutzfeldt-Jakob disease presenting as non-convulsive status epilepticus: A case report.
- Time-dependence of graph theory metrics in functional connectivity analysis.
- Pre-surgical PET mapping predicts surgical outcome after anterior temporal lobectomy.
- A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.
- Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.
- Stroke incidence rates in a biracial metropolitan population: The importance of county-level data.
- Impact of IDH-1 mutation status on outcome in clinical trials for recurrent glioblastoma.
- Severe epileptic encephalopathy is a frequent neurological comorbidity of children affected by the MECP2 duplication syndrome.
[Oral Presentation]
- Safety profile of unblinded internal pallidal deep brain stimulation for medically refractory Tourette syndrome.
- A case of neurosarcoidosis masquerading as subacute inflammatory demylelinating polyneuropathy.
- Chronotypes, nocturnal melatonin level and excessive daytime sleepiness in Parkinson's disease (PD).
- Reasons for prolonged length of stay in the epilepsy monitoring unit.
- Rare and fulminant presentation of adult Moyamoya disease: A case report.
- PRISM II: Effectiveness of dextromethorphan 20 mg/quinidine 10 mg (Nuedexta®) for treatment of pseudobulbar affect secondary to dementia, stroke, or traumatic brain injury: Combined results of a multicenter open-label study.
- Paradoxical worsening dystonia after deep brain stimulation in a patient with neurodegeneration with brain iron accumulation.
- Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.
[Oral Presentation]
- Randomized, double-blind, placebo-controlled studies to evaluate treatment with aducanumab (BIIB037) in patients with early Alzheimer's disease: Phase 3 study design.
[Oral Presentation]
- Comparing two 123I-Ioflupane SPECT processing methods for determination of basal ganglia volumes in patients with parkinsonian-like features.
- Admission systemic inflammatory response syndrome and outcome following intracerebral hemorrhage in a multicenter study.
- Predictors of in-hospital speech therapy referral in aphasic acute ischemic stroke patients within a population.
- Degree of functional independence after an ischemic stroke affects quality of life similarly in men and women.
- Bacterial endocarditis and acute stroke: A population-based study.
- Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.
- A projection of endovascular therapy eligibility in the United States: A population-based analysis.
- Incidence and temporal trends in in-hospital stroke: A preliminary analysis from the Greater Cincinnati/Northern Kentucky Stroke Study.
- A retrospective comparison of medical eligibility for acute ischemic stroke clinical trials compared with hospital enrollment rates: Greater Cincinnati/Northern Kentucky Population.
- Stroke incidence in the Greater Cincinnati/Northern Kentucky Stroke Study is decreasing significantly in men but not women.
[Oral Presentation]
- Factors influencing differential outcomes in stent retriever trials: Comparison to a new outcome model based on percent utilization of rt-PA.
- Analysis of outcomes from the endovascular treatment of posterior circulation strokes in the modern era of stent retriever thrombectomy.
- Selective serotonin reuptake inhibitors and risk of intracerebral hemorrhage.
[Oral Presentation]
- The impact of specific neuroanatomical location in deep supratentorial intracerebral hemorrhage (ICH): Findings from the ethnic/racial variations of ICH study.
- Association of ischemic stroke location and demographic variables with percutaneous endoscopic gastrostomy placement.
[Oral Presentation]
- Prevalence of positive troponins and association with abnormal echocardiograms in acute ischemic stroke.
- Impact of metformin on survival following ischemic stroke in patients with diabetes: The Greater Cincinnati Northern/Kentucky Stroke Study (GCNKSS).
- Dementia treatment was associated with reduced risk of intacerebral hemorrhage.
- SPACE-COT: Studying the physiological and anatomical cerebral effects of carbon dioxide and head down tilt: An international collaborative project with the German Aerospace Center (DLR).
[Oral Presentation]
- Vittamed intracranial pressure device evaluation study: Final results.
[Oral Presentation]
- Testing mechanical countermeasures for cephalad fluid shifts.
- Psychogenic urinary retention associated with head down tilt bed rest: A rare medical complication.
- Effects of head down tilt with or without 0.5% CO2 on intracranial and intraocular pressure: results from the SPACE-COT study.
- Effects of head down tilt on internal jugular vein volume: Preliminary results from the SPACE-COT study.
- Effects of head down tilt on intracranial blood volume: Preliminary results from the SPACE-COT study.
- Zero-G and ICP: Invasive and noninvasive ICP monitoring of astronauts on the ISS & multimodal modeling towards noninvasive assessment of ICP in weightlessness and biomarker identification of predisposition to VIIP syndrome.
- Brain gene expression signatures from cerebrospinal fluid exosome RNA profiling.
- Comparative patient satisfaction and efficacy of a Parkinson's Disease Enrichment Program (PEP).
- Deep brain stimulation (DBS) for treatment of therapy-refractory obsessive compulsive disorder (OCD): A case study highlighting neurocognitive and psychiatric changes.
- Errors on the first 10 items of the Test of Memory Malingering predicts failure on later trials of the Test of Memory Malingering.
- Performance validity in deep brain stimulation candidates.
- Cognitive, somatic, and emotional changes in patients with mild traumatic brain injury (mTBI) and orthopedic injuries at baseline and three months post-injury.
- Logopenic progressive aphasia in patient with meningioma: Neuropsychological evaluations over time.
- Stand-alone ayurvedic treatment in acute ischemic stroke.
[Oral Presentation]
- Leaky ryanodine receptor-2 mutation lowers threshold for hypoxic spreading depolarization.
- Time-dependence of graph theory metrics in functional connectivity analysis.
- An international, curated KCNQ2 registry, database and website.
- KCNQ2 encephalopathy: Novel single amino acid deletion variants strongly suppress currents and are responsive to SF0034.
- Interictal relative gamma power as a biomarker for anti-epileptic drug response in absence epilepsy.
- MECP2 duplication is associated with severe epileptic encephalopathy in the presence of permissive genetic background.
- KCNQ2 p.Arg198Gln, a gain-of-function variant presenting recurrently as West syndrome without preceding neonatal seizures.
- Novel clinical features of KCNQ2 encephalopathy associated with the gain-of-function variant, R201C.
- A critical developmental window for 17β-estradiol anti-epileptogenic effect in a mouse model of x-linked infantile spasms.
- Pharmacological rescue of KCNQ2 channels carrying early-onset epileptic encephalopathy mutations.
- Electrographic seizure detection and effectiveness of responsive neurostimulation in periventricular nodular heterotopias.
- Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.
- Physician trust in older adults with diabetes.
- Unusual presentation of reversible vasoconstriction syndrome in post-partum woman.
- Results from the DAPPER study: Inpatient double-blind, placebo-controlled withdrawal study of 3,4-diaminopyridine base (3,4-DAP) in subjects with Lambert-Eaton myasthenic syndrome.
- A rare heteroplasmic tRNALeu(CUN) mutation presenting with refractory seizures and myopathy.
- Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
[Previously Presented]
- Teaching mental health in middle schools: Two initiatives targeting students in two urban middle schools.
- Ethics, professionalism and health policy program (EP3): Creating a longitudinal curriculum linked to ACGME milestones in training.
- Cardiac arrhythmogenic leaky ryanodine receptor 2 mutation increases cortical excitability and lowers threshold for spreading depolarization in mouse brain.
- Excessive Ras-MAPK-dependent synaptic clustering drives enhanced motor learning in the MECP2-duplication mouse model of syndromic autism.
- Characteristics of seizure termination in primary and secondarily generalized seizures.
- Validation of olfactory identification deficit as a biomarker of Alzheimer's disease.
- Population receptive field changes in hV5/MT+ of healthy subjects with simulated visual field scotomas.
- Successful thrombectomy in a 10 year-old boy with restrictive cardiomyopathy after cardioembolic infarct.
- Rare placental tumor: A report of two mesenchymomas.
- Safety of treadmill exercise testing in Parkinson disease.
- Results of a double-blind placebo-controlled study of 3,4-diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS).
- Cell type-specific STORM super-resolution imaging of cannabinoid signaling in brain circuits.
[Oral Presentation]
- Managing stress and anxiety.
[Oral Presentation]
- Neonatal estradiol prevents infantile spasms and seizures in arx-linked infantile spasms syndrome.
[Platform Presentation]
- Utilization of fMRI in patients with epilepsy and right hemispheric dominance.
[Platform Presentation]
- Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient-reported ratings to those of caregiver proxies in a 12-week open-label trial (PRISM II).
- Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Examination of CNS-LS outcomes in a 12-week open-label trial (PRISM II).
- Dextromethorphan/quinidine for treatment of pseudobulbar affect in patients with dementia: Treatment effects by concomitant antidepressant use in a 12-week open-label trial (PRISM II).
[Platform Presentation]
- TTP488 path to registration: Leveraging enrichment strategies.
- TTP488: From futile to fast track.
- Selection of resources from a vaccination standing order program toolkit during a randomized trial to improve vaccination rates in a PBRN.
- Content of patient instructions section of an EHR generated after visit summary affects patient satisfaction.
- Headache and cutaneous allodynia in older adults without cognitive impairment.
[Previously Presented]
- Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
[Previously Presented]
- Headache and cutaneous allodynia in older adults without cognitive impairment.
- Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
- Comparative patient satisfaction and efficacy of a Parkinson's disease enrichment program (PEP).
- XCiDaBLE: Observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the USA.
- Progressive supranuclear palsy and statin use.
- DBS experience at a tertiary care referral center.
- American multiple system atrophy natural history study.
- Cervical dystonia and work productivity: Results from the cervical dystonia patient registry for the observation of onabotulinumtoxinA efficacy.
- Dystonia-spasticity in a patient with a novel SLC25A12 mutation.
- Gait and balance in Parkinson's disease (PD) following bilateral Subthalamic Nucleus (STN) and Globus Pallidus Interna (GPi) stimulation: 36 month follow-up of CSP#468 cohort.
- Psychogenic movement disorders: Are there neurocognitive differences between patients with non-epileptic seizures vs those with other hyperkinetic motor manifestations?
- Clinical utility of apraclonidine in ptosis.
- An unusual case of central nervous system Rosai-Dorfman disease.
- Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
- Reticular myoclonus in type I myotonic dystrophy.
- The use of thrombolysis among acute ischemic stroke patients with limited English proficiency.
- Increased frequency of early dispensed but unused tPA shortens door to needle times in potentially eligible thrombolysis patients presenting to a tertiary stroke center.
- Patient characteristics and outcomes among early-arriving acute stroke patients for whom alteplase was dispensed but not administered.
[Oral Presentation]
- Validation of olfactory deficit as a biomarker of Alzheimer's disease.
- Seizure outcome after epilepsy surgery in patients with intractable non-lesional epilepsy.
- Reliability of the severity subscale of the revised Toronto Spasmodic Torticollis Rating Scale (TWSTRS-2).
[Oral Presentation]
- PRISM II: An open-label study to assess the safety, tolerability, and effectiveness of dextromethorphan 20 mg/quinidine 10 mg for treatment of pseudobulbar affect secondary to dementia, stroke, or traumatic brain injury: Results from the Alzheimer's disease/dementia cohort.
- XCiDaBLE: An observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Final results from the blepharospasm cohort.
- Decompressive hemicraniectomy for spontaneous supratentorial intracerebral hemorrhage: A descriptive analysis.
- Autoimmune epilepsy: Clinical features, management and outcomes.
- Use of best practice alerts in electronic medical records to improve care for women of childbearing age taking anti-seizure medications.
- The impact of cervical dystonia on work productivity: An analysis from the CD Patient Registry for the Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
- Dystonia-spasticity in a patient with a novel SLC25A12 mutation.
- "Review of systems" questionnaire as a predictive tool for psychogenic non-epileptic seizures.
- vCJD in the United States - Analysis of four cases.
- Atypical presentation of inclusion body myositis.
- "Speechless" after a seizure: A rare case of postictal aphemia.
- SUNCT responding to botulinum toxin.
- Hemichorea in a patient with diabetic ketoacidosis.
- Decompressive hemicraniectomy for supratentorial spontaneous intracerebral hemorrhage: A retrospective case-control study using propensity score matching.
- Thrombolysis-associated parenchymal hemorrhage is not associated with CT perfusion variables.
- Using research-domain criteria (R-Doc) to understand biological markers of anxiety.
- Differential Ankyrin-G binding of voltage-gated sodium and KCNQ2/3 potassium channels is mediated by an overlapping N-terminal binding site.
- Exploring racial differences in cognitive function.
- Baseline clinical and infarct characteristics as predictors of poor outcomes in patients not thrombolysed due to mild or resolving symptoms ("too good to treat").
- Admission hemoglobin and sodium values are important factors associated with good outcome after acute ischemic stroke.
- Sustained reliability in dysphagia screening by registered nurses.
[Oral Presentation]
- Incidence of new or worsening renal insufficiency (RI) among stroke patients receiving IV contrast dye: A population-based study.
- Reasons why rt-PA was not given: Physician documentation vs. chart abstraction.
- Trends in anticoagulant-associated intracerebral hemorrhage and cardioembolic ischemic stroke.
[Oral Presentation]
- Using simulation mannequins to train nurses in stroke dysphagia screening.
- Temporal trends of emergency department arrival times after acute ischemic stroke: A population-based study.
- Racial differences in ischemic stroke subtypes: The Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS).
- Population-based eligibility for a stroke prevention trial evaluating novel anticoagulants and embolic strokes of uncertain etiology: Similar eligibility as for IV rt-PA.
- Analysis of gender and time to arrival among ischemic stroke patients in the Greater Cincinnati/Northern Kentucky Stroke Study.
- Multi-center experience with low dose intravenous abciximab in large vessel posterior circulation stroke.
- Modeling outcome after intracerebral hemorrhage indicates no benefit from lowering blood pressure.
[Oral Presentation]
- Early improvement in NIHSS is common during inter-hospital transfer and is associated with lower in-hospital mortality.
- Pre-workout supplement triggered Call-Fleming Syndrome.
- Chaining likelihood ratios to detect psychogenic non-epileptic events (PNEE).
- The relation between the WMT and CVLT-2 in a sample of patients evaluated for dementia.
- Neuropsychological improvement following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.
- Prospective memory in OEF/OIF veterans with PTSD with or without mild traumatic brain injury using virtual week.
- Persistent post-concussive symptoms and cortical thinning in mild traumatic brain injury.
- Added value of neuropsychological assessment to the Clinical Dementia Rating Scale in assessing mild cognitive impairment.
- Examination of the severe impairment profile in dementia evaluations.
- Comparison of psychogenic movement disorder patients with non-epileptic seizures vs other hyperkinetic motor manifestations: an integrated model of psychosocial and neuropsychological functioning.
- Psychometric properties of the Patient Competency Rating Scale in a seizure disorder population.
- Improvement in psychiatric status following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.
- An examination of cognitive deficits after controlling for respondent validity in veterans with chronic PTSD.
- Volumetric and DTI analyses of sports concussion.
- White matter integrity and its relationship to PTSD symptoms and sleep quality in OEF/OIF veterans.
- Paroxysmal generalized electrographic delta activity with confusion during natalizumab infusion.
- Treatment patterns and patient disposition in the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE).
- Long-term effects of botulinum toxin injections.
- Hepatic safety of eslicarbazepine acetate: Summary of five Phase II and three Phase III adjunctive trials.
- Characteristics of seizure termination in focal and generalized seizures.
- Computer-automated focus lateralization of temporal lobe epilepsy using fMRI.
- Impact of psychogenic non-epileptic seizure (PNES) diagnosis on acute care resource utilization, role for psychiatric consultation, and follow-up within a Dallas county hospital system.
- Rhythmic ictal nonclonic extremity movements in temporal lobe epilepsy: A reappraisal.
- Autoimmune epilepsy: Clinical features, management and outcomes.
- Brain graph theory topology changes associated with anti-epileptic drug use.
- Responsive stimulation of eloquent cortex.
- Unique characteristics of patients with comorbid epileptic and psychogenic nonepileptic seizures.
- (1-3)insulin-like growth factor 1 suppresses seizures and hypsarrhythmia in an animal model of infantile spasms.
[Platform Presentation]
- KCNQ2-deficiency: Clinical spectrum of epilepsy, encephalopathy, and response to ezogabine.
- Responsive neurostimulation in patients with periventricular nodular heterotopia (PNH).
- A KCNQ2/3 mutation causing severe epilepsy disrupts channel targeting to the axon initial segment.
- Treatment resistance correlates with ECG abnormalities in a pilot clinical surveillance of epilepsy patients.
- Provider survey of attitudes toward and uses of an electronic after visit summary.
- Patterns of glycemic control with exclusive oral hypoglycemic agent use in a community health care setting.
- Increased risk of hypoxic depolarization of the brainstem autonomic circuit in a mouse SUDEP model.
- Neural mechanisms of circuit homeostasis failure in MeCP2 disorders.
- Organization of human area V5/MT+ and sensitivity to motion coherence after lesions of the primary visual cortex.
- Exploring racial differences in cognitive function among older adults with diabetes.
- WIP safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with Alzheimer's disease/dementia: PRISM-II.
- Antioxidant biomarkers predict annualized change in MMSE score in MCI and AD patients in the TARCC cohort.
- Volumetric integral phase-shift spectroscopy (VIPS), in detecting early cerebral edema: Hemodialysis as a proof of principle model.
[Platform Presentation]
- Human albumin (HA) usage in subarachnoid hemorrhage (SAH) patients at US academic medical centers: Analysis of the University Healthsystem Consortium (UHC) database.
- Comparing recruitment among geographic regions in multinational Alzheimer's disease clinical trials.
- Regional variation in Alzheimer's disease progression in a clinical trial setting.
- Development of a codebook to describe the content of the patient instructions section of an EHR-generated after visit summary.
- Treatment patterns and patient disposition in the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
- Convergent validity of the revised motor and psychiatric TWSTRS modules of the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
- Effectiveness and safety in the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
- MER vs. MRI guidance in placement of DBS electrodes for Parkinson's disease.
- Impact of post traumatic stress disorder (PTSD) on the clinical expression of REM sleep behavior disorder (RBD) in veterans with Parkinson's disease (PD).
- Methodology for a symptomatic impact study using a portable essential tremor (ET) monitor to direct therapeutic interventions.
- Parkinson's disease and ocular melanoma in veterans.
- Reliability and validity of the revised TWSTRS psychiatric module (TWSTRS-PSYCH) of the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
- Adverse effects of bevacizumab in brain tumor patients.
- Venous thromboembolism (VTE) and glioblastoma.
- New risk score improves vasospasm prediction following subarachnoid hemorrhage using markers of vascular compliance.
- Optical coherence tomography visualization of optic nerve head structure detects acute changes in the intracranial pressure.
- Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Treatment patterns and subject disposition.
- Graph theory based functional connectivity in lateralized temporal lobe epilepsy.
[Platform Presentation]
- Infantile cerebral arterial calcification.
- Cardiac valve strands in ischemic stroke: Strand effects and outcomes of medical or surgical intervention.
- Clinimetric testing of the modules for the Comprehensive Cervical Dystonia Rating Scale (CCDRS).
[Platform Presentation]
- Multiple autoimmune antibody limbic encephalitis: A case in a pregnant woman.
- Oxidative metabolism during forearm exercise in McArdle disease.
- Treatment outcomes in Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).
- Epidemiological pilot analysis of epilepsy patients in a community clinic aims to inform effective care.
- Improved progression free survival in 1p/19q co-deleted anaplastic oligodendroglioma treated with both chemotherapy and radiation therapy at diagnosis.
[Platform Presentation]
- How long is long enough? The utility of prolonged inpatient video EEG monitoring.
- Thrombolytic outcomes for acute ischemic stroke in patients with primary brain tumors in the United States.
- Clinical outcomes of aneurysmal subarachnoid hemorrhage with cocaine use in the United States.
[Platform Presentation]
- Alleviating maneuvers (sensory tricks) in cervical dystonia.
- Reversible dementia with myoclonus due to concurrent HSV-2 and syphilis central nervous system infection in an immunocompetent man.
- Zung Self Rating Depression Scale in Parkinson's disease: A validity study in veterans.
- A distinctive delayed form of exertional rhabdomyolysis.
[Platform Presentation]
- Not PFK deficiency.
- Mentored peer review of standardized manuscripts for teaching neurology residents biostatistics, research methodology, and peer review.
- Dopamine transporter imaging in essential tremor with and without parkinsonian features.
[Platform Presentation]
- Hereditary spastic paraplegia due to a novel mutation in SPG11 gene presenting as dopa responsive dystonia, parkinsonism and spasticity.
- Resource utilization in patients with suspected psychogenic non epileptic seizures and drug resistant epilepsy in the Harris County Health District between 2009 and 2012.
- A distinctive delayed form of exertional rhabdomyolysis.
- Fixed weakness in McArdle disease.
- Exercise intolerance with congenital anomalies.
- Rare family with autosomal dominant oculopharyngeal muscular dystrophy showing anticipation.
- Progression and stability of cognitive asymmetry in a large sample of Alzheimer's disease patients.
- Perceived competency and quality of life deficits in individuals experiencing psychogenic non-epileptic events.
- A longitudinal investigation of sleep quality following mild traumatic brain injury: Comparison with orthopedic and non-injured controls.
- Patients with sports-related mTBI return to activities more rapidly than patients with motor vehicle crash-related mTBI.
- The relation of postconcussive symptom report and cognitive testing in an mTBI population: The effect of performance validity test results.
- Serial diffusion tensor imaging in subacute uncomplicated mild traumatic brain injury.
- Effects of PTSD, mild traumatic brain injury, and alcohol abuse on sleep quality in OEF/OIF veterans.
- ICD-9 code positive predictive value for stroke subtype in a population-based epidemiology study.
- Use of emergency medical services by stroke patients.
[Oral Presentation]
- Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis.
- Prevalence of echocardiographic abnormalities in acute ischemic stroke.
- Impact of substance abuse on timely treatment with rt-PA: A population-based study.
- Prevalence of unsuspected renal insufficiency in stroke patients presenting to the emergency department: A population-based assessment.
[Oral Presentation]
- Predictors of platelet transfusion in patients with intracerebral hemorrhage.
- Stroke in the young: Preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
[Oral Presentation]
- Temporal trends in stroke incidence over the past twenty years: Stroke incidence has stabilized, racial disparity is not improving.
- Moderate alcohol use protects from intracerebral hemorrhage: Findings from the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
- Migraine and risk of intracerebral hemorrhage in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
- Racial-ethnic blood pressure differences in acute intracerebral hemorrhage.
[Oral Presentation]
- Does intraventricular hemorrhage lead to a normal pressure hydrocephalus-like syndrome?
- Stroke recurrence rates are not changing over time.
[Oral Presentation]
- A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke.
- Improving quality of care and outcomes in the community through the inclusive collaboration between a certified comprehensive stroke center and regional hospitals.
- Clinical outcomes following thrombolysis for acute ischemic stroke in patients with systemic malignancy: A nationwide case-control study.
- Clinical outcomes following thrombolysis for acute ischemic stroke in patients with primary brain tumors: A nationwide population study.
- Treatment of ischemic stroke with recombinant tissue plasminogen-activator in pregnancy: A population study.
- ICH & FUNC scores in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
- Prior use of statins may reduce hematoma growth in intracerebral hemorrhage patients.
- Utilization of vascular imaging in stroke: A population based study.
- Is obesity a marker of good or bad functional outcome after ischemic stroke?
- Longitudinal feasibility testing of the MINDSET vers 2.1: A clinic-based decision support system for epilepsy self-management.
- Predictors of postoperative seizure outcome: a longitudinal study of temporal and extratemporal resections.
- Right hemispheric ictal asystole - Report of two cases.
- Discordance between functional magnetic resonance imaging (fMRI) and Wada test for language lateralization.
- Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience in 82 patients.
- STOP SUDEP Program: Application of visual automated fluorescence electrophoresis in the qualitative profiling of archived SUDEP samples.
- Practical implications of methodological differences in the Wada test protocols.
- Pore loop KCNQ2 mutations causing epileptic encephalopathy strongly suppress wild type KCNQ2 currents when co-expressed in mammalian cells.
- In vivo 2-photon confocal microscopy of cortical absence epilepsy.
- Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures.
- How long is long enough? The utility of prolonged inpatient video EEG monitoring.
- KCNQ2 targeting to the axon initial segment is disrupted in a mutant form causing severe epilepsy.
- Ankyrin-G as a potential molecular mechanism linking epilepsy and comorbid mood disorder.
- Antiepileptic drugs and movement disorders: A frequently neglected story.
- Survival outcomes of patients with recurrent anaplastic glioma treated with bevacizumab.
- Glioblastoma and leptomeningeal dissemination.
- Bexarotene decreases hyperexcitability in two mouse models with epilepsy.
- Paranodal ankyrins: Enigmatic glial anchors.
- State dependence of noise correlations in monkey primary visual cortex.
- The roles of ankyrin-G in node of Ranvier formation in vivo.
- Estimation of average single-unit receptive field size by fMRI.
- Human area V5/MT+ organization changes following lesions of the primary visual cortex.
- Peripheral nerve graft implants into the substantia nigra of subjects with Parkinson's disease undergoing deep brain stimulation surgery: a safety study.
- Population receptive field measurements in the visual cortex of macaque monkeys with and without retinal lesions.
- Genetic ablation of betaII-spectrin in the central nervous system results in axon degeneration, epilepsy and postnatal lethality.
- Sudden unexplained death in epilepsy: Can genomics help?
[Plenary Talk]
- A new class of antioxidant carbon nanoparticles: Superoxide to oxygen generators.
- Comparison of outcomes with pipeline and SILK flow diverters for the treatment of intracranial
aneurysms: A systematic review of literature.
- Efficacy and safety of IPX066, a carbidopa-levodopa, extended-release formulation, in early Parkinson's disease.
- A pooled analysis identifies the potential to improve upon intravenous rt-PA.
[Oral Presentation]
- Generation of a pooled outcome model for traumatic brain injury to use for prediction of potential trial success.
- Takotsubo cardiomyopathy increases mortality in traumatic brain injury patients: analysis of the nationwide inpatient sample.
- Clinical outcomes of venous thromboembolism in subarachnoid hemorrhage patients: a U.S. population study.
- Profound olfactory impairment in idiopathic intracranial hypertension.
- Distortion product otoacoustic emissions for non-invasive intracranial pressure assessment.
- Race and resting-state fMRI.
[Oral Presentation]
- A study to assess the safety, tolerability, and effectiveness of Nuedexta (dextromethorphan 20 mg/quinidine 10 mg) in the treatment of pseudobulbar affect (PBA) [PRISM II].
- Ordered subset analysis CNV association with Alzheimer's disease AAO phenotypes.
- The long-term safety and efficacy of thalamic deep brain stimulation in essential tremor.
- Minimal clinically important changes in UPDRS scores in early PD in rotigotine clinical trials.
- Continuous home monitoring of essential tremor using motion sensors.
- Cervical Dystonia Patient Registry for Observation of onaBotulinumtoxinA Efficacy (CD PROBE): Baseline demographic and clinical characteristics.
- Long-term outcomes from the VA/NIH Cooperative Study on deep brain stimulation for Parkinson's disease.
- Sensory tricks (corrective maneuvers) in cervical dystonia.
- Sleep disordered breathing and excessive sleepiness in Parkinson's disease.
- Safinamide significantly improves responder rates in fluctuating Parkinson's disease (PD) patients as add-on to levodopa (SETTLE).
- Long-term safety of neurotrophic factor gene therapy using AAV2-neurturin (CERE-120) in Parkinson's disease.
- Tosedostat and posterior reversible encephalopathy syndrome (PRES).
[Oral Presentation]
- Severe neurological disability in cancer patients acutely infected with the West Nile virus (WNV).
- Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
- Neuromyelitis optica presenting as multiple sclerosis worsening on natalizumab.
- Treatment of idiopathic relapsing transverse myelitis.
- Case series of cardiac complications during fingolimod first dose observation period.
- Efficacy of fingolimod in ethnic minorities.
- Two-year follow-up results of the HALT MS clinical trial (ITN033AI).
- Classification and diagnosis of myopathy from EMG signals.
[Platform Presentation]
- Combined thalamic and subthalamic nucleus stimulations in Parkinson disease.
- Effect of combined subthalamic and nigral stimulation on gait and postural stability in Parkinson's disease.
- FDG-PET reveals reduced metabolic activity in the basal ganglia of a patient with anti-NMDA receptor encephalitis.
- Examining anti-dementia drug persistence in Alzheimer's disease (AD) patients.
- BK virus-related progressive multifocal leukoencephalopathy.
- A case of limb shaking transient ischemic attacks associated with middle cerebral artery stenosis and functional aortic stenosis.
- Movement disorders in golfers.
- Treatment of idiopathic relapsing transverse myelitis.
- XCiDaBLE: An observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Interim results from the first 145 subjects with cervical dystonia.
- Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients with high t-helper cell count: Report of two cases.
[Previously Presented]
- Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE): Baseline demographic and clinical characteristics.
- Treatment of intracranial aneurysms with pipeline embolization device: A systematic review of literature.
- Identifying the correlates of pseudobulbar affect in patients with parkinsonian disorders and ALS.
- Continuous home monitoring of essential tremor using motion sensors.
- Long-term efficacy, safety, and side effect profile of botulinum toxin injections in dystonia - a 20-year follow-up.
- Parkinson's disease and narcolepsy.
- Safinamide add on to L-dopa: A randomized, placebo-controlled, 24-week global trial in patients with Parkinson's disease (PD) and motor fluctuations (SETTLE).
- Glycogen breakdown is preserved during exercise in severe muscle phosphorylase b kinase deficiency.
[Previously Presented]
- Exploring the impact of Parkinson disease (PD) susceptibility genes in elders without PD.
[Platform Presentation]
- Transthoracic echocardiography for lacunar strokes: Do we need it in all patients?
- Safety and efficacy of 5 mg and 10 mg dalfampridine extended release tablets in patients with multiple sclerosis: First results from a double-blind, placebo-controlled trial.
- Zolpidem improves tardive dyskinesia with and without akathisia.
- Clinical and imaging data in essential tremor with parkinsonian features.
- The long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
- Clinical characteristics and predictors of outcome in patients with Moyamoya Disease in the United States: Experience from two clinical centers.
- Knowledge and attitudes about epilepsy in a low socioeconomic population.
- Neuroscience research opportunities to increase diversity program orientation.
[Oral Presentation]
- Glycogen breakdown is preserved during exercise.
- Not PFK deficiency.
[Oral Presentation]
- Secondary stroke prevention program: Effect on stroke specific quality of life.
- Implementation of a secondary stroke prevention program: Effect on medication adherence.
- Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.
- Outcomes after tPA in African American women with explicit consideration of baseline factors.
- Extending the time window with low dose IV abciximab in acute non-lacunar stroke.
- Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.
- High utilization of CAS procedures among the elderly in the post CREST era.
- Increased carotid stenting for nonspecific symptoms in the post-CREST era.
- Executive functioning across the lifespan: An examination of the D-KEFS.
- Neural correlates of a novel Spanish word recognition fMRI memory task.
- A simple method for enhancing prediction of longitudinal decline in instrumental activities of daily living in Alzheimer's patients.
- Improving predictive validity of the Clinical Dementia Rating Scale for functional outcomes.
- How to select between the Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA) when accounting for the base rate of the sample and the level of severity being screened for.
- Sensitivity and specificity of the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in screening for mild and severe cognitive impairment related to dementia.
- Predicting caregiver burden from patient functional ability and mood.
- Exploring the impact of anxiety on learning in the California Verbal Learning Test-2nd edition.
- Treatment effects in resting state fMRI in veterans with comorbid alcohol abuse, post-traumatic stress disorder, and mild traumatic brain injury.
- Learning stories vs. word lists: The role of executive functioning.
- Use of the Health History Checklist (HHC) to detect patients experiencing psychogenic nonepileptic events (PNEE) on a long-term monitoring unit.
- Normal aging and verbal memory: A comparison of tests.
- Frontostriatal changes detected by DTI tractography in Parkinson's disease dementia.
- Diffusion tensor imaging findings in mild traumatic brain injury and orthopedic injury.
- Racial differences in perceived risk, self-efficacy, and fear of stroke.
- Public perceived risk of stroke, myocardial infarction, and cancer.
- Location of intracerebral hemorrhage in a tri-ethnic cohort: the ERICH study.
- Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.
- Risk of intracerebral hemorrhage with combined antiplatelet and anticoagulant use.
[Oral Presentation]
- Classification of periventricular white matter disease (WMD) in clinical radiology reports vs. direct film review in ischemic stroke patients.
- Outcomes after tPA in African American women with explicit consideration of baseline factors.
- Extending the time window with low dose IV abciximab in acute non-lacunar stroke.
- Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.
- Withdrawal of care in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
[Oral Presentation]
- Apolipoprotein E and use of statins in intracerebral hemorrhage.
[Oral Presentation]
- Casein kinase Iε phosphorylation of TDP-43 causes oligomerization and enhances toxicity in vivo.
- Genetic variation of the serotonin transporter (5-HTTLPR) in human fear conditioning and extinction.
- Clustering of mutations in a North American series supports a dominant-negative mechanism of KCNQ2 encephalopathy.
- Regional atrophy in temporal lobe epilepsy: Correlations with cognitive impairment.
- SUDEP Tissue Donation Program (STOP): Collaborative network in support of SUDEP registry, tissue repository and human translational research.
- Universal DNA extraction protocol for the utilization of alternative tissue sources in downstream epilepsy genetic analysis.
- SUDEP research consortium: A new collaborative network to discover predictive genes, mechanisms and biomarkers of SUDEP.
[Investigators' Workshop]
- Loss of tau protein reduces hyperexcitability in mouse and drosophila genetic models of epilepsy.
- Myotonia in brain: 'Skeletal' chloride channel ClC-1 linked to idiopathic generalized epilepsy with focal myotonia.
- Channotyping epilepsy: Profiling personal variation in ion channel genes.
- An abbreviated support group therapy for psychogenic nonepileptic events: A neurologist-initiated program in an epilepsy center.
- Treatment of KCNQ2 encephalopathy with ezogabine.
- 17?-estradiol decreases seizure and interictal spike frequency in a genetic mouse model of X-linked infantile spasms.
- Electrocorticographic events preceding sudden unexplained death in epilepsy (SUDEP).
- Mexican American normative references on tasks of memory and language: The Texas Mexican American normative studies.
- Normative data for Mexican American on tasks of executive and physiometric functions: The Texas Mexican American normative studies.
- Normative performance on the RBANS in a multi-ethnic bilingual cohort: The Texas Mexican American normative studies.
- Adaptation and norming of the Boston Naming Test for Spanish-speaking older adults in the USA.
- Internal carotid artery dissection with visual accompaniments.
- Movement disorders in golfers - Four case reports and a brief review of literature.
- GABAB receptor limbic encephalitis: Case report and a brief literature review.
- Eye movement abnormalities in thalamic midbrain junction infarcts: Report of two cases.
[Previously Presented]
- Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients with high t-helper cell count: Report of two cases.
- Multiple sclerosis patient treated with natalizumab develops immune thrombocytopenic purpura.
- Factor structure of the Zarit Burden Interview and relation to dementia severity and patient neuropsychological performance.
- Neuronal Elavl proteins regulate RNA splicing and abundance to control brain glutaminase expression and neuronal excitability.
- Visualization of the population receptive field structures in human visual cortex.
- Impact of single cell firing on in vivo cortical activity.
- Pattern motion and direction selectivity in mouse V1.
- Population activity in the motor cortex of the MeCP2 duplication mouse.
- Risk factors for in-hospital pneumonia in intracerebral hemorrhage.
- Eye movement abnormalities in thalamic midbrain junction infarcts: Report of two cases.
- Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington disease.
- A prospective, observational trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia
(CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of
CD on patients using the cervical dystonia impact profile (CDIP).
- A prospective, observational trial evaluating Xeomin [IncobotulinumtoxinA] for cervical dystonia or blepharospasm in the US - Preliminary baseline results for patients with blepharospasm.
- Mutations in the novel protein PRRT2 cause infantile convulsions with paroxysmal kinesigenic dyskinesia.
- Protective association between ACE inhibitors and lobar intracerebral hemorrhage.
- Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.
- Genetic susceptibility for amyloid pathology in Alzheimer's disease.
- Integrating human and fly genetics to understand Alzheimer's disease susceptibility.
- Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
[Platform Presentation]
- Incidence of Lewy body negative parkinsonism in a community based sample.
- Inclusion of axial rigidity may improve diagnostic accuracy for dementia with Lewy bodies.
- Prior statin use reduces rate of delayed cerebral ischemia after subarachnoid hemorrhage.
- Angiogram-negative subarachnoid hemorrhage (aN-SAH): Not as benign as you would think.
- Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.
- Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA.
[Platform Presentation]
- Comparing perfusion computed tomography to digital subtraction angiography in detecting delayed cerebral ischemia.
- The utility of DynaCT in evaluation of subarachnoid hemorrhage: A case report.
- Using genetic polymorphisms to predict fear and the development of anxiety disorders.
[Oral Presentation]
- Assessing quality of life in pain populations: Utility of a single-item measure.
- Premorbid IQ and intrinsic progression rate explain substantial variance in observed progression of Alzheimer's disease (AD) on multiple measures.
- Factors influencing time to nursing home placement in persons with probable Alzheimer's disease.
- Factors that influence long term care placement in an Alzheimer disease cohort.
- Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease.
- Dimebon in Alzheimer's disease: Summary and contract of three efficacy trials.
- Population receptive field mapping in human subjects after lesions of the visual pathway.
- Population receptive field measurements in the visual cortex of macaque monkeys.
- Flu-like and systemic symptoms following treatment with botulinum toxins.
- AAV2-Neurturin (CERE-120) and Parkinson's disease: The safety and feasibility of combined substantia nigral and putaminal stereotactic targeting via a phase 1/2b clinical trial in advanced Parkinson's disease.
- Cervical dystonia subtypes baseline results from the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE).
- Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington's disease.
- XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of CD on patients using the cervical dystonia impact profile.
- XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm in the United States - Preliminary baseline results for patients with blepharospasm.
- Analysis of CYP2D6 genotype and response to tetrabenazine.
- Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome.
- Neuroprotection by neuropeptide orexin A in a cellular model of Parkinson's disease.
- Entropy measurements in pallidal neurons in dystonia and Parkinson disease.
- Pathological sleepiness and age in Parkinson's disease.
- Concomitant use of antidepressants and neuroleptics with tetrabenazine during treatment of Huntington's disease.
- Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease.
- Tetrabenazine for moderate vs. severe/disabling chorea associated with Huntington's disease.
- Parkinson's Study Group Neurosurgical Working Group (PSG-NSWG) deep brain stimulation (DBS) non-motor symptoms (NMS) survey: Real world pre-operative practice patterns.
[Previously Presented]
- Anti-parkinsonian effects of Nurr1 activator in UPS impairment induced animal model of Parkinson's disease.
- Pooled analysis of three cluster randomized hypertension control trials in African-Americans.
- Population receptive field measurements in macaque visual cortex.
[Platform Presentation]
- Genetic analyses of Parkinson's disease endophenotypes.
[Platform Presentation]
- Parkinson's Study Group Neurosurgical Working Group (PSG-NSWG) deep brain stimulation (DBS) non-motor symptoms (NMS) survey: Real world pre-operative practice patterns.
- Left ventricular hypertrophy is more common in blacks than whites with intracerebral hemorrhage.
- Flu-like and systemic symptoms following treatment with botulinum toxins.
- Complication rates among women receiving contemporary carotid revascularization procedures.
- Severity of cervical dystonia: Baseline characteristics from the Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CDPROBE).
- Stroke associated with severe cerebral vasospasm after petroclival meningioma resection.
- Concomitant use of antidepressants and neuroleptics with tetrabenazine during treatment of Huntington's disease (HD).
- Ion channel modifications in epilepsy.
- Rare case of recurrent meningitis due to neurocysticercosis.
- IncobotulinumtoxinA (Xeomin®) is well tolerated for the treatment of blepharospasm when injected according to patient needs.
- Hyperacute stenting for acute ischemic stroke is associated with a high rate of symptomatic intracranial hemorrhage.
- Functional connectivity MRI asymmetries in lateralized temporal lobe epilepsy.
- Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.
- Long-term neuropsychological follow-up in pallidal stimulation for medically-refractory Tourette syndrome.
- Outcomes of endovascular intervention in post cardiac catheterization ischemic strokes.
- Analysis of the behavioral features conferred by the intermediate allele for Huntington disease in the prospective Huntington at risk observational study (PHAROS).
- XCiDaBLE: A phase 4, observational, prospective trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States - Preliminary baseline disease severity and quality of life data.
- Sporadic CJD (VV2 Type) presenting with central vestibular abnormalities.
- Early predictors of progression in idiopathic sensory neuropathy.
- Dystonic respiratory dysregulation and other breathing disorders associated with dystonia.
- Comparing clinical features of young-onset, middle-onset and late-onset Parkinson's disease.
- Clinical and radiologic spectrum of corpus callosum infarctions: A case series.
- Excessive sleepiness and depression in Parkinson's disease.
- Genome-wide association study of Gilles de la Tourette Syndrome.
- The Clinical Skills Examination Training Program (CSET): An interactive training exercise for evaluators.
- Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease.
- Tetrabenazine for moderate vs. severe/disabling chorea associated with Huntington's disease (HD).
- Anti-epileptic drug use and outcome in the ethnic and racial variations in intracerebral hemorrhage (ERICH) study.
[Oral Presentation]
- Diagnostic reliability of DaTscan in movement disorders.
- West Nile virus infection associated with central nervous system vasculitis and strokes.
- The protection of dopamine neurons in dissociated midbrain cultures with neurotrophic factor combinations from MPP+ toxicity.
[Previously Presented]
- Progressive weakness in a patient with static encephalopathy and colpocephaly.
- Use of the Health Attitude Survey (HAS) to detect patients experiencing Psychogenic Non-Epileptic Events (PNEE) on a long-term monitoring unit.
- Plasma cortisol does not predict rate of cognitive decline in Alzheimer's patients.
- Patterns of reliable digit span performance in patients with Alzheimer's disease.
- Neuropsychological correlates of early impaired self-awareness following traumatic brain injury.
- The relation of regional diffusion tensor imaging with incentivized event-based prospective memory in children following traumatic brain injury.
- Amnestic MCI, sleep disturbance, and cognitive functioning.
- Determination of suspect effort: Primarily Spanish-speaking TBI patients and the test of memory malingering.
- Correlation between persistent memory impairment following mild, blast-related TBI and PTSD symptoms in OEF/OIF service members and veterans.
- Establishing common data elements for adult and pediatric traumatic brain injury research.
- Can EEG sampling be used as an effective tool for detecting clinically significant seizures?
- Has patient selection for carotid endarterectomy and stenting changed over time? Carotid revascularization in the post CREST era.
- Carotid revascularization in elderly asymptomatic patients: Are the results optimal?
- Acute hyperglycemia induces functional cerebrovascular uncoupling associated with worsened outcome and impaired reperfusion.
- Antioxidant carbon-based nanomaterials: In-vitro protection and in-vivo effects on the neurovascular unit.
[Platform Presentation]
- Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling.
- A new more sensitive method to assess balance among stroke trial populations.
- A systematic analysis of endovascular and intravenous therapy for ischemic stroke based on time window using a novel outcome model.
- Differential effect of high cholesterol by intracerebral hemorrhage location.
[Moderated Poster]
- Protocol for rapid acquisition and interpretation of head CT in acute stroke patients eligible for thrombolysis.
- Auto-generated summary maps for CT-perfusion improve interobserver reliability.
- Rate of inappropriate statin use after intracerebral hemorrhage.
- Intracellular dialysis can be exploited to distinguish sources of intracellular Zn2+ accumulation in hippocampal neurons.
- Dissection of tauopathy mechanisms using unbiased genetic screening in the Drosophila retina.
[Invited Plenary Speaker]
- Does memory test performance have localizing significance in pediatric epilepsy?
- Intact vs. impaired ictal sensorium: Does it affect outcome of psychogenic nonepileptic events following disclosure of diagnosis.
- Dendritic AMPA receptor deficit on cortical interneurons in the stargazer mouse model of absence epilepsy.
- NMDA receptor activation prolongs the duration of ionic dyshomeostasis following spreading depolarization in murine brain slices.
- Blue cheese/Alfy affects autophagy activation and tau toxicity in a Drosophila model of tauopathy.
- Propagation of spreading depolarizations is limited by the synaptic release and extracellular actions of Zn2+.
- Flupirtine reverses hyperexcitability in Kv1.1 potassium channel deficient myelinated vagal axons.
- Tau loss regulates excitability in mouse and Drosophila genetic models of epilepsy.
- RNA binding protein hnRNP K/bancal and its intronic microRNA miR-7 exert opposite effects on tau toxicity through regulation of Insulin Receptor Substrate/chico and GSK-3beta activity.
- Protection of cultured dopamine neurons from MPP+ requires presence of several neurotrophic factors.
- ADAM11 is responsible for trafficking of Kv1 subunits to cerebellar basket cell terminals.
- Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia.
- Early 17-beta-estradiol treatment decreases seizure and interictal spike frequency in the ARX(GCG)10+7 genetic mouse model of X-linked infantile spasms.
- Population receptive field mapping in human subjects with lesions of the visual cortex.
- Transformation of visual sensory information from cortical layer 4 to layer 2/3: The second stage of visual cortical processing.
- Horizontal and vertical eye movements in Huntington's disease patients and age matched controls.
- Population receptive field measurements in visual cortex of macaque monkeys.
- Suppression of the protein kinase PKR promotes network hypersynchrony and enhanced cognition.
- Evaluation of video teleconferencing technology to provide chronic disease self-management access for rural veterans.
- Tissue, time and thrombolysis.
[Keynote Address]
- The protection of dopamine neurons in dissociated midbrain cultures with neurotrophic factor combinations from MPP+ toxicity.
- Comparison of subthalamic (STN) and pallidal (GPI) deep brain stimulation (DBS) on gait and balance in patients with Parkinson's disease (PD).
- Association of PSP with chemical occupational exposure factors.
- Neurological outcome scale for traumatic brain injury: Predictive validity and sensitivity to change.
- Visuospatial construction measures and their utility in identifying dementia of the Alzheimer's type.
- Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
[Platform Presentation]
- Clinical utility of continuous electroencephalogram (CEEG) monitoring in hypothermia after cardiac arrest.
- What can endophenotypes teach us about Parkinson's disease?
[Oral Presentation]
- A systematic analysis of intravenous and endovascular therapy for ischemic stroke using a novel predictive outcome model.
- Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients.
- Sustained efficacy of long-term incobotulinumtoxin-a (Xeomin®; botulinum neurotoxin type-a, free from accessory proteins) treatment for cervical dystonia, blepharospasm and upper limb post-stroke spasticity.
- Predicting women's feminist perspectives: The effects of internalization of masculine role norms and attitudes toward men.
- Serum granulocyte colony stimulating factor and Alzheimer's disease.
- The impact of depression on cognition varies by APOE4 status.
- Biomarkers associated with cardiovascular risk in the Texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and homocysteine.
- Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort.
- A candidate causal variant in the CR1 locus.
- Plasma sphingomyelin is associated with cognitive progression in Alzheimer's disease.
- Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease.
- A serum protein-based algorithm for the detection of Alzheimer's disease.
- Racial/ethnic group differences in the association of APOE ε4 genotype and visuospatial test performance in a non-demented sample.
- Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression.
- Factors that influence survival in Alzheimer's patients.
- The cognitive correlates of functional status: a new approach to dementia.
- Genetic factors associated with the rate of cognitive decline in Alzheimer's disease.
- A genome-wide association scan for episodic memory decline in aging.
- Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
[Platform Presentation]
- Genome-wide association scan replication for biomarker endophenotypes of Alzheimer's disease.
- Developing and validating of diagnostic algorithm for Alzheimer's disease.
- NMDA-R activation contributes to metabolic burden following spreading depolarization in murine hippocampal slices.
- Deep brain stimulation: Hardware related complications in patients with movement disorders.
- The long-term impact of early versus delayed treatment with rotigotine transdermal system in patients with early-stage, idiopathic Parkinson's disease.
- IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with blepharospasm across dosing intervals in a repeated dose-study.
- The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.
- Correlation of patient impression with the cervical dystonia impact questionnaire.
- Convergence spasm in conversion disorders: Prevalence in psychogenic and other movement disorders compared to controls.
- Constant current DBS: A randomized controlled clinical trial in Parkinson's disease: 12 month results.
- Essential tremor quantification during activities of daily living.
- Identification of a novel downstream target of Nurr1 transcription factor for midbrain dopamine neuron development.
- Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE): Study design of a prospective observational registry.
- A mechanistic study of proteasome inhibition-induced iron misregulation in dopaminergic neuron degeneration.
- Amplitude fluctuations in essential tremor. A prospective study.
- A randomized controlled trial of constant current DBS active stimulation versus off stimulation in Parkinson's disease.
- Efficacy and safety of IPX066, a new carbidopa-levodopa (CD-LD) extended-release formulation, in LD-naive early Parkinson's disease (APEX-PD trial).
- Patients' perspective of tetrabenazine two years after FDA approval.
- Alpha-synuclein: Possible link between Parkinson's disease and melanoma.
- Situational sleep tendency in "sleepy" veterans with Parkinson's disease.
- Brain glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG33 repeat length in the Huntington's disease gene.
- Postural instability and gait difficulty scores from the MDS-UPDRS.
- Assessing dissociative pathology in psychogenic movement disorders: Clinical utility of the Dissociative Experiences Scale-II.
- Safety data in a randomized controlled trial of constant current deep brain stimulation versus lead placement alone for treatment of motor fluctuations in Parkinson's disease.
- Peripheral trauma and movement disorders: A systematic review of reported cases.
- Antioxidant carbon nanotubes: In-vitro characterization and in-vivo effects on cerebrovascular regulation.
- How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
[Previously Presented]
- Hyperglycemia is an independent risk factor for poor outcome after rtPA only in the large artery stroke subtype.
- Novel analysis methodology indicates extended window low-dose IV abciximab improves outcome.
- The sacral spine and coccygeal space.
- A case report of cryptosporidium diagnosed by small bowel biopsy in an AIDS patient.
- Mind the time: a quality improvement project to increase the percent of ischemic stroke patients receiving intravenous t-PA within 60 minutes after emergency department arrival.
- Population receptive field mapping in human subjects with visual cortical lesions.
- Population receptive field measurements in a macaque monkey with macular degeneration.
- Ablation and protection of dopaminergic neurons in zebrafish embryos.
- Teaching communication skills to learners: A faculty development workshop.
- Distal limb discoloration in patients with multiple sclerosis - Case series of 41 patients.
- Deep brain stimulation system revision, and hardware related complications in 512 patients with movement disorders.
- Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of pain-related outcomes.
- Double trouble: Neuroleptic malignant syndrome (NMS) clouding initial presentation of anti-NMDA-receptor encephalitis (ANRE).
- Efficacy and safety of donepezil 23 mg/day in patients with moderate-to-severe Alzheimer's disease with concomitant memantine use.
- Efficacy and safety of repeated incobotulinumtoxin A injections in subjects with cervical dystonia previously treated with botulinum toxin.
- Efficacy and safety of repeated incobotulinumtoxin A injections in subjects with cervical dystonia previously naive to botulinum toxin treatment.
- Intermediate CAG repeats: Analysis of the cooperative Huntington's observational research trial.
- Essential tremor quantification during activities of daily living.
- Levodopa is necessary to improve gait and balance in Parkinson's patients after deep brain stimulator implantation.
- Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of physician-reported outcomes.
- Carotid endarterectomy in normal and high surgical risk patients: A study of regional variation.
- Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.
- Coding and decoding pathogenic ion channels in epilepsy.
- Double-blind, placebo-controlled fixed-dose trial of IPX066, a novel carbidopa-levodopa (CD-LD) extended-release formulation, in early Parkinson's disease (APEX-PD).
- AMPK-mediated neuroprotection on cellular models of Parkinson's disease.
- Differences in the association of peripheral insulin and cognitive function in non-diabetic ad cases and normal controls.
- Epidemiology of patients transported by ambulance with seizures in Andhra Pradesh, India: A prospective analysis.
[Oral Presentation]
- Decreased CBV is not a good measure of infarct core in acute ischemic stroke.
[Oral Presentation]
- Incidence of multiple sclerosis in patients presenting with neurogenic bladder.
- Chronotypes in Parkinson's disease: What are they? And what can they predict?
- A genome-wide association scan for episodic memory decline in aging.
[Platform Presentation]
- Functional fine mapping of the CR1 locus identifies a causal variant for Alzheimer's disease susceptibility.
[Platform Presentation]
- Cervical dystonia patient registry for observation of BOTOX® efficacy (CD PROBE): Interim results of patient-reported outcomes.
- Postural instability and gait difficulty scores from the MDS-UPDRS.
- Psychosocial profiles of psychogenic movement disorder patients with non-epileptic seizures and other abnormal motor manifestations.
- Variations in the use of preoperative medications for carotid endarterectomy patients.
- Diffusion tensor tractography of the internal capsule in depressed and anxious Parkinson's disease patients.
- Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
[Platform Presentation]
- CMT and tremor — is it really CMT?
- Unusual case of myasthenia gravis and high white blood cell count.
- A 65 year old female with subacute onset of limb weakness.
- A case of the dancer who can no longer dance.
- Legs weakness, isolated quadriceps atrophy and elevated CPK.
- The acute diffusion lesion reliably represents infarct core: Clinically relevant reversibility is rare.
- Implementation of the American Stroke Association Sharegiver Program (Peer Support).
- Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype.
- Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
- A multidisciplinary quality improvement project to address delays in CT imaging and thrombolytic treatment in acute stroke patients.
- MRI based TIA triage study.
- Longitudinal voxel-based analysis in traumatic brain injury: A comparison of diffusion tensor imaging metrics over an 18-month post-injury interval.
- Performance on the structured inventory of malingered symptoms in known epilepsy and psychogenic non-epileptic seizure groups.
- The relation of perforant pathway and temporal lobe structures to memory function in patients with severe traumatic brain injury.
- Differential recall of nouns and verbs in patients with probable Alzheimer's disease (AD).
- Cognitive reserve as a moderator for the relationship between depression and cognitive functioning in Alzheimer's disease.
- Explaining discrepant math performance in children with epilepsy: Relative contribution of cognitive and attentional factors.
- Centrum semiovale and corpus callosum integrity in relation to information processing speed of patients with severe traumatic brain injury.
- Cortisol levels in Alzheimer's patients are related to premorbid functioning and rate of progression.
- Monetary incentive effects on event-based prospective memory one year after traumatic brain injury in children.
- Neuropsychological correlates of early impaired self-awareness following traumatic brain Injury.
- Diffusion tensor imaging of incentive effects in prospective memory three months after pediatric traumatic brain injury.
- Cortical thinning in adolescence.
- Age related changes in variability in on WAIS-IV subtests.
- A comparison of Rey-15 scoring systems and alternative indices of suspect effort with primarily Spanish speaking older adults.
- The relation between diffusion tensor imaging and volumetrics in the midbrain and brainstem and neurological functioning in severe traumatic brain injury.
- A mechanistic study on the medicinal use of mint in diarrhea.
- Pharmacological basis for the medicinal use Mentha Arvensis in airway disorders.
- Genomics of cognitive decline and neuropathology.
[Oral Presentation]
- An unbiased genetic screen for modifiers of tauopathy using both loss and gain of function approaches.
- Simultaneous EEG and fMRI of sleep spindles and K-complexes.
- High resolution copy number variation of ion channel genes in epilepsy.
- Hippocampal networks in temporal lobe epilepsy: A seed-based fMRI study.
- Induction of psychogenic non-epileptic events: Success rates vary with ictal semiology and neuropsychological profile.
- Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience at four centers.
- Effect of temporal lobe epilepsy on the default mode network.
- How helpful are repeat epilepsy monitoring unit admissions after an initial nondiagnostic evaluation?
- Metabolic dependence of zinc effects on spreading depression in murine brain slices.
- Modulation of tau oligomers by passive vaccination.
- MeCP2 deficiency in GABAergic neurons recapitulates Rett syndrome phenotypes.
- Characterization of tau oligomers in Alzheimer's disease.
- Assessing the spatio-temporal dynamics of visual receptive fields by fMRI.
- Population receptive field mapping in human subjects with visual cortical lesions.
- Synergistic effects of tau and alpha-synuclein in dopaminergic neurons.
- Tau oligomers in Parkinson disease and dementia with Lewy bodies and their connection with alpha-synuclein oligomers.
- Population receptive field mapping in a macaque monkey with macular degeneration.
- Rehabilitation of prospective memory in children after traumatic brain injury.
- Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
[Platform Presentation]
- Sectional anatomy of the pelvic floor.
- Teaching communication skills to learners.
- Neurocritical care morbidity and mortality (M&M): A multidisciplinary systems-based approach for improving patient care.
- The neurocritical care telestroke network: Extending high quality care to the underserved community for reasonable cost.
- Single brain death examination does not improve organ transplantation.
- Development of the Women's Traditional Attitudes of Men Scale (WTAMS).
- Gender role journey.
- Chronic disease: Framework, education and practice.
- Chronic disease: A telehealth Transition Assistance Program (TAP) for veteran caregivers.
- An inflammatory endophenotype of Alzheimer's disease.
- Presence of cardiovascular disease is associated with slower cognitive decline in Alzheimer's disease in the absence of cerebrovascular pathology.
- A serum protein-based diagnostic algorithm for Alzheimer's disease.
- Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease.
- Association of genetic variation in the electron transport chain and Alzheimer's disease.
- Genome-wide association scan for biomarker endophenotypes of Alzheimer's disease.
- Longitudinal analysis of intermediate CAGn repeat length expansion in the prospective Huntington's disease at-risk observational study (PHAROS).
- Alpha-synuclein oligomers in Parkinson's disease and Lewy body dementia.
- CD-PROBE (cervical dystonia patient registry for observation of BOTOX® efficacy) — preliminary safety data.
- Validation of a cervical dystonia questionnaire (CDQ).
- Prospective 5-year natural history study of probable multiple system atrophy (MSA) in 175 North American subjects.
- Safety and efficacy of repeated NT 201 (botulinum neurotoxin type A free from complexing proteins) injections of patients with blepharospasm.
- Validation of a motor screen for undiagnosed parkinsonism: The Baylor Functional Assessment Screen (BFAS).
- CD-PROBE (cervical dystonia patient registry for observation of BOTOX® efficacy) — CD impact on quality of life (QOL) and patient reported outcomes (PRO).
- The formation of pore-like amyloid aggregates in movement disorders.
- Role of tau oligomers in Parkinson's disease and dementia with Lewy bodies.
- Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease.
- Use of an interactive voice response system by patients with blepharospasm receiving repeated injections of NT 201 (botulinum neurotoxin type A free from complexing proteins).
- Assessing patients' access to tetrabenazine (Xenazine) after FDA approval.
- Curcumin accelerates the clearance of mutant alpha-synuclein and injured mitochondria via autophagy induction.
- Handedness and Parkinson's disease.
- SETTLE study design: A 24-week, double-blind, placebo-controlled study of the efficacy and safety of safinamide as add-on therapy to levodopa in patients with Parkinson's diseases.
- Neuropsychological assessment of monolingual Spanish speaking Parkinson's disease patients in the United States pre and post STN-DBS.
- Open-label extension trial assessing the effects of long-term treatment with rotigotine in subjects with early-stage, idiopathic Parkinson's disease: Results from up to 7 years.
- Retrospective study of the therapeutic effect of deep brain stimulation in multiple system atrophy.
- Orthostatic tremor: A review of 40 cases.
- Classification accuracy and spatial networks of motion coherence and direction using real-time fMRI.
- The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.
- Recurrent and multiphasic disseminated encephalomyelitis, case series.
- Distal lower limb discoloration in patients with multiple sclerosis.
- Sleep disorders in multiple sclerosis.
- Use of natalizumab in Hispanic patients with relapsing remitting multiple sclerosis.
- Computer-assisted cognitive rehabilitation for multiple sclerosis — Updated findings.
- Rebalancing the NINDS rt-PA trial.
- Effects of miRNA-22 on embryonic rat cortical neurogenesis.
[Oral Presentation]
- Unilateral opercular lesion and eating-induced epileptic spasms.
- Clinical experience with generic levetiracetam in a tertiary care epilepsy clinic.
- Relation of the Alzheimer's disease susceptibility allele at the CR1 locus to cognitive decline and Alzheimer's disease neuropathology in older persons.
[Platform Presentation]
- Uncinate fasciculus integrity and impaired problem solving and memory in complex partial seizures.
- Upper face chorea in Huntington disease.
- Effect of tetrabenazine (TBZ) on motor function in patients with Huntington disease (HD).
- Multiple sclerosis and other CNS demyelination after treatment with tumor necrosis factor alpha blockers.
- Comparison of detection rates of non-convulsive status epilepticus and non-convulsive seizure in critically ill patients using routine EEG and continuous EEG in a busy county and a private hospital.
- Intravenous immunoglobulin (IVIG) in treatment of central pontine and extrapontine myelinolysis.
- CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy) — A multicenter, observational study of onabotulinumtoxin A injections in cervical dystonia (CD) patients — Interim patient reported outcome data.
- CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy) — A multicenter, observational study of repeated onabotulinumtoxin A injections in cervical dystonia (CD) patients — Preliminary baseline data.
- A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
- Clinical correlates of eye movements in Huntington disease.
- Ubiquitin proteasome system impairment mouse model of Parkinson's disease.
- Prevalence of seizures in HIV patients measured in the outpatient setting.
- HIF-1α-mediated neuroprotection on MPP+-induced apoptosis in SH-SY5Y cells.
- The natural progression of clinical symptoms in Parkinson's disease may not be faster in the earlier stages: Results from the ADAGIO delayed-start study.
- Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
[Platform Presentation]
- Open-label extension trial assessing the effects of long-term treatment with rotigotine in subjects with early-stage, idiopathic Parkinson's disease: Results from up to seven years.
- Asian over representation among patients with hemifacial spasm compared to cranial dystonia.
- Alzheimer's disease risk alleles in PCDH11X and SORL1 are associated with the rate of cognitive decline in subjects with multiple sclerosis.
[Platform Presentation]
- A novel set shifting fMRI task identifies differences in brain activation in Parkinson's disease and healthy controls.
- Active exploration of and commitment to gender roles: A new scale.
- Attitudes and perceptions of medical students at the University of Jordan towards medical research.
- Visual cortex plasticity in adulthood: Why consensus remains elusive.
[Platform Presentation]
- Different roles of extracellular and intracellular Zn2+ in spreading depression-like events in hippocampal slice.
- Unusual case of a brachial plexus disorder.
- A 32-year-old male with predominantly distal weakness, atrophy and myotonia.
- A case of myopathy associated with monoclonal gammopathy.
- No differential effect of tPA based on final stroke etiologic subtype: A reanalysis of the NINDS tPA trial.
[Moderated Poster]
- Apparent diffusion coefficient correlates with Tmax in acute ischemic stroke.
- Tissue salvageability in the penumbra decreases linearly with increasing Tmax.
[Oral Presentation]
- A genetic mouse model of epilepsy with interneuronopathy and autistic-like features.
- Classification accuracy and spatial networks of motion coherence using real-time fMRI.
- The Dementia Severity Rating Scale: Factor structure and neuropsychological correlates.
- Veterans with dementia and their caregivers: Neuropsychological correlates of caregiver burden.
- Assessment of the efficacy of immediate release methylphenidate, sustained release methylphenidate, and modafinil for patients with primary brain tumor.
- Change in quality of life as a function of duration of stimulant treatment in primary brain tumor patients.
- Wing phenotypes produced by misexpression of an ALS-associated TDP-43 mutation include supernumerary veins: A possible clue to signaling pathways.
- Real-time fMRI can decode visual mental imagery during a motion coherence task.
- Genome-wide association scans for cognitive decline.
[Oral Presentation]
- Rasagiline provides symptomatic benefit in early Parkinson's disease (PD).
- Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD).
- Treatment of dysautonomia associated with Parkinson's disease.
- Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?
- Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.
- Simultaneous EEG and fMRI of vertex sharp transients.
- Everyday verbal memory and pediatric epilepsy.
- High frequency EEG activity associated with ictal events in the TTX model of infantile spasms.
- Long QT mouse model links the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.
- Impact of evidence-based recommendations on referral pattern for epilepsy surgery.
- Epilepsy and neurocysticercosis in Houston, Texas.
- A burst suppression pattern at termination of secondarily generalized seizures.
- Single brain death examination with confirmatory cerebral blood flow testing as an alternative to the standard dual brain death examination.
- Influence of levodopa and psychotropic medication on emotional and physical symptoms of depression before and following STN-DBS for the treatment of Parkinson's disease.
- Alternating fluency performance following bilateral STN DBS for the treatment of Parkinson's disease.
- MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.
- MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.
- Internally mediated developmental desynchronization of neocortical network activity.
- Functional correlation of brain loci during cognitive tasks in multiple sclerosis.
- Non-convulsive seizure phenotypes and dementia in mice and humans.
- AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD): Efficacy and safety results from a controlled Phase 2 clinical trial.
- Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.
- Program evaluation of medical student professionalism curriculum at Baylor College of Medicine.
- "Poetry of life" on medicine and patient relationships.
[Oral Presentation]
- Event-based prospective memory performance during subacute recovery following moderate to severe TBI in children: Effects of monetary incentives.
- Patterns of cortical thinning in relation to event-based prospective memory performance of children with traumatic brain injury.
- Neural correlates of event-based prospective memory in children 3 months after moderate to severe traumatic brain injury: A volumetric study.
- Changes in the cingulate in acute mild TBI detectable with diffusion tensor imaging and their relation to memory function.
- Neural repair at the systems level: Lessons from the visual system.
[Platform Presentation]
- Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis.
- Final results from the Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis study.
- Automated 24 well neuro-screening system with life support.
- Multiparametric NeuroLab with integrated MEA and life support.
- Cultural stressors, coping mechanisms, and subjective well-being in urban adolescents.
- Clinical depression, anxiety, and PTSD as risk factors for morbidity following coronary artery bypass grafting surgery.
- The Self-management TO Prevent (STOP) Stroke Tool: A final alpha testing.
- Human KvLQT1 mutations in mice link the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.
- Impact of maternal anxiety and age of child on restrictions in childhood activities.
- Summary of the U.S. National Institute of Neurological Disorders and Stroke (NINDS)
Workshop on SUDEP.
- Long-term deep brain stimulation for essential tremor: 12- year clinicopathologic follow up and literature review.
- Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor.
- Impact of STN-DBS on health-related quality of life in patients with Parkinson's disease.
- Tourette syndrome in adults.
- Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) in treatment-naive cervical dystonia patients.
- Efficacy and safety of NT 201, botulinum neurotoxin type A free from complexing proteins) in pre-treated cervical dystonia patients.
- A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.
- Transcription factor PITX3 in Parkinson's disease.
- Correlation between Kinesia system assessments and clinical TETRAS scores in patients with essential tremor.
- 17-AAG protects against rotenone-induced apoptosis in SHSY5Y cells via HSP70 induction.
- Resveratrol, a polyphenol found in red wine, protects against rotenone-induced apoptosis through autophagy induction.
- The course of depressive symptoms in early Parkinson's disease.
- Parkinson's disease — Characteristics of disease onset in a veteran population.
- Mood differences between women diagnosed with psychogenic movement disorders and psychogenic seizures.
- Diagnosis of left ventricular hypertrophy by precordial vs. limb lead criteria in the analysis of ECGs over time in young athlete.
- Prevalence of LVH in athletes classified by race and gender.
- Clinical and radiographic improvement of an acutely aggressive case of multiple sclerosis treated with cyclophosphamide.
- Prevalence of sleep disorders in multiple sclerosis.
- Spasmodic dysphonia in MS: A rare symptom or a possible association?
- Seizures in MS patients: A retrospective study.
- HALT-MS--Intense immunosuppression and stem cell transplantation for RRMS.
- Long-term sc IFN beta-1a treatment in RRMS: Cumulative dose effects.
- Continuous vs non-continuous long-term sc IFN beta-1a treatment in RRMS.
- Diffuse white matter abnormalities and neurologic manifestations in a patient with anti-ro positive antibodies. Case Report.
- Occurrence of herpes zoster in multiple sclerosis patients treated with natalizumab.
- Platelet inhibition may explain results with abciximab in the treatment of acute ischemic stroke.
- A method to generate a control population for acute ischemic stroke trials: Validation with NINDS and application to a phase 1 treatment series.
- The written and oral administration of the Symbol Digit Modality Test in Huntington disease.
- How well does the ADAS-cog measure the spectrum of Alzheimer's disease severity? An item response theory analysis.
- Polyarteritis nodosa-type vasculitis isolated to the central nervous system: A first case report of a fulminant primary CNS vasculitis variant.
- Efficacy and safety of NT 201 (neurotoxin free from complexing proteins) in cervical dystonia.
- Age at onset and pre- morbid IQ influence early progression rates in AD.
- Material specific memory impairment is associated with unilateral cingulum bundle structural integrity in intractable temporal lobe epilepsy.
- Apocynin decreases consequences of nitric oxide synthase uncoupling in experimental neonatal hypoxia-ischemia.
- Efficacy and safety of NT 201 (botulinum neurotoxin free from complexing proteins) in blepharospasm.
- A post-hoc analysis of cumulative dose effects of subcutaneous interferon beta-1a on clinical and MRI outcomes in relapsing-remitting multiple sclerosis: Results over the long term.
- Long-term effects of interferon beta-1a dose on relapse rate in relapsing-remitting multiple sclerosis: Results from a post- hoc analysis of PRISMS study data.
- Late stent thrombosis following self-expanding intracranial stent placement.
- Stent supported revascularization of acute basilar artery occlusion beyond 8 hours of stroke onset.
- An efficient and robust method for the fractional anisotropy analysis of white matter tracts based on automated template matching in talairach space.
- Toxoplasmosis myopathy as a manifestation of HIV immune reconstitution inflammatory syndrome.
- ApoE genotype in ALS.
- Rapamycin protects against rotenone-induced apoptosis through autophagy induction in SH-SY5Y cells.
- Covered stent in the treatment of internal carotid arteriovenous fistulae.
- Stent without concomitant coil embolization for anterior circulation cerebral aneurysms.
- Safety of treatment of more multiple aneurysms in the same session.
- In-stent restenosis on follow-up angiography among patients treated with stenting in acute ischemic stroke.
- Safety of stent supported intracranial revascularization in the setting of acute ischemic stroke.
- A controlled study of the long-term cognitive outcome of bilateral subthalamic nucleus deep brain stimulation.
- HALT MS — Phase II clinical trial of high dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for active relapsing- remitting multiple sclerosis.
- Systematic bias in blood pressure measurement between health care systems - Implications for quality of care research.
- Rates of abnormal screening electrocardiograms differ greatly between U.S. collegiate cohorts.
- Tuberculosis meningitis: Risk factors, treatments and outcomes in a case series.
- Optimizing the accuracy and safety of shoulder injection procedures with cross-sectional anatomic schematics.
- Anesthesiologist with muscle cramps.
- A tale of two diseases.
- Muscular dystrophy with subacute onset.
- Another patient with burning feet.
- A case of a painful leg.
- VWF pathway: A new animal model of lacunar stroke.
- Restoring balance: A method to adjust for randomization imbalances in stroke clinical trials.
- The optimal coregistered mismatch ratio to predict a favorable clinical response following recanalization varies based on Tmax threshold.
- Foundations for a successful start: lessons learned from site initiation in the antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.
- Perfusion/diffusion mismatch salvage is maximal in regions with mild-moderate perfusion deficits and correlates with clinical outcome.
- Reversible acute diffusion lesions appear to be already reperfused on baseline MRI.
- Apparent diffusion coefficient distinguishes ischemic core from reversible diffusion lesions.
[Oral Presentation]
- Apparent diffusion coefficient distinguishes penumbra from benign oligemia.
[Oral Presentation]
- Effect of systolic blood pressure treatment on perihematomal edema. Results from the antihypertensive treatment of acute cerebral hemorrhage (ATACH) study.
- A pilot study of executive functions in PTSD.
- Significance of the apolipoprotein E ε2 allele in Alzheimer's patients' memory functioning.
- Incentive effects on time-based prospective memory in children and adolescents with traumatic brain injury.
- Respiratory function is not related to cognitive impairment in patients with amyotrophic lateral sclerosis (ALS).
- Implementation of patient self-management programs among veterans in VA.
- Predictors of individual visual memory decline after right anterior temporal lobe resection.
- Systematic screening in a busy clinical setting improves identification of depression in people with epilepsy.
- Correlation of vitamin D levels and bone mineral density in anti-epileptic induced osteoporosis.
- Vitamin D deficiency and compliance with supplementation in anti-epileptic drugs (AED) treatment.
- Periventricular nodular heterotopia electrical stimulation produces visual hallucinations.
- Risk of seizures after spontaneous hemorrhage involving the temporal lobe.
- Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).
- Tissue-specific, functional toxicity of cytostatic and anaesthetic drugs in primary neuronal cell cultures.
- Endovascular stent supported coil and onyx glue embolization of carotico-cavernous fistulae.
- Stent alone treatment for anterior circulation cerebral aneurysms.
- Stent without concomitant coil embolization for dissecting external carotid aneurysms.
- A case of methemoglobinemia after awake fiberoptic intubation following anterior cervical discectomy with fusion (ACDF).
- Coagulopathy is an independent predictor of inhospital mortality in patients with acute subdural hematoma.
- Altered age of onset in Alzheimer's disease with diabetes mellitus.
- Is frontal dysfunction associated with dysarthria in patients with Amyotrophic Lateral Sclerosis (ALS)?
- Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.
- A systematic analysis of intravenous rt-PA vs. endovascular therapy with respect to therapeutic time window in acute ischemic stroke.
- Low-dose intravenous abciximab and heparin for large vessel acute ischemic stroke: Comparison with natural history models.
- Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease?
- Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis.
- RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis.
- Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis.
- Effects of MiRNA-372 on embryonic rat cortical neurogenesis.
- Culturally specific predictors of subjective well-being in urban adolescents.
- Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).
- Eighteen-month data from an open-label extension of a one-year controlled trial of dimebon in patients with mild-to-moderate Alzheimer's disease.
- Interrater reliability between expert and nonexpert physicians in the assessment of amnestic MCI in the community setting.
- Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study.
- The effects of donepezil on Alzheimer's disease progression monitored by MRI.
- Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort.
- The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Effect of atorvastatin on Alzheimer's disease progression by APOE4 genotype.
- Automated multiparametric 24 well neuro screening system.
- MEA supported cortical cultures as a novel tool in Alzheimer's research.
- Tissue-specific neurotoxicity of cytostatic and anaesthetic drugs.
[Platform Presentation]
- Coil design optimization for magnetic stimulation of neural tissue cultures on MEAs.
- Unusual motor-phonic tic mimicking essential palatal myoclonus (EPM).
- Correlation between clinical rating of parkinsonian and essential tremor and quantitative assessments.
- The essential tremor rating assessment scale (TETRAS).
- Spinocerebellar Ataxia 8: Variable phenotype and unique pathogenesis.
- Evaluation of a Parkinson's disease screening questionnaire for use in a community-based setting.
- The role of dopaminergic medication doses in impulse control disorders (ICD) in Parkinson's disease (PD).
- Expanded study of NURR1 gene expression in patients with Parkinson's disease.
- Deep brain stimulation of the subthalamic nucleus for peripherally-induced parkinsonism.
- A randomized, double-blind, placebo-controlled study of atomoxetine for freezing of gait in Parkinson's disease.
- Rapamycin rescues lactacystin-induced dopaminergic neuron injury in vivo.
- Association between laterality (right or left) of onset of motor symptoms and degree of speech impairment in veterans with Parkinson's disease (PD).
- Deep brain stimulation (DBS) parameters and gait in Parkinson's disease (PD).
- Neuropsychological functioning of Parkinson's disease patients two years post subthalamic nucleus deep brain stimulation surgery.
- Experience with MRI safety and DBS: Data from the National Parkinson Foundation Centers of Excellence.
- Improved prediction of treatment success in stroke based on pooled control arms.
- Volume and nature of patient telephone calls in a large movement disorders center.
- Characteristics of Archimedean spiral drawing in patients with psychogenic tremor.
- Site performance in an investigator-run multiple sclerosis clinical trial.
- Inter-rater reliability between expert and nonexpert physicians in the diagnosis of amnestic MCI in the community setting.
- Dimebon improves patient function and decreases caregiver assistance time in Alzheimer's disease: One-year clinical trial results.
- Morbidity associated with psychogenic movement disorders in children.
- Phenomenology of psychogenic movement disorders in children.
- Dimebon improves memory, orientation, language, and praxis in patients with mild to moderate Alzheimer's disease: Results of a one-year placebo-controlled study.
- Neurocysticercosis and epilepsy in a county hospital in Houston, Texas.
- New version of the UPDRS (MDS-UPDRS): Factor analysis.
- CNS vasculitis as a manifestation of systemic sclerosis.
- Craving for sweets and other compulsive behaviors in patients with Parkinson's disease.
- Acamprosate improves impulse control disorders in Parkinson's disease.
- Brain activation in Parkinson's disease during a functional magnetic resonance imaging set shifting task: Preliminary findings.
- Phase II clinical trial (HALT-MS: Immune tolerance network) of high dose immunosuppressive therapy (HDIT) and autologous hematopoetic stem cell transplantation (AHSCT) for active relapsing-remitting (RR) multiple sclerosis (MS): Early results.
- Successful treatment of cognitive decline in Sneddon syndrome associated with hepatitis C with cyclophosphamide.
- Treatment of freezing of gait in Parkinson's disease with deep brain stimulation of the pedunculopontine nucleus.
- Role of deferoxamine and autophagy induction in rotenone-induced apoptosis.
- Vitamin E use is associated with improved survival in an AD cohort.
- Estradiol for the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
- Diabetes mellitus: Risk or protective factor in ALS?
- Changes in emotional versus physical symptoms of depression following sub-thalamic nucleus deep brain stimulation for Parkinson's disease.
- Frequency and severity of restless legs syndrome in multiple sclerosis: A population study from southeast Texas.
- Hemidystonia-hemiatrophy syndrome.
- The relationship between cognitive functioning and whole brain diffusion tensor imaging abnormalities in Parkinson's disease.
- The relationship between diffusion tensor tractography and cognitive functioning in Parkinson's disease.
- Neurocysticercosis in Houston: An 8-year experience in a tertiary care center.
- The self-management to prevent stroke clinic: teaching, translational research and technology.
- Platelet aggregation unit inhibition to guide abciximab therapy in acute ischemic stroke: preliminary results.
- A method to predict stroke trial success based on pooled control arms.
- Antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.
- A case of FSH?
- A case of nemaline myopathy masquerading as fascioscapulohumeral dystrophy.
- A case of Ehlers-Danlos.
- Progressive ascending weakness in an acquired immunodeficiency syndrome patient.
- Peau d'Orange skin changes and muscle weakness.
- Diffuse painful muscle spasms.
- Why does my patient have camptocormia?
- The Self-management TO Prevent (STOP) Stroke Clinic: Teaching, translational research and technology.
- Growth curve analysis of changes in spatial and verbal learning characteristics after anterior temporal lobectomy.
- Masking epilepsy by combining two epilepsy mutations.
- Genomic research in the era of identifiable genetic information.
- Retrospective analysis of levetiracetam prescribing patterns and trends among women of reproductive age from 2003 to 2007.
- Usage pattern of intravenous levetiracetam in an inner city hospital.
- Mirtazapine induced complex partial epilepsy.
- Persistent focal neocortical abnormalities in the TTX model of infantile spasms.
- Transient brain MRI changes after prolonged seizures.
- Varied roles of BK-type potassium channels in the regulation of neuronal excitability: Which are important for epilepsy?
- Topiramate does not significantly diminish hemiparesis during the amobarbital Wada test.
- Complex partial status epilepticus (CPSE) and acute repetitive complex partial seizures (ARCPS): retrospective review of incidence and management at TUH.
- Stroke secondary prevention: an exemplar for the chronic care model.
- Multiple sclerosis and antiphospholipid syndrome: Case report.
- Encefalomielitis diseminada recurrente y multifásica reporte de 2 casos.
[Recurrent Disseminated Encephalomyelitis: Report of 2 Cases]
- Experience with natalizumab in a group of ms patients from southeast Texas.
- Recurrent disseminated encephalomyelitis: Report of 2 cases.
- Is restless legs syndrome more frequent and severe in the multiple sclerosis population? Study in multiple sclerosis patients from southeast Texas.
- Exposure to anti-dementia drugs slows clinical progression of Alzheimer's disease (AD).
- Behavioral and cognitive dysfunction in amyotrophic lateral sclerosis.
- Uncovering the etiology of bilateral lower extremity fasciculations and hypertrophy using electrodiagnosis: A case report.
- I'm not an environmentalist, I just think like one.
- Real world response to Katrina.
- Point mutation in signal receptor inhibits retinoic acid-induced neuronal differentiation via Cdk5-p27 signaling in neuroblastoma cell.
- FTD-like cognitive and behavioral changes in ALS.
- Preliminary validation of the ALS Cognitive Behavioral Screen (ALS-CBS)™.
- Results of a one-year randomized, placebo-controlled trial of dimebon for the treatment of mild to moderate Alzheimer's disease.
- Lipitor's effect in Alzheimer's dementia (LEADe) study: Baseline characteristics.
- Clinical factors associated with the preprogression rate (PPR) in Alzheimer's disease (AD).
- The dementia and disability in Thai elderly project: Prevalence of mild cognitive impairment with one-year follow-up and the prevalence of dementia in community-dwelling Thai elderly.
- Rotigotine transdermal patch as a treatment of nocturnal symptoms in patients with idiopathic Parkinson's disease.
- Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version.
- Clinical features of movement disorders in hemochromatosis.
- Deep brain stimulation for tardive dyskinesia and akathisia.
- Health related quality of life in essential tremor patients undergoing deep brain stimulation.
- Health related quality of life in Parkinson's disease patients undergoing deep brain stimulation.
- Switch from an oral dopamine agonist to rotigotine transdermal patch in Parkinson's disease.
- Motor and behavioral outcomes after bilateral GPi deep brain stimulation for severe Tourette syndrome.
- Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
- Shoulder pain in Parkinson's disease.
- The other Babinski sign in hemifacial spasm.
- The specificity and sensitivity of "applause sign" in differentiating PSP and other parkinsonian syndromes.
- Brain permeable iron chelators M-30 and AK-28 rescue degenerated nigral dopamine neurons in animal model of PD.
- Multiple sclerosis and other autoimmune diseases.
- Behavior of multiple sclerosis during pregnancy and after delivery.
- A phase II study of high-dose immunosuppressive therapy (HDIT) using carmustine, etoposide, cytarabine, and melphalan (beam) + thymoglobulin, and autologous CD34+ hematopoietic stem cell transplant (HCT) for the treatment of poor prognosis multiple sclerosis. HALT-MS.
- Frequency and severity of restless legs syndrome in ms patients from southeast Texas.
- Multiple sclerosis in African Americans: A cohort from southeast Texas.
- Computer-assisted cognitive rehabilitation in patients with multiple sclerosis.
- The concept of "functional uncoupling" as a cause of vascular dysfunction following neonatal hypoxic/ischemic injury.
- Malignant Tourette syndrome.
- Results of the Avonex Combination Trial (ACT).
- Three parkin mutations in a family with Parkinson's disease.
- Dimebon improves cognition, function, and behavior in patients with mild- moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled study.
- Autopsy-proven Huntington disease with 29 trinucleotide repeats.
[Previously Presented]
- Autophagy induction and its neuroprotection on neurotoxin-induced cell injury relevant to Parkinson's disease.
- Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study.
- Motor overflow, contralateral dystonia and mirror movements in focal hand dystonia.
- Head injury with amnesia and risk of multiple system atrophy (MSA).
- Novel brain permeable iron chelators prevent lactacystin induced ubiquitin-proteasome inhibition and degeneration of nigrostriatal dopamine neurons.
- Proteasome inhibition in substantial nigra induces sustained dopamine cells degeneration.
- Design and baseline data for a study of Lipitor's effect in Alzheimer's disease (LEADe).
- Comparison of neuroprotective and neurorescue capabilities of rasagiline and selegiline, against lactacystin induced nigrostriatal degeneration.
- Agreement between stage of change and measured behavioral endpoints: Implications for intervention design.
- Association between serum c-peptide levels and the risk of cardiovascular disease in nondiabetic individuals: Data from the National Health and Nutrition Examination Survey.
- Unusual cause of rhabdomyolysis.
- Progressive muscle weakness and joint contractures.
- Recurrent compartment syndrome.
- It's snowing! Seven cases of persistent migrainous visual aura.
- Does acetazolamide act in intra-axonal flow?
- Development of child and parent report measures of subjective memory.
- Factors associated with good outcome following intra-arterial therapy for acute ischemic stroke: a severity-adjusted systematic review.
- Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.
- Expression profile of voltage-gated sodium channel genes in two knockout mouse models exhibiting spontaneous seizures.
- Development of a transgenic mouse model of spike-wave epilepsy by overexpression of α1G T-type calcium channels.
- The prevalence of inter-ictal cardiac arrhythmias and LQT gene variants in patients with idiopathic epilepsy.
- Neonatal blockade of cortical or hippocampal activity: A possible model of infantile spasms.
- Efficacy of bisphosphonates in treatment of osteoporosis in men receiving antiepileptic drugs.
- Coagulopathy is an independent predictor of in-hospital mortality in patients with acute subdural hematoma.
- Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.
- The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
- Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
- Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population.
- Hyperhidrosis due to thalamic deep brain stimulation in a patient with essential tremor.
- Clinical features that distinguish psychogenic and essential tremor.
- Short-term effects of tetrabenazine on chorea associated with Huntington disease.
[Previously Presented]
- Autopsy-proven Huntington disease with 29 trinucleotide repeats.
- Enhancement of autophagy and neuroprotection by rapamycin in lactacystin-induced injury of dopaminergic neurons.
- Executive dysfunction and comorbid conditions in Tourette syndrome.
- Craving sweets in Parkinson's disease.
- GPI deep brain stimulation for Tourette syndrome improves tics and psychiatric co-morbidities.
- Overflow, contralateral and mirror hand dystonia.
- Hemiparkinsonism-hemiatrophy syndrome.
- Different faces of hemifacial spasm: Etiological classification.
- Runner's dystonia.
- Relationship of MRI localization and cognition in DBS.
- Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.
- A Mexican pedigree with Parkinson's disease, essential tremor and bell's palsy associated with parkin but not HS1BP3 gene mutation.
- Genetic analysis of the SLITRK1 gene in Caucasian patients with Tourette syndrome.
- Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
[Previously Presented]
- Medications associated with the onset of tardive dyskinesia.
- Short-term effects of tetrabenazine on chorea associated with Huntington disease.
- Recurrent myelitis associated with hepatitis C infection.
- Functional uncoupling of endothelial nitric oxide and superoxide radical following neonatal hypoxia/ischemia.
- Relation of blood oxygenation in the first hours of life and school age outcomes in "healthy" children born at very low birthweight.
- Ion channel gene interactions in inherited epilepsy.
- Predicting progression and survival in Alzheimer's disease.
- Is functional decline necessary for a diagnosis of Alzheimer's disease?
- Clinically presenting mild cognitive impairment (MCI): Variable presentations and their outcomes.
- Preprogression rate, cardiovascular comorbidity, and survival in Alzheimer's disease.
- Magnetic stimulation and depression of non-homogeneous networks in primary neuronal cell cultures.
[Platform Presentation]
- Induction of carcinogenesis by concurrent inactivation of p53 and Pten in mouse ovary.
[Oral Presentation]
- Rationale, design, and baseline data for the Avonex Combination Trial (ACT).
- Predicting progression of Alzheimer's disease.
- Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.
- Long term safety of deep brain stimulation for the treatment of Parkinson's disease.
- Nurrl deficiency predisposes to apoptosis induced by lactacystin in SH-SY5Y cells in vitro.
- Bilateral GPI deep brain stimulation for Tourette syndrome.
- Frontostriatal cognitive functioning 6 months following bilateral subthalamic nucleus deep brain stimulation.
- Association between cognitive function and metabolic control parameters in treated patients with type 2 diabetes.
- The implication of glutamic acid decarboxylase autoantibodies in nystagmus: A case report.
- A systematic review of mortality and functional outcome in catheter-based therapy for acute ischemic stroke: comparison to predictive models.
- Relationship between admission glucose and outcome in the intravenous abciximab/heparin in acute stroke phase 1 study.
- Progressive numbness and weakness in a diabetic patient: Is it all diabetic neuropathy?
- Spontaneous mutilating acral ulcers in nondiabetic patients: The spectrum of differential diagnosis.
- Neuropsychological and demographic correlates of apraxia in a large cohort of Alzheimer's patients.
- Phonemic cued performance on the Boston Naming Test: Longitudinal change and its correlates in Alzheimer's disease.
- Neuropsychological outcome after bilateral deep brain stimulation surgery for advanced Parkinson's disease: Base rates adjusted for practice effects, test unreliability, and natural disease progression.
- Naming improvement with phonemic cues: Which Alzheimer's patients benefit most?
- Category-letter fluency discrepancies in healthy older adults: Normative data and reliability.
- Subclinical rhythmic epileptiform discharge of adults (SREDA): Atypical SREDA in an adolescent.
- What is the duration of EEG needed to diagnose childhood absence epilepsy (CAE)?
- Verbal memory declines are largest for patients with depression and anxiety after anterior temporal lobectomy.
- Efficacy and safety of rufinamide monotherapy for the treatment of patients with refractory partial seizures.
- Impaired semantic memory in temporal lobe epilepsy — What is the role of anterior temporal lobectomy?
- Epilepsy disability and applying for social supplemental income (SSI) and or social security disability income (SSDI).
- Measurement of cerebral blood flow regulation by transcranial Doppler during complex partial seizures.
- Magnetic stimulation and depression of nonhomogeneous networks in primary neuronal cell cultures.
- Semantic memory is more impaired in dominant than in nondominant temporal lobe epilepsy.
- Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.
- Botulinum toxin type B Observational Study (BOS).
- The nurse's role in diagnosis and treatment of acute stroke.
- SiRNA knockdown of signal receptor in human embryonic kidney cells.
- A novel approach in transitional cardiac rehabilitation.
- Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]
- Diabetes care, management and future research directions.
[Oral Presentation]
- Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.
- Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard-ratio analysis.
- Ultrasound-augmented thrombolysis improves outcome in hyperglycaemic stroke.
[Platform Presentation]
- Oxygen treatment after perinatal hypoxia-ischemia reduces neuronal damage at short survival times, but worsens injury with long-term survival.
[Platform Presentation]
- Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]
- Genetic analysis of G309D and W4370PA mutations of PINK1 in Parkinson's disease.
- New version of the UPDRS: Development methods and working document for field testing.
- A variant in the HS1-BP3 gene is associated with familial essential tremor.
- Mild cognitive impairment types and their outcomes.
- ADAS-Cog change rates in MMSE Strata relevant to clinical trials.
- Convergence spasm and other psychogenic eye movement disorders.
- Tics associated with other disorders.
- HSP70 inducer VPA inhibits rotenone-induced apoptosis in SH-SY5Y cells.
- Relationship of premorbid IQ and education to progression of Alzheimer's disease.
- Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
[Previously Presented]
- Botulinum toxin treatment for oromandibular dystonia and bruxism in patients with Tourette syndrome.
- Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]
- Videophone exercise motivation for peripheral arterial disease patients.
[Previously Presented]
- Brain attack - Time lost is brain lost.
- Determining preoperative indicators for transitional cardiac rehabilitation after heart surgery.
- Videophone exercise motivation for peripheral arterial disease patients.
- Gait and balance assessment in parkinsonian disorders.
- Small interfering RNA (SiRNA) targeting the PINK1 induces apoptosis in human SH-SY5Y cells.
- Reduced NURR1 gene expression affects expression of dopaminergic phenotypic markers and Parkinson's disease-related genes.
- Globus pallidus deep brain stimulation in dystonia.
- Relationship among psychiatric, motor and cognitive functioning in non-demented individuals with Parkinson's disease.
- Tetrabenazine: Does prior history of depression preclude this drug as a treatment option?
- Botulinum toxin type B Observational Study (BOS).
- Prevalence of cervical dystonia and spasmodic torticollis in the United States.
- Medications associated with the onset of tardive dyskinesia.
- Predictors of battery life for the Activa® Soletra 7426 neurostimulator.
- Subthalamic deep brain stimulation in patients with a previous pallidotomy.
- Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
- Parkinsonism associated with adalimumab in a patient with rheumatoid arthritis.
- Use of the CES-D for assessing depression in minority MTBI patients.
- The effects of interferon-alpha and 13-cis retinoic acid on the cognitive function of adults with aggressive squamous cell carcinoma.
- Delaying the execution of to-be-performed actions over brief delays impairs performance following mild traumatic brain injury in children.
- Confirmatory factor analysis of the Center for Epidemiologic Studies Depression (CES-D) Scale in mild to moderate traumatic brain injury.
- Resolution of "Dense Dot Sign" after acute ischemic stroke is associated with better outcome.
- Faster and complete recanalization may overcome the negative effect of hyperglycemia on stroke outcome.
- Absence of mossy fibers in NeuroD/BETA2 null mice prevents pilocarpine-induced status epilepticus.
- Utility of intermittent bedside electroencephalographic monitoring in the pediatric intensive care setting.
- Secretion and functional analysis of LGI/Epitempin family members.
- A relational database for neurophysiology report generation and research.
- Botulinum toxin serotype A compared to B in cervical dystonia: Randomized, double-blind, parallel study.
- The safety of deep brain stimulation in patients with Parkinson's disease, essential tremor, and other movement disorders.
- Safety and efficacy of tetrabenazine in the treatment of Huntington's disease and other choreas.
- The Tremor Rating Scale (TRS).
- Donepezil is safe and well-tolerated in AD patients at doses of up to 20 mg/day.
- Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.
- Immunohistochemical labeling of RGSZ2 protein in mouse CNS.
- Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits.
- Longitudinal analysis of the Alzheimer's Disease assessment scale in a large cohort of probable AD patients.
- Memantine treatment for mild to severe Alzheimer's disease: Clinical trials summary.
- Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease.
- Intravenous abciximab in complicated cardioembolic stroke patients with high NIHSS.
- Memantine treatment is beneficial for functional capacities of patients with moderate to severe Alzheimer's disease.
- Reversibility of dense CT "dot" sign predicts recovery after abciximab and heparin.
- Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome.
- Tetrabenazine: Effective treatment for tardive dyskinesia.
- A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor.
- Nurr1 gene targeting therapy for Parkinson disease.
- The pharmacological and biological effects of pramipexole on dopamine neuron associated genes: DAT, VMAT-2, and Nurr1.
- Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression.
- Long-term prognosis of psychogenic movement disorders.
- Psychogenic dystonia: Clinical characteristics and long-term progression.
- A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox) and botulinum toxin, type B (Myobloc) on systemic and ocular autonomic symptoms and physiology in patients with cervical dystonia.
- Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders.
- Is depression a predictor of outcome after bilateral subthalamic deep brain stimulation in patients with Parkinson's disease?
- Camptocormia: Pathogenesis, classification and response to therapy.
- Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia.
- Haplotype analysis at the ETM2 locus in American and Singaporean populations with familial essential tremor.
- Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
- Essential tremor in children.
- Psychogenic tremor: Long-term outcome.
- Effects of ropinirole on progression of parkinsonism in Nurr1-deficient mice and its underlying mechanisms.
- Dopaminergic properties and anti-parkinsonian effects of IPX750 in rodent models of Parkinson's disease.
- The pharmacological and biological effects of pramipexole on dopamine transporter.
- Decreased Nurr1 mRNA in peripheral blood lymphocytes in Parkinson's disease.
- The efficacy and safety of fluphenazine in patients with Tourette syndrome.
- A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox®) and botulinum toxin, type B (Myobloc™) on autonomic symptoms and physiology in patients with cervical dystonia.
- Temporal course of the motor effects of subthalamic DBS after stopping stimulation.
- Regional and developmental localization of ion-channel genes coexpressed in heart and brain.
- Use of video-EEG monitoring in the differential diagnosis of post-traumatic seizure disorders.
- Persistent changes in seizure susceptibility and GABAergic neurotransmission after recurrent early-life seizures.
- Expression of apoptosis inhibitor protein MCL1 linked to neuroprotection in CNS neurons.
- Presidential symposium: The developing epileptic brain.
- Seizures recorded in patients with mesial temporal sclerosis seen on MRI: Should we "scan and cut" or still rely on long-term video-EEG monitoring?
- Elevated T-type calcium currents in thalamic neurons are associated with spike-wave seizure generation in the mouse mutant Coloboma (Cm/+).
- Expression pattern of candidate epilepsy ion channel genes in mouse and human brains.
- Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variants MOR-1C and MOR-1 in the mouse spleen and kidney.
- Motor inhibition and the BOLD response in the motor cortex.
- Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-Based Impression of Change-Plus version: A comparison of Alzheimer's disease versus vascular dementia.
- Long-term treatment with the NMDA antagonist, memantine: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease.
- Haplotype analysis of unrelated individuals with familial essential tremor.
- Comparison of postoperative improvement of staged bilateral subthalamic stimulation in patients with advanced Parkinson's disease.
- Apolipoprotein E controls risk and age at onset of Parkinson disease.
- Glutathione S-Transferase, Omega-1 (GSTO1) modifies age at onset of Alzheimer disease and Parkinson disease.
- Long term treatment of restless legs syndrome with dopamine agonists.
- The epidemiology of myoclonus in the medical and surgical intensive care unit (ICU).
- Specific mitochondrial haplogroups affect risk for late-onset Parkinson disease.
- Dual-task functioning in mild and moderately severe Parkinson's disease patients.
- Norm-adjusted test scores among complicated mild head injury subtypes.
- The effects of IFN-alpha +13-CRA on patients with squamous cell carcinoma.
- Clinical, electroencephalographic and neuroradiologic characteristics of secondary bilateral synchrony in localization-related epilepsy.
- Utility of continuous video-EEG monitoring in a veteran population: Review of 144 consecutive patients.
- Memory assessment in Spanish-speaking patients with lateralized temporal lobe epilepsy: Can differences be detected?
- EEG abnormalities and epilepsy in Smith-Magenis syndrome and in a genetic mouse model.
- The effect of topiramate on excitatory synaptic transmission in mouse hippocampus.
- Anosognosia during the intracarotid amobarbital (Wada) test is unrelated to memory score or side of injection.
- Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.
- Age-related tolerability of tetrabenazine.
- Tetrabenazine in the treatment of Tourette syndrome.
- Premonitory sensations in tics.
- Reduced Nurr1 expression increases the susceptibility to dopaminergic toxins via nitric oxide.
- Computerized posturography balance assessment of patients with bilateral vim deep brain stimulation.
- Evaluating factors that can influence spirography ratings in patients with essential tremor.
- Upregulation of Nurr1 gene expression by dopamine receptor agonist pramipexole in human neuroblastoma SHSY-5Y cells.
- Reliability of limits of stability measures in Parkinson's disease.
- Minocycline in Huntington's disease: A pilot study.
- Gait and Balance Scale (GABS): Validation and utilization.
- Experience with bilateral subthalamic nucleus (STN) stimulation for Parkinson's disease (PD).
- Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.
- Pleuropulmonary fibrosis after 11 years of pergolide treatment.
- The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study.
- Working memory functioning in mild and moderately severe Parkinson's disease patients.
- Dystonia in Friedreich's ataxia.
- Assessment of neurologic function following short duration spaceflight utilizing a standardized rating scale.
- Neurovestibular effects of long-duration spaceflight: a summary of Mir phase 1 experiences.
- How well do cerebral spinal fluid tau levels discriminate autopsy confirmed Alzheimer's disease from other dementia diagnoses?
- Pathogenesis and treatment strategies for selected therapies under development.
- Long term treatment with the NMDA antagonist memantine: results of a 24-week, open label extension study in moderately severe to severe Alzheimer's disease.
- Cognitive function and cardiovascular risk factors in adults 30-59 years old (NHANES III).
- Inhibitory neural activity produces a significant BOLD response in human cortical areas.
- Selective physician blood pressure remeasurement in the office setting may contribute to poor hypertension control.
- Survival in patients with dementia from a large multi ethnic population.
- An event-related fMRI investigation of motor preparatory processes.
- Diagnosis of post-concussional disorder in brain injury and extra-cranial trauma.
- Relationship between gender and psychiatric disorders after TBI.
- Neuropsychological test scores among complicated mild head injury subtypes.
- Growth curve analysis of decline in instrumental activities of daily living in AD patients.
- Measurement invariance of the WAIS-R in AD among patients at higher versus lower levels of dementia severity.
- WAIS-R factor structure in AD: Comparison of alternative models and assessment of generalizability.
- Comparison of the CIQ and EGOS as measures of outcome n mild to moderate TBI and a matched general trauma sample.
- Health-related quality of life perceptions in patients with postconcussional disorder.
- Ten year outcome of infantile spasms treated with high vs. low dose ACTH.
- Estimated and current intellectual function in patients with intractable epilepsy.
- Temporal intermittent rhythmic delta activity: Prevalence, lateralization and MRI correlation in an adult, outpatient population.
- Magnetoencephalography mislocalizes interictal epileptogenic activity in mesial temporal epilepsy.
- The effect of Ammon's horn sclerosis and atypical sclerosis on memory functioning following temporal lobectomy.
- Neurological impairment, developmental delay and postneonatal seizures two years after EEG-video documented seizures in near-term and full-term neonates: Report of the clinical research centers for neonatal seizures.
- Differential early expression of novel genes in the hippocampus after pilocarpine-induced status epilepticus in inbred mouse strains with high and low seizure susceptibility.
- Vagus nerve stimulation: Correlation of changes in spike morphology with seizure control.
- The effect of Ammon's horn sclerosis and atypical sclerosis on seizure frequency following temporal lobectomy.
- Increased calcium currents in thalamocortical relay cells of tottering and lethargic mice.
- The role of the cerebellum in motor learning and performance.
- Self-assessed knowledge of diabetes management in a low-income, minority patient population.
- Racial differences among patients with Alzheimer's disease from a large multi ethnic population.
- The prevalence of restless legs syndrome in patients with Parkinson's disease.
- The cognitive benefits of galantamine are sustained for at least 24 months: Results of a long-term extension trial in Alzheimer's disease.
- Exploring the relationship between Parkinson's disease and restless legs syndrome.
- Implicit sequence encoding and expression of learning.
- Outcome of complicated mild head injury subtypes.
- Genetic aggregation of calcium channel defects in mice simulates non-Mendelian inherited human epilepsy.
- Bilateral memory dysfunction in epilepsy surgery candidates detected by the intracarotid amobarbital procedure (Wada) test.
- Wada difference a Wada makes: Comparison of two Wada memory tests.
- Expression of a family of calcium channel γ-subunits (CACNG 1-8) in mice.
- Absence of pilocarpine-induced status epilepticus in NeuroD knock out mice.
- Changes in presynaptic Ca currents and transmitter release are synapse-dependent in epileptic mice with calcium channel mutations.
- QOLIE-31 in idiopathic generalized epilepsy.
- Gender differences in psychogenic nonepileptic seizure etiologies and semiologies.
- Altered calcium currents in thalamocortical relay cells of stargazer, a mouse epilepsy model caused by a calcium channel gamma sub-unit mutation.
- Improvement in systolic blood pressure control in a predominantly African-American health center.
- Cholinesterase inhibitors: Benefits and limitations.
- Olanzapine treatment for dopaminergic induced hallucinations.
- Daytime sleepiness in patients with Parkinson's disease.
- Donepezil preserves activities of daily living in Alzheimer's disease patients: Results from a 1-year placebo-controlled functional survival study.
- Profoundly advanced Alzheimer's disease: Patient characteristics, functional status, disease progression, and care burden.
- Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.
- Meta-K-means clustering as a means to separate different functional components of a cognitive task in fMRI single trial data.
- A role for PAR-1 in oocyte determination.
[Platform Presentation]
- Uninterrupted long-term donepezil treatment results in optimal efficacy with retained safety.
- Kappa-opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.
- Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year placebo-controlled attrition study.
- Separation of motor preparation and execution regions using meta-K-means clustering on single trial data.
[Oral Presentation]
- The pattern of synaptophysin expression after middle cerebral artery occlusion and post-infarction MK-801 treatment.
- Optimal donepezil efficacy in Alzheimer's disease is dependent on continued administration.
- Does ApoE4 correlate with MRI changes in Alzheimer's disease?
- Clinical benefits of donepezil: Results from a long-term phase III extension trial.
- A drosophila homologue of c. elegans PAR-1.
[Platform Presentation]
- A drosophila homologue of c. elegans PAR-1.
[Platform Presentation]
- Donepezil improves cognition and global function in Alzheimer's disease: Results from U.S. and multinational phase III clinical trials.
- Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease patients.
- The presence of APO E4 does not influence rate of decline in Alzheimer's disease.
- Ethnic differences in 24-hour blood pressure control in treated hypertensives.
- Current therapeutic standards in the treatment of Alzheimer's disease.
- Research outcome measures in Alzheimer's disease: Statistical significance, effect size and responder analysis - How do they translate to clinical relevance?
- Subcellular relocalization of dishevelled mediates polarity signaling.
[Platform Presentation]
- Mutation of the voltage-dependent calcium channel beta subunit gene Cchb4 is associated with absence seizures and ataxia in the lethargic (lh) mouse.
- A mutation in the sodium/hydrogen exchanger-1 gene causes ataxia and epilepsy in the slow-wave epilepsy mutant mouse.
- Risk factors for neonatal seizures: A population-based study, Harris County, TX, 1992-1994.
- Subtype-specific downregulation of glutamate transporter gene expression in three models of temporal lobe epilepsy.
- Relationship between reduction in cerebral blood flow and superoxide anion following fluid percussion injury of the brain.
- Neuro-otologic evaluation of spatial disorientation and vestibular dysfunction in naval aviation personnel.
- Case report II. Severe and prolonged drowsiness, fatigue, and mood changes in the aviator referred for air sickness.
- Cardiovascular responses to a mixed-gas breathing paradigm for hypoxia induction.
- Outcome measures in dementia trials-video CIBIC validity and reliability.
- Superoxide production by neutrophils in stroke.
- Donepezil HCI (E2020) improves cognitive and global function in patients with mild and moderately severe Alzheimer's disease: Results of a 15-week phase III study.
- Production of extracellular superoxide anion during reperfusion following cerebral ischemia correlates with cerebral infarction.
- Spatial orientation mobile field laboratory assessment of U.S. Navy divers exposed to underwater sound.
- Implementation of a marine aircraft wing sustained operations plan during combat (Operation Desert Storm).
- Assessment of eye movements during high intensity underwater (U/W) sound exposures in U.S. Navy divers.
- U.S. Navy experience with type II decompression sickness and the association with patent foramen ovale.
- Prevalence of uncontrolled hypertension in a population of Alzheimer's patients.
- Assessment of vestibular function of divers exposed to high intensity low frequency underwater sound.
- Dishevelled is a multifunctional signal transducer.
[Platform Presentation]
- Rate of dementia of the Alzheimer's type (DAT) in subjects with mild cognitive impairment.
- E-2020 Produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer's disease (AD): Results of a 30-week phase III trial.
- Pharmacologic evidence for autonomic sudomotor dysfunction in patients with Alzheimer's disease.
- Reliability and validity of a new clinical global rating scale for Alzheimer's clinical trials.
- A new clinical global rating scale for Alzheimer's clinical trials.
- Estrogen and psychomotor performance.
- Human factors in navy/marine fixed and rotary wing class-a mishaps involving 3rd generation night vision goggles (NVG) 1987-1993.
- Atrial fibrillation associated with airsickness.
- A calculated measure to predict rate of progression in Alzheimer's disease.
- Sex differences involving naming in Alzheimer's disease: Stronger relationships with left hemisphere functioning in men.
- Psychometric profiles of Alzheimer's disease (AD) with/without white matter changes compared to subcortical ischemic vascular dementia (IVD).
- Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs.
- Neuropsychological differentiation of corticobasal degeneration from Alzheimer's disease.
- Dysfluency in the speech of AD patients.
- Literacy and cognition in northern Thailand.
- The impact of extended deprenyl treatment in Parkinson's disease patients not requiring levodopa therapy.
- Simulation analysis of a large British pedigree segregating a newly characterized autosomal dominant language disorder: Familial developmental dysphasia.
- Neuroimaging findings and clinical variables associated with psychosis in Alzheimer's disease.
- Correlates of asymmetric motor speed in Alzheimer's disease.
- Neuropsychological correlates of apraxia in Alzheimer's disease patients.
- Single photon emission computerized tomography (SPECT) in Alzheimer's disease and multiple-infarct dementia.
- Establishing the limits of the mini-mental state: MMS "subtests" versus a full neuropsychological battery.
- Positive and negative psychiatric symptoms in Alzheimer's disease.
- Patent foramen ovale and type II altitude decompression sickness.
- The alien hand and related signs.
- Recurrent posterior-type aphasia associated with a seizure focus.
- Progressive nonfluent aphasia.
- Quantitative 2-DG study of the brainstem of the rat during nystagmus produced by lesion of the lateral semicircular ampulla.
- Central nervous system glucose utilization rate in the nystagmic rat.
- Effects of stress management and dietary changes in treating ischemic heart disease.
American Epilepsy Society (AES)
74th Annual Meeting in Seattle, Wash. (Dec. 4-8, 2020)
Society of Neuro-Oncology (SNO)
25th Virtual Annual Scientific Meeting and Education Day (Nov. 19-21, 2020)
Society of Vascular and Interventional Neurology (SVIN)
Virtual 2020 Annual Meeting (Nov. 18-21, 2020)
Joint European Stroke Conference and World Stroke Congress
Virtual Conference (Nov. 7-9, 2020)
Houston Neuropsychological Society
Virtual Fall Symposium (Oct. 24, 2020)
American Congress of Rehabilitation Medicine (ACRM)
Virtual 97th Annual Meeting (Oct. 21-24, 2020)
American Neurological Association (ANA)
145th Annual Meeting in Los Angeles, Calif. (Oct. 4-6, 2020)
Neurocritical Care Society (NCS)
Virtual 18th Annual Meeting (Sept. 22-25, 2020)
Virtual 18th International Conference of Numerical Analysis and Applied Mathematics (ICNAAM)
Rhodes, Greece (Sept. 17-23, 2020)
International Society for Pharmacoepidemilogy (ISPE)
International Conference on Pharmacoepidemilogy (ICPE) All Access 2020 virtual event (Sept. 16-17, 2020)
Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 12-16, 2020)
8th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
MS Virtual 2020 (Sept. 11-13, 2020)
2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)
American Academy of Clinical Neuropsychology (AACN)
18th Annual Meeting in Washington, DC (June 10-13, 2020)
Professional Society for Health Economics and Outcomes Research (ISPOR)
Virtual 2020 Annual Meeting (May 18-20, 2020)
American Academy of Neurology (AAN)
72nd Annual Meeting in Toronto, Ontario, Canada (April 25 - May 1, 2020)
Society of Behavioral Medicine (SBM)
2020 Virtual Annual Meeting and Scientific Sessions (April 1-4, 2020)
American Society on Aging (ASA)
Virtual Annual Conference in Atlanta, Ga. (March 24-27, 2020)
Texas Scottish Rite Hospital for Children
42nd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 20-21, 2020)
American Stroke Association
2020 International Stroke Conference in Los Angeles, Calif. (Feb. 19-21, 2020)
International Neuropsychological Society (INS)
48th Annual Meeting in Denver, Colo. (Feb. 5-8, 2020)
University of Houston Health Research Institute
Health: A Call to Action Conference in Houston, Texas (Jan. 30-31, 2020)
National Aeronautics and Space Administration (NASA)
2020 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 27-30, 2020)
American Epilepsy Society (AES)
73rd Annual Meeting in Baltimore, Md. (Dec. 6-10, 2019)
National Academy of Neuropsychology (NAN)
39th Annual Meeting in San Diego, Calif. (Nov. 13-16, 2019)
University of Pittsburgh Medical School
UPMC Critical Care Symposium in Pittsburgh, Penn. (Nov. 11, 2019)
American Congress of Rehabilitation Medicine (ACRM)
96th Annual Meeting in Chicago, Ill. (Nov. 5-8, 2019)
Society for Neuroscience (SFN)
49th Annual Meeting in Chicago, Ill. (Oct. 19-23, 2019)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
66th Annual Meeting in Austin, Texas (Oct. 16-19, 2019)
Neurocritical Care Society (NCS)
17th Annual Meeting in Vancouver, British Columbia, Canada (Oct. 15-18, 2019)
American Neurological Association (ANA)
144th Annual Meeting in St. Louis, Mo. (Oct. 13-15, 2019)
Movement Disorder Society (MDS)
23rd International Congress of Parkinson's Disease and Movement Disorders in Nice, France (Sept. 22-26, 2019)
Lone Star Stroke Research Consortium
Annual Meeting in Austin, Texas (July 19, 2019)
2019 Alzheimer's Association International Conference (AAIC)
Los Angeles, Calif. (July 14-18, 2019)
Gordon Research Conferences (GRC)
GRC Inhibition in the CNS Conference in Newry, Maine (July 7-9, 2019)
Baylor College of Medicine (BCM)
2nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019)
International Association of Parkinsonism and Related Disorders (IAPRD)
XXIV World Congress on Parkinson's Disease and Related Disorders in Montreal, Canada. (June 16-19, 2019)
American Academy of Clinical Neuropsychology (AACN)
17th Annual Meeting in Chicago, Ill. (June 5-8, 2019)
World Parkinson Congress (WPC)
Kyoto, Japan (June 4-7, 2019)
European Stroke Organisation (ESO)
5th Conference in Milan, Italy (May 22-24, 2019)
Professional Society for Health Economics and Outcomes Research (ISPOR)
2019 Annual Meeting in New Orleans, La. (May 18-22, 2019)
Psychiatric Associations of Puerto Rico
Second Summit in Río Grande, Puerto Rico (May 2019)
American Academy of Neurology (AAN)
71st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)
University of Pittsburgh
Mitchell P. Fink Scholar Day in Pittsburgh, Penn. (April 16, 2019)
Parkinson Study Group (PSG)
32nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Phoenix, Ariz. (April 6, 2019)
14th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
Lisbon, Portugal (March 26-31, 2019)
North American Neuro-Ophthalmology Society (NANOS)
45th Annual Meeting in Las Vegas, Nev. (March 16-21, 2019)
Hispanic Neuropsychological Society (HNS)
3rd Biannual Conference in New York City, N.Y. (Feb. 23, 2019)
Texas Scottish Rite Hospital for Children
41st Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 21-22, 2019)
International Neuropsychological Society (INS)
47th Annual Meeting in New York, N.Y. (Feb. 20-23, 2019)
American Stroke Association
2019 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2019)
National Aeronautics and Space Administration (NASA)
2019 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 22-25, 2019)
American Epilepsy Society (AES)
72nd Annual Meeting in New Orleans, La. (Nov. 30 - Dec. 4, 2018)
Society of Neuro-Oncology (SNO)
23rd Annual Scientific Meeting and Education Day in New Orleans, La. (Nov. 15-18, 2018)
Huntington Study Group (HSG)
Annual Meeting in Houston, Texas (Nov. 8-10, 2018)
Society for Neuroscience (SFN)
48th Annual Meeting in San Diego, Calif. (Nov. 3-7, 2018)
American Neurological Association (ANA)
143rd Annual Meeting in Atlanta, Ga. (Oct. 21-23, 2018)
11th World Stroke Congress
Montreal, Canada (Oct. 17-20, 2018)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
65th Annual Meeting in Washington, DC (Oct. 10-13, 2018)
Movement Disorder Society (MDS)
22nd International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, China (Oct. 5-9, 2018)
Neurocritical Care Society (NCS)
16th Annual Meeting in Boca Raton, Fla. (Sept. 25-28, 2018)
American Psychological Association (APA)
126th Annual Convention in San Francisco, Calif. (Aug. 9-12, 2018)
2018 Alzheimer's Association International Conference (AAIC)
Chicago, Ill. (July 22-26, 2018)
2018 Congress of Neurological Surgeons (CNS)
Annual Meeting in Houston, Texas (June 22, 2018)
Organization of Human Brain Mapping (OHBM)
2018 Annual Meeting in Singapore (June 17-21, 2018)
American Society for Stereotactic and Functional Neurosurgery (ASSFN)
2018 Biennial Meeting in Denver, Colo. (June 2-5, 2018)
American Society of Clinical Oncology (ASCO)
54th Annual Meeting in Chicago, Ill. (June 1-5, 2018)
European Stroke Organisation (ESO)
4th Conference in Gothenburg, Sweden (May 16-18, 2018)
Columbia University College of Physicians and Surgeons
1st International Tremor Congress in New York City, N.Y. (May 11-12, 2018)
International Conference on Integrative Medicine and Health
2018 Annual Meeting in Baltimore, Md. (May 8-11, 2018)
University of Pittsburgh
Mitchell P. Fink Scholar Day in Pittsburgh, Penn. (April 24, 2018)
American Academy of Neurology (AAN)
70th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)
San Juan Bautista School of Medicine
Symposium: Resiliency upon disaster in Caguas, Puerto Rico (April 7, 2018)
American Association of Neuroscience Nurses (AANN)
50th Annual Meeting in San Diego, Calif. (March 17-20, 2018)
American Stroke Association
2018 International Stroke Conference in Los Angeles, Calif. (Jan. 24-26, 2018)
National Aeronautics and Space Administration (NASA)
2018 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 22-25, 2018)
Vivekananda Yoga Anusandhana Samsthana (V-YASA)
22nd International Conference on Frontiers in Yoga Research and Its Applications in Prashanti Kutiram, Bangalore, India (Jan. 5-8, 2018)
American Epilepsy Society (AES)
71st Annual Meeting in Washington, DC (Dec. 1-5, 2017)
Society for Neuroscience (SFN)
47th Annual Meeting in Washington, DC (Nov. 11-15, 2017)
Society of Vascular and Interventional Neurology (SVIN)
10th Annual Meeting in Boston, Mass. (Nov. 8-11, 2017)
American Society for Metabolic and Bariatric Surgery (ASMBS)
ObesityWeek 2017 in Washington, DC (Oct. 29 - Nov. 2, 2017)
National Academy of Neuropsychology (NAN)
37th Annual Meeting in Boston, Mass. (Oct. 25-28, 2017)
American Congress of Rehabilitation Medicine (ACRM)
94th Annual Conference in Atlanta, Ga. (Oct. 23-28, 2017)
American Neurological Association (ANA)
142nd Annual Meeting in San Diego, Calif. (Oct. 15-17, 2017)
Neurocritical Care Society (NCS)
15th Annual Meeting in Waikoloa, Hawaii (Oct. 10-13, 2017)
Stanford University
Cannabinoid Signaling in Epilepsy: Pathways to Therapy Workshop in Stanford, Calif. (Oct. 9-10, 2017)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
64th Annual Meeting in Phoenix, Ariz. (Sept. 13-16, 2017)
32nd International Epilepsy Congress (IEC)
Barcelona, Spain (Sept. 2-6, 2017)
American Psychological Association (APA)
125th Annual Convention in Washington, DC (Aug. 3-6, 2017)
2017 Alzheimer's Association International Conference (AAIC)
London, United Kingdom (July 15-20, 2017)
Movement Disorder Society (MDS)
21st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada (June 4-8, 2017)
Consortium of Multiple Sclerosis Centers (CMSC)
31st Annual Meeting in New Orleans, La. (May 24-27, 2017)
European Stroke Organisation (ESO)
3rd Conference in Prague, Czech Republic (May 16-18, 2017)
Ponce Health Sciences University (PHSU)
13th Annual Scientific Conference in Ponce, Puerto Rico (May 13, 2017)
Institute for Healthcare Advancement (IHA)
16th Health Literacy Conference in Irvine, Calif. (May 3-5, 2017)
6th World Intracranial Hemorrhage Conference (WICH)
Baltimore, Md. (May 1-3, 2017)
Baylor College of Medicine (BCM)
Annual Quality Improvement and Patient Safety Conference 2017 in Houston, Texas (April 26, 2017)
American Academy of Neurology (AAN)
69th Annual Meeting in Boston, Mass. (April 22-28, 2017)
American Stroke Association
2017 International Stroke Conference in Houston, Texas (Feb. 22-24, 2017)
Society of General Internal Medicine (SGIM)
2017 Southern Regional Meeting in New Orleans, La. (Feb. 10-12, 2017)
International Neuropsychological Society (INS)
45th Annual Meeting in New Orleans, La. (Feb. 1-7, 2017)
International Neurotoxin Association (INA)
Toxins 2017 3rd International Conference in Madrid, Spain (Jan. 18-21, 2017)
American Epilepsy Society (AES)
70th Annual Meeting in Houston, Texas (Dec. 2-6, 2016)
American Heart Association
2016 Scientific Sessions in New Orleans, La. (Nov. 12-16, 2016)
Society for Neuroscience (SFN)
46th Annual Meeting in San Diego, Calif. (Nov. 12-16, 2016)
American Neurological Association (ANA)
141st Annual Meeting in Baltimore, Md. (Oct. 16-18, 2016)
Neurocritical Care Society (NCS)
14th Annual Meeting in National Harbor, Md. (Sept. 15-18, 2016)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
63rd Annual Meeting in New Orleans, La. (Sept. 14-17, 2016)
International OCD Foundation (IOCDF)
23rd Annual OCD Conference in Chicago, Ill. (July 29-31, 2016)
2016 Alzheimer's Association International Conference (AAIC)
Toronto, Canada (July 22-28, 2016)
Federation of American Societies for Experimental Biology (FASEB)
Science Research Conference (Neural Mechanisms in Cardiovascular Regulation: Novel Research and Disease Treatment Strategies) in Saxtons River, Vt. (July 17-22, 2016)
16th International Symposium on Intracranial Pressure (ICP) and Neuromonitoring
Boston, Mass. (June 28 - July 2, 2016)
Movement Disorder Society (MDS)
20th International Congress of Parkinson's Disease and Movement Disorders in Berlin, Germany (June 19-23, 2016)
National Institute of Mental Health and Neuro-Sciences (NIMHANS)
symposium on "History of psychiatry in India: Traditional systems and mental health" in Bangalore, India (June 15-16, 2016)
Consortium of Multiple Sclerosis Centers (CMSC)
30th Annual Meeting in National Harbor, Md. (June 1-4, 2016)
2016 American Society of Neurophysiological Monitoring (ASNM)
Annual Meeting in Chicago, Ill. (May 12-15, 2016)
American Academy of Neurology (AAN)
68th Annual Meeting in Vancouver, BC, Canada (April 15-21, 2016)
Association of University Radiologists (AUR)
64th Annual Meeting in San Diego, Calif. (March 29 - April 1, 2016)
American Stroke Association
2016 International Stroke Conference in Los Angeles, Calif. (Feb. 17-19, 2016)
National Aeronautics and Space Administration (NASA)
Human Research Program Investigators' Workshop in Galveston, Texas (Feb. 10, 2016)
International Neuropsychological Society (INS)
44th Annual Meeting in Boston, Mass. (Feb. 3-6, 2016)
Vivekananda Yoga Anusandhana Samsthana (V-YASA)
21st International Conference on Frontiers in Yoga Research and Its Applications in Prashanti Kutiram, Bangalore, India (Jan. 3-5, 2016)
American Epilepsy Society (AES)
69th Annual Meeting in Philadelphia, Penn. (Dec. 4-8, 2015)
Gerontological Society of America (GSA)
68th Annual Meeting in Orlando, Fla. (Nov. 18-22, 2015)
XXII World Congress of Neurology (WCN)
Santiago, Chile (Oct. 31 - Nov. 5, 2015)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
62nd Annual Meeting in Honolulu, Hawaii (Oct. 28-31, 2015)
American Academy of Pediatrics (AAP)
2015 National Conference and Exhibition in Washington, DC (Oct. 23-27, 2015)
American Society for Bioethics and Humanities (ASBH)
17th Annual Meeting in Houston, Texas (Oct. 22-25, 2015)
Society for Neuroscience (SFN)
45th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2015)
Society of Vascular and Interventional Neurology (SVIN)
8th Annual Meeting in Bonita Springs, Fla. (Oct. 15-18, 2015)
Society for Pediatric Pathology (SPP)
Fall Meeting in Toronto, Ontario, Canada (Oct. 1-4, 2015)
American Neurological Association (ANA)
140th Annual Meeting in Chicago, Ill. (Sept. 27-29, 2015)
7th European Workshop on Cannabinoid Research
Sestri Levante, Italy (Sept. 17-19, 2015)
University of Puerto Rico
Department of Students with Disabilities in Bayamón, Puerto Rico (September 2015)
31st International Epilepsy Congress (IEC)
Istanbul, Turkey (Sept. 5-9, 2015)
2015 Alzheimer's Association International Conference (AAIC)
Washington, DC (July 18-23, 2015)
North American Primary Care Research Group (NAPCRG)
2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015)
University of Kentucky
2015 Clinical & Translational Neuroscience Exposition in Lexington, Ky. (June 26, 2015)
American Headache Society
57th Annual Scientific Meeting in Washington, DC (June 18-21, 2015)
Movement Disorder Society (MDS)
19th International Congress of Parkinson's Disease and Movement Disorders in San Diego, Calif. (June 14-18, 2015)
American Association of Neuropathologists, Inc. (AANP)
91st Annual Meeting in Denver, Colo. (June 11-14, 2015)
International Myotonic Dystrophy Consortium (IDMC)
10th Meeting in Paris, France (June 8-10, 2015)
American Society of Clinical Oncology (ASCO)
51st Annual Meeting in Chicago, Ill. (May 29 - June 2, 2015)
University of Toronto
3rd International Conference on Knowledge Gaps in Parkinson's disease and Other Movement Disorders in Toronto, Canada (May 8-10, 2015)
American Stroke Association
Quality of Care and Outcomes Research Scientific Sessions in Baltimore, Md. (April 29 - May 1, 2015)
American Academy of Neurology (AAN)
67th Annual Meeting in Washington, DC (April 18-25, 2015)
European Stroke Organisation (ESO)
1st Conference in Glasgow, Scotland (April 17-19, 2015)
Anxiety and Depression Association of America (ADAA)
2015 Annual Conference in Miami, Fla. (April 9-12, 2015)
Experimental Biology (EB)
2015 Annual Meeting in Boston, Mass. (March 28 - April 1, 2015)
10th University of Alabama at Birmingham (UAB)
Health Disparities Research Symposium in Birmingham, Ala. (March 17-18, 2015)
American Stroke Association
2015 International Stroke Conference in Nashville, Tenn. (Feb. 11-13, 2015)
Texas Neurological Society
18th Annual Winter Conference in Austin, Texas (Feb. 6-8, 2015)
International Neuropsychological Society (INS)
43rd Annual Meeting in Denver, Colo. (Feb. 4-7, 2015)
American Clinical Neurophysiology Society (ACNS)
2015 Annual Meeting in Houston, Texas (Feb. 3-8, 2015)
International Neurotoxin Association (INA)
Toxins 2017 2nd International Conference in Lisbon, Portugal (Jan. 14-17, 2015)
American Epilepsy Society (AES)
68th Annual Meeting in Seattle, Wash. (Dec. 5-9, 2014)
North American Primary Care Research Group (NAPCRG)
42nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014)
Society for Neuroscience (SFN)
44th Annual Meeting in Washington, DC (Nov. 15-19, 2014)
Gerontological Society of America (GSA)
2014 Resource Centers for Minority Aging Research (RCMAR) Cognitive Health Disparities Research & National Policy Workshop in Washington, DC (Nov. 5, 2014)
American Neurological Association (ANA)
139th Annual Meeting in Baltimore, Md. (Oct. 12-14, 2014)
Neurocritical Care Society (NCS)
12th Annual Meeting in Seattle, Wash. (Sept. 11-14, 2014)
2014 Alzheimer's Association International Conference (AAIC)
Copenhagen, Denmark (July 12-17, 2014)
North American Primary Care Research Group (NAPCRG)
2014 Practice-Based Research Network Conference in Bethesda, Md. (June 30 - July 1, 2014)
Movement Disorder Society (MDS)
18th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden (June 8-12, 2014)
American Society of Clinical Oncology (ASCO)
50th Annual Meeting in Chicago, Ill. (May 30 - June 3, 2014)
American Academy of Neurology (AAN)
66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)
Texas Scottish Rite Hospital for Children
36th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 13-14, 2014)
International Neuropsychological Society (INS)
42nd Annual Meeting in Seattle, Wash. (Feb. 12-15, 2014)
American Stroke Association
2014 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2014)
American Epilepsy Society (AES)
67th Annual Meeting in Washington, DC (Dec. 6-10, 2013)
Society of Neuro-Oncology (SNO)
18th Annual Meeting in San Francisco, Calif. (Nov. 21-24, 2013)
Society for Neuroscience (SFN)
43rd Annual Meeting in San Diego, Calif. (Nov. 9-13, 2013)
American Neurological Association (ANA)
138th Annual Meeting in New Orleans, La. (Oct. 13-15, 2013)
Neurocritical Care Society (NCS)
11th Annual Meeting in Philadelphia, Penn. (Oct. 1-4, 2013)
XXI World Congress of Neurology (WCN)
Vienna, Austria (Sept. 21-26, 2013)
Alzheimer's Association, Houston and Southeast Texas Chapter
7th Annual Research Symposium on Alzheimer's Disease (Sept. 12, 2013)
Northwestern University
Evanston, Ill. (August 2013)
2013 Alzheimer's Association International Conference (AAIC)
Boston, Mass. (July 13-18, 2013)
Movement Disorder Society (MDS)
17th International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia (June 16-20, 2013)
European Neurological Society (ENS)
23rd Annual Meeting in Barcelona, Spain (June 8-11, 2013)
American Society of Clinical Oncology (ASCO)
49th Annual Meeting in Chicago, Ill. (May 31 - June 4, 2013)
Consortium of Multiple Sclerosis Centers (CMSC)
27th Annual Meeting in Orlando, Fla. (May 29 - June 1, 2013)
Society for Industrial and Applied Mathematics (SIAM)
13th International Conference on Data Mining in Austin, Texas (May 2-4, 2013)
Society for Neuroscience - Bluegrass Chapter (BGSFN)
29th Annual Spring Neuroscience Research Meeting in Lexington, Ky. (April 8, 2013)
American Academy of Neurology (AAN)
65th Annual Meeting in San Diego, Calif. (March 16-23, 2013)
University of Puerto Rico
San Juan, Puerto Rico (February 2013)
Texas Scottish Rite Hospital for Children
35th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 14-15, 2013)
American Heart Association/American Stroke Association
2013 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2013)
International Neuropsychological Society (INS)
41st Annual Meeting in Montreal, Waikoloa, Hawaii (Feb. 6-9, 2013)
American Stroke Association
2013 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2013)
Keystone Symposium
New Frontiers in Neurodegenerative Disease Research Meeting in Santa Fe, N.M. (Feb. 5, 2013)
University of Puerto Rico
21st Annual Puerto Rico Neuroscience Conference in Old San Juan, Puerto Rico (Dec. 1, 2012)
American Epilepsy Society (AES)
66th Annual Meeting in San Diego, Calif. (Nov. 30 - Dec. 4, 2012)
National Academy of Neuropsychology (NAN)
32nd Annual Meeting in Nashville, Tenn. (Nov. 7-10, 2012)
Baylor College of Medicine (BCM)
Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012)
Houston Neuropsychological Society
2012 Annual Symposium in Houston, Texas (October 2012)
Society for Neuroscience (SFN)
42nd Annual Meeting in New Orleans, La. (Oct. 13-17, 2012)
World Stroke Organization (WSO)
8th World Stroke Congress in Brasilia, Brazil (Oct. 10-13, 2012)
American Neurological Association (ANA)
137th Annual Meeting in Boston, Mass. (Oct. 7-9, 2012)
Neurocritical Care Society (NCS)
10th Annual Meeting in Denver, Colo. (Oct. 4-7, 2012)
University of Puerto Rico
San Juan, Puerto Rico (August 2012)
American Psychological Association (APA)
120th Annual Convention in Orlando, Fla. (Aug. 2-5, 2012)
Alzheimer's Association International Conference (AAIC)
Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012)
AREADNE Foundation, Inc.
Conference in Santorini, Greece (June 21-24, 2012)
Movement Disorder Society (MDS)
16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland (June 17-21, 2012)
American Society of Hypertension (ASH)
27th Annual Scientific Meeting and Exposition in New York, N.Y. (May 19-22, 2012)
Vision Sciences Society (VSS)
12th Annual Meeting in Naples, Fla. (May 11-16, 2012)
Parkinson Study Group (PSG)
26th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012)
American Academy of Neurology (AAN)
64th Annual Meeting in New Orleans, La. (April 21-28, 2012)
University of Pittsburgh
Undergraduate Honors Research Fair in Pittsburgh, Penn. (April 2012)
Texas Scottish Rite Hospital for Children
34th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 23-24, 2012)
International Neuropsychological Society (INS)
40th Annual Meeting in Montreal, Quebec, Canada (Feb. 15-18, 2012)
American Clinical Neurophysiology Society (ACNS)
2012 Annual Meeting in San Antonio, Texas (Feb. 7-12, 2012)
American Stroke Association
2012 International Stroke Conference in New Orleans, La. (Feb. 1-3, 2012)
2011 International Society for Zinc Biology (ISZB)
Meeting in Melbourne, Australia (Jan. 15-19, 2012)
Biochemical Society
Conference: The biology and pathology of tau and its role in tauopathies II in Cambridge, U.K. (Jan. 8-9, 2012)
American Epilepsy Society (AES)
65th Annual Meeting in Baltimore, Md. (Dec. 2-6, 2011)
Society for Neuroscience (SFN)
41st Annual Meeting in Washington, DC (Nov. 12-16, 2011)
Honor Society of Nursing, Sigma Theta Tau International (STTI)
41st Biennial Convention in Grapevine, Texas (Oct. 29 - Nov. 2, 2011)
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
World Stroke Day in Pondicherry, India (Oct. 29, 2011)
University of Pittsburgh
Science 2011: Next Gen Conference in Pittsburgh, Penn. (Oct. 6-7, 2011)
American Neurological Association (ANA)
136th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)
Neurocritical Care Society (NCS)
9th Annual Meeting in Montreal, Quebec, Canada (Sept. 21-24, 2011)
Michael J. Fox Parkinson's Research Foundation
Genetic Epidemiology of Parkinson's Disease Consortium Meeting in Evanston, Ill. (Sept. 18-21, 2011)
European Federation of Neurological Societies (EFNS)
15th Congress in Budapest, Hungary (Sept. 10-13, 2011)
American Psychological Association (APA)
119th Annual Convention in Washington, DC (Aug. 4-7, 2011)
2011 International Conference on Alzheimer's Disease (ICAD)
Paris, France (July 16-21, 2011)
Gordon Research Conferences (GRC)
Excitatory Synapses & Brain Function Meeting in Easton, Mass. (June 26 - July 1, 2011)
Movement Disorder Society (MDS)
15th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada (June 5-9, 2011)
International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 2011, 25th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Barcelona, Spain (May 25-28, 2011)
European Stroke Conference (ESC)
20th Annual Meeting in Hamburg, Germany (May 24-27, 2011)
International Neuromodulation Society (INS)
10th World Congress in London, United Kingdom (May 21-26, 2011)
American College of Physicians (ACP)
Michigan Chapter Scientific Meeting in Ann Arbor, Mich. (May 20, 2011)
American Heart Association
2011 Quality of Care and Outcomes Research Meeting (QCOR) in Washington, DC (May 12-14, 2011)
Plasticise
2nd Annual Meeting in Stresa, Italy (May 4-6, 2011)
University of Edinburgh
Edinburgh, Scotland (April 26, 2011)
The Southern Group on Educational Affairs
Meeting in Houston, Texas (April 14-16, 2011)
American Academy of Neurology (AAN)
63rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)
AD/PD
10th International Congress on Alzheimer's and Parkinson's Diseases in Barcelona, Spain (March 9-13, 2011)
Keystone Symposium
Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011)
Texas Scottish Rite Hospital for Children
33rd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 17-18, 2011)
American Stroke Association
2011 International Stroke Conference in Los Angeles, Calif. (Feb. 8-11, 2011)
International Neuropsychological Society (INS)
39th Annual Meeting in Boston, Mass. (Feb. 2-5, 2011)
Aga Khan University
Annual Research Assembly in Karachi, Pakistan (2011)
Rush University
ROS/MAP Investigator Meeting in Chicago, Ill. (2011)
2010 American Society for Cell Biology (ASCB)
Annual Meeting in Philadelphia, Penn. (Dec. 11-15, 2010)
American Epilepsy Society (AES)
64th Annual Meeting in San Antonio, Texas (Dec. 3-7, 2010)
Society for Neuroscience (SFN)
40th Annual Meeting in San Diego, Calif. (Nov. 13-17, 2010)
Mission Connect/TIRR Foundation
Scientific Meeting in Houston, Texas (Nov. 12, 2010)
American Society of Human Genetics (ASHG)
60th Annual Meeting in Washington, DC (Nov. 2-6, 2010)
29th International Congress of Clinical Neurophysiology (ICCN)
Kobe, Japan (Oct. 28 - Nov. 1, 2010)
Baylor College of Medicine (BCM)
Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2010)
Neurocritical Care Society (NCS)
8th Annual Meeting in San Francisco, Calif. (Sept. 15-18, 2010)
American Psychological Association (APA)
118th Annual Convention in San Diego, Calif. (Aug. 12-15, 2010)
Honor Society of Nursing, Sigma Theta Tau International (STTI)
21st International Nursing Research Congress in Orlando, Fla. (July 12-16, 2010)
2010 International Conference on Alzheimer's Disease (ICAD)
Honolulu, Hawaii (July 10-15, 2010)
European Neurological Society (ENS)
20th Annual Meeting in Berlin, Germany (June 19-23, 2010)
Movement Disorder Society (MDS)
14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010)
Organization of Human Brain Mapping (OHBM)
16th International Conference in Barcelona, Spain (June 6-10, 2010)
Consortium of Multiple Sclerosis Centers (CMSC)
24th Annual Meeting in San Antonio, Texas (June 2-5, 2010)
European Stroke Conference (ESC)
19th Annual Meeting in Barcelona, Spain (May 25-28, 2010)
Rutgers/UMDNJ-Robert Wood Johnson Medical School
Research Session in Piscataway, N.J. (April 2010)
American Academy of Neurology (AAN)
62nd Annual Meeting in Toronto, Canada (April 10-17, 2010)
Southwestern Psychological Association (SWPA)
2010 Annual Convention in Dallas, Texas (April 8-10, 2010)
University of Jordan
Scientific Day at Faculty of Medicine in Amman, Jordan (April 6, 2010)
Howard Hughes Medical Institure (HHMI)
Structural Plasticity in the Mammalian System Symposium at Janelia Farm in Chevy Chase, Md. (March 2010)
American Society for Neurochemistry (ASN)
41st Annual Meeting in Santa Fe, N.M. (March 6-10, 2010)
Texas Scottish Rite Hospital for Children
32nd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 25-26, 2010)
American Stroke Association
2010 International Stroke Conference in San Antonio, Texas (Feb. 23-26, 2010)
Baylor College of Medicine (BCM)
20th Annual Rush and Helen Record Neuroscience Forum in Galveston, Texas (Feb. 19-21, 2010)
International Neuropsychological Society (INS)
38th Annual Meeting in Acapulco, Mexico (Feb. 3, 2010)
NINDS and ALS Association
Workshop: Advances in Disease Modeling for ALS and FTD in San Diego, Calif. (2010)
Rice University and the Texas Medical Center
Bioscience Research Collaborative in Houston, Texas (2010)
Rush University
CHAP Investigator Meeting in Chicago, Ill. (2010)
World Federation of Neurology (WFN)
XVIII World Congress on Parkinson's Disease and Related Disorders in Miami Beach, Fla. (Dec. 13-16, 2009)
American Epilepsy Society (AES)
63rd Annual Meeting in Boston, Mass. (Dec. 4-8, 2009)
Neurocritical Care Society (NCS)
7th Annual Meeting in New Orleans, La. (Nov. 11-14, 2009)
Baylor College of Medicine (BCM)
Current Neurology 2009 in Houston, Texas (Oct. 31 - Nov. 1, 2009)
Society for Neuroscience (SFN)
39th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2009)
Baylor College of Medicine (BCM)
Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2009)
Society of Teachers of Family Medicine (STFM)
Northeast Region Conference in Rye Brook, N.Y. (October 2009)
North American Brain Injury Society (NABIS)
7th Annual Conference on Brain Injury in Austin, Texas (Oct. 14-17, 2009)
American Neurological Association (ANA)
134th Annual Meeting in Baltimore, Md. (Oct. 11-14, 2009)
Optical Society of America (OSA)
Annual Vision Meeting in Seattle, Wash. (Sept. 24, 2009)
European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009)
International Federation for Medical and Biological Engineering (IFMBE)
World Congress on Medical Physics and Biomedical Engineering in Munich, Germany (Sept. 7-12, 2009)
US Department of Defense
Military Health Research Forum 2009 in Kansas City, Mo. (Aug. 31 - Sept. 3, 2009)
American Psychological Association (APA)
117th Annual Convention in Toronto, Canada (Aug. 6-9, 2009)
VA Mental Health
3rd Annual Conference in Washington, DC (July 21-23, 2009)
Honor Society of Nursing, Sigma Theta Tau International (STTI)
20th International Nursing Research Congress in Vancouver, Canada (July 13-17, 2009)
2009 International Conference on Alzheimer's Disease (ICAD)
Vienna, Austria (July 11-16, 2009)
28th International Epilepsy Congress (IEC)
Budapest, Hungary (June 29 - July 2, 2009)
Movement Disorder Society (MDS)
13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France (June 7-11, 2009)
American College of Sports Medicine (ACSM)
56th Annual Meeting in Seattle, Wash. (May 27-30, 2009)
Consortium of Multiple Sclerosis Centers (CMSC)
23rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)
European Stroke Conference (ESC)
18th Annual Meeting in Stokholm, Sweden (May 26-29, 2009)
American Academy of Neurology (AAN)
61st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)
American Heart Association
Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference in Washington, DC (April 23-25, 2009)
American College of Cardiology (ACC)
58th Annual Scientific Session in Orlando, Fla. (March 29-31, 2009)
Baylor College of Medicine (BCM)
James K. Alexander Research Symposium in Houston, Texas (March 2009)
Association of Academic Physiatrists (AAP)
Annual Meeting in Colorado Springs, Colo. (Feb. 24-28, 2009)
Texas Scottish Rite Hospital for Children
31st Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 19-20, 2009)
American Stroke Association
2009 International Stroke Conference in San Diego, Calif. (Feb. 17-20, 2009)
International Neuropsychological Society (INS)
37th Annual Meeting in Atlanta, Ga. (Feb. 11-14, 2009)
VA's Health Services Research & Development Service (HSR&D)
Quality Enhancement Research Initiative (QUERI) National Meeting in Phoenix, Ariz. (Dec. 10-12, 2008)
American Epilepsy Society (AES)
62nd Annual Meeting in Seattle, Wash. (Dec. 5-9, 2008)
American Academy of Physical Medicine and Rehabilitation (AAPM&R)
2008 Annual Assembly in San Diego, Calif. (Nov. 20-23, 2008)
Society for Neuroscience (SFN)
38th Annual Meeting in Washington, DC (Nov. 15-19, 2008)
National Multiple Sclerosis Society (NMSS)
Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008)
International Symposium on ALS/MND
19th Annual Meeting in Birmingham, UK (Nov. 3-5, 2008)
Society of Vascular and Interventional Neurology (SVIN)
2nd Annual Meeting in Miami, Fla. (Oct. 24-26, 2008)
Neurocritical Care Society (NCS)
6th Annual Meeting in Miami, Fla. (Oct. 23-25, 2008)
6th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders
Dresden, Germany (Oct. 16-19, 2008)
American Neurological Association (ANA)
133rd Annual Meeting in Salt Lake City, Utah (Sept. 21-24, 2008)
World Stroke Organization (WSO)
10th International Symposium on Thrombolysis and Acute Stroke Therapy in Budapest, Hungary (Sept. 21-23, 2008)
World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
Montreal, Quebec, Canada (Sept. 17-20, 2008)
Rutgers/UMDNJ-Robert Wood Johnson Medical School
Poster Session in Piscataway, N.J. (August 2008)
American Psychological Association (APA)
116th Annual Convention in Boston, Mass. (Aug. 14-17, 2008)
Mechanisms of Epilepsy and Neuronal Synchronization
Gordon Research Conference in Waterville, Maine (Aug. 3-8, 2008)
2008 International Conference on Alzheimer's Disease (ICAD)
Chicago, Ill. (July 26-31, 2008)
Natural and Medical Sciences Institute (NMI)
6th International Meeting on Substrate-integrated Microelectrode Arrays in Reutlingen, Germany (July 8-11, 2008)
Movement Disorder Society (MDS)
12th International Congress of Parkinson's Disease and Movement Disorders in Chicago, Ill. (June 22-26, 2008)
Consortium of Multiple Sclerosis Centers (CMSC)
22nd Annual Meeting in Denver, Colo. (May 28-31, 2008)
European Stroke Conference (ESC)
17th Annual Meeting in Nice, France (May 13-16, 2008)
American Academy of Neurology (AAN)
60th Annual Meeting in Chicago, Ill. (April 12-19, 2008)
Baylor College of Medicine (BCM)
Research Symposium in Houston, Texas (March 2008)
American Stroke Association
2008 International Stroke Conference in New Orleans, La. (Feb. 20-22, 2008)
Texas Scottish Rite Hospital for Children
30th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 20-22, 2008)
American Stroke Association
International Stroke Conference, 2008 State-of-the-Art Stroke Nursing Symposium in New Orleans, La. (Feb. 19, 2008)
International Symposium on ALS/MND
18th Annual Meeting in Toronto, Canada (Dec. 1-3, 2007)
American Epilepsy Society (AES)
61st Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 4, 2007)
Michael E. DeBakey Veterans Affairs Medical Center
Advanced Practice Nursing Conference on the Management of Chronic Disease in Houston, Texas (November 2007)
National Academy of Neuropsychology (NAN)
27th Annual Meeting in Scottsdale, Ariz. (Nov. 14-18, 2007)
Mexican Academy of Neurology
31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007)
European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007)
American Neurological Association (ANA)
132nd Annual Meeting in Washington, DC (Oct. 7-10, 2007)
Association of Academic Physiatrists (AAP)
Annual Meeting in San Juan, Puerto Rico (Sept. 27-30, 2007)
American Psychological Association (APA)
115th Annual Convention in San Francisco, Calif. (Aug. 17-20, 2007)
Colombian Academy of Neurology
VIII Meeting in Cali, Colombia (Aug. 16-19, 2007)
American Nurses Association (ANA)
Symposium on Nursing Care in Life, Death and Disaster in Atlanta, Ga. (June 2007)
Memorial Sloan-Kettering Cancer Research Center
Poster Session in New York, N.Y. (June 2007)
2nd International Frontotemporal Dementia in ALS Research Conference
London, Ontario Canada (June 10-13, 2007)
Alzheimer's Association International Conference (AAIC)
Washington, DC (June 9-12, 2007)
Movement Disorder Society (MDS)
11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)
Consortium of Multiple Sclerosis Centers (CMSC)
21st Annual Meeting in Washington, DC (May 30 - June 2, 2007)
International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 2007, 23rd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Osaka, Japan (May 20-24, 2007)
American Academy of Neurology (AAN)
59th Annual Meeting in Boston, Mass. (April 28 - May 5, 2007)
8th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
Salzburg, Austria (March 14-18, 2007)
American Heart Association
47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Orlando, Fla. (Feb. 28 - March 3, 2007)
Texas Scottish Rite Hospital for Children
29th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 22-23, 2007)
North American Neuro-Ophthalmology Society (NANOS)
33rd Annual Meeting in Snowbird, Utah (Feb. 10-15, 2007)
International Neuropsychological Society (INS)
35th Annual Meeting in Portland, Ore. (Feb. 7-10, 2007)
American Stroke Association
2007 International Stroke Conference in San Francisco, Calif. (Feb. 7-9, 2007)
American Epilepsy Society (AES)
60th Annual Meeting in San Diego, Calif. (Dec. 1-5, 2006)
International Symposium on ALS/MND
17th Annual Meeting in Yokohama, Japan (Nov. 30 - Dec. 2, 2006)
Neurocritical Care Society (NCS)
4th Annual Meeting in Baltimore, Md. (Nov. 4-5, 2006)
Mexican Academy of Neurology
30th Annual Meeting in Merida, Yucatan, Mexico (Oct. 30 - Nov. 4, 2006)
Movement Disorder Society (MDS)
10th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)
American Neurological Association (ANA)
131st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)
5th International Conference on Frontotemporal Dementia
San Francisco, Calif. (Sept. 6-8, 2006)
International Society for Developmental Neuroscience (ISDN)
16th Biennial Meeting in Banff, Canada (Aug. 24-28, 2006)
Mechanisms of Epilepsy and Neuronal Synchronization
Gordon Research Conference in Waterville, Maine (Aug. 6-11, 2006)
10th International Conference on Alzheimer's Disease and Related Disorders
Madrid, Spain (July 15-20, 2006)
Natural and Medical Sciences Institute (NMI)
5th International Meeting on Substrate-integrated Microelectrode Arrays in Reutlingen, Germany (July 4-7, 2006)
World Federation of Neurology (WFN)
11th International Congress on Neuromuscular Diseases in Istanbul, Turkey (July 2-7, 2006)
Center for Advanced Biotechnology and Medicine
Piscataway, N.J. (June 2006)
American Academy of Neurology (AAN)
58th Annual Meeting in San Diego, Calif. (April 1-8, 2006)
American Heart Association/National Heart, Lung, and Blood Institute
46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Phoenix, Ariz. (March 2-5, 2006)
North American Neuro-Ophthalmology Society (NANOS)
32nd Annual Meeting in Tucson, Ariz. (Feb. 25 - March 2, 2006)
American Stroke Association
2006 International Stroke Conference in Kissimmee, Fla. (Feb. 16-18, 2006)
Texas Scottish Rite Hospital for Children
28th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 16-17, 2006)
International Neuropsychological Society (INS)
34th Annual Meeting in Boston, Mass. (Feb. 1-4, 2006)
American Epilepsy Society (AES)
59th Annual Meeting in Washington, DC (Dec. 2-6, 2005)
Society for Neuroscience (SFN)
35th Annual Meeting in Washington, DC (Nov. 12-16, 2005)
Mexican Academy of Neurology
29th Annual Meeting in Chihuahua, Mexico (Oct. 29 - Nov. 3, 2005)
American Neurological Association (ANA)
130th Annual Meeting in San Diego, Calif. (Sept. 25-28, 2005)
Michael E. DeBakey Veterans Affairs Medical Center
Nurse Education Lecture Series in Houston, Texas (Sept. 9, 2005)
Memorial Sloan-Kettering Cancer Research Center
Poster Session in New York, N.Y. (August 2005)
European Federation of Neurological Societies (EFNS)
20th Annual National Conference in Fort Lauderdale, Fla. (June 17-21, 2005)
Rutgers/UMDNJ-Robert Wood Johnson University Hospital
New Brunswick, N.J. (June 2005)
2nd Alzheimer's Association International Conference (AAIC)
Washington, DC (June 9-12, 2005)
International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 2005, 22nd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Amsterdam, The Netherlands (June 7-11, 2005)
American Telemedicine Association (ATA)
10th Annual Meeting in Denver, Colo. (April 17-20, 2005)
American Academy of Neurology (AAN)
57th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)
Veterans Health Administration
Care Coordination and Leadership Forum in Salt Lake City, Utah (April 5, 2005)
Central Texas Veterans Health Care System
19th Annual Nursing Research Day in Waco, Texas (April 1, 2005)
Michael E. DeBakey Veterans Affairs Medical Center
Advanced Cardiac Life Support Course in Houston, Texas (April 1, 2005)
VA Research Day
Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas (March 29, 2005)
Movement Disorder Society (MDS)
9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)
International Neuropsychological Society (INS)
33rd Annual Meeting in St. Louis, Mo. (Feb. 2-5, 2005)
American Stroke Association
30th International Stroke Conference in New Orleans, La. (Feb. 2-4, 2005)
American Epilepsy Society (AES)
58th Annual Meeting in New Orleans, La. (Dec. 3-7, 2004)
American Neurological Association (ANA)
129th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)
Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
18th Annual Symposium in Toronto, Canada (Oct. 3, 2004)
European Federation of Neurological Societies (EFNS)
8th Congress in Paris, France (Sept. 4-7, 2004)
Memorial Sloan-Kettering Cancer Research Center
Poster Session in New York, N.Y. (August 2004)
9th International Conference on Alzheimer's Disease and Related Disorders
Philadelphia, Penn. (July 17-22, 2004)
International Stroke Society (ISS)
5th World Stroke Congress in Vancouver, British Columbia, Canada (June 23-26, 2004)
XXIVth Collegium Internationale Neuro-Psychopharmacologicum (CINP) Congress
Paris, France (June 20-24, 2004)
International Stroke Society (ISS)
8th International Symposium on Thrombolysis and Acute Stroke Therapy in Whistler, British Columbia, Canada. (June 19-22, 2004)
Movement Disorder Society (MDS)
8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)
American Academy of Neurology (AAN)
56th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)
American Society for Experimental NeuroTherapeutics (ASENT)
6th Annual Meeting in Bethesda, Md. (March 11-13, 2004)
International Neuropsychological Society (INS)
32nd Annual Meeting in Baltimore, Md. (Feb. 4-7, 2004)
American Epilepsy Society (AES)
57th Annual Meeting in Boston, Mass. (Dec. 5-10, 2003)
25th International Epilepsy Congress (IEC)
Lisbon, Portugal (Oct. 12-16, 2003)
Memorial Sloan-Kettering Cancer Research Center
Poster Session in New York, N.Y. (August 2003)
Organization of Human Brain Mapping (OHBM)
9th International Conference on Functional Mapping of the Human Brain in New York, NY (June 18-22, 2003)
American Academy of Neurology (AAN)
55th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)
International Neuropsychological Society (INS)
31st Annual Meeting in Honolulu, Hawaii (Feb. 5-8, 2003)
American Epilepsy Society (AES)
56th Annual Meeting in Seattle, Wash. (Dec. 6-11, 2002)
Movement Disorder Society (MDS)
7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)
American Neurological Association (ANA)
127th Annual Meeting in New York City, N.Y. (Oct. 12-16, 2002)
Barany Society
6th NASA Symposium on The Role of the Vestibular Organs in the Exploration of Space (Sept. 30 - Oct. 3, 2002)
8th International Conference on Alzheimer's Disease and Related Disorders
Stockholm, Sweden (July 20-25, 2002)
American Headache Society
44th Annual Scientific Meeting in Seattle, Wash. (June 21-23, 2002)
Society for Epidemiologic Research (SER)
35th Annual Meeting in Palm Desert, Calif. (June 19-21, 2002)
Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
International Conference in Hannover, Germany (June 8, 2002)
International Society for Magnetic Resonance in Medicine (ISMRM)
10th Annual Meeting in Honolulu, Hawaii (May 18-24, 2002)
American Society of Hypertension (ASH)
17th Annual Meeting in New York, N.Y. (May 14-18, 2002)
World Federation of Neurology (WFN)
Research Group on Neuroepidemiology. Regional North American Annual Meeting in Denver, Colo. (April 19, 2002)
Society for the Neural Control of Movement (NCM)
12th Annual Meeting in Naples, Fla. (April 14-21, 2002)
International Neuropsychological Society (INS)
30th Annual Meeting in Toronto, Canada (Feb. 13-16, 2002)
American Epilepsy Society (AES)
55th Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 5, 2001)
Society for Neuroscience (SFN)
31st Annual Meeting in San Diego, Calif. (Nov. 10-15, 2001)
North American Primary Care Research Group (NAPCRG)
29th Annual Meeting in Halifax, Nova Scotia, Canada (Oct. 13-16, 2001)
World Federation of Neurology (WFN)
Research Group on Neuroepidemiology. Regional North American Annual Meeting in Philadelphia, Penn. (May 9, 2001)
American Academy of Neurology (AAN)
53rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)
Society for the Neural Control of Movement (NCM)
11th Annual Meeting in Seville, Spain (March 25-30, 2001)
International Neuropsychological Society (INS)
29th Annual Meeting in Chicago, Ill. (Feb. 14-17, 2001)
American Epilepsy Society (AES)
54th Annual Meeting in Los Angeles, Calif. (Dec. 1-6, 2000)
North American Primary Care Research Group (NAPCRG)
28th Annual Meeting in Amelia Island, Fla. (Nov. 4-7, 2000)
7th International Conference on Alzheimer's Disease and Related Disorders
Washington, DC (July 9-18, 2000)
Movement Disorder Society (MDS)
6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)
American Academy of Neurology (AAN)
52nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)
International Society for Magnetic Resonance in Medicine (ISMRM)
8th Annual Meeting in Denver, Colo. (April 1-7, 2000)
Genetics Society of America (GSA)
41st Annual Drosophila Research Conference in Pittsburgh, Penn. (March 22-26, 2000)
American Society of Consultant Pharmacists (ASCP)
30th Annual Meeting in St. Loius, Mo. (Nov. 10-13, 1999)
Society for Neuroscience (SFN)
29th Annual Meeting in Miami Beach, Fla. (Oct. 23-28, 1999)
European College of Neuropsychopharmacology (ECNP)
12th Congress in London, United Kingdom (Sept. 21-25, 1999)
Organization of Human Brain Mapping (OHBM)
5th International Conference on Functional Mapping of the Human Brain in Düsseldorf, Germany (June 22-26, 1999)
International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 1999, 19th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Copenhagen, Denmark (June 13-17, 1999)
European Neurological Society (ENS)
9th Annual Meeting in Milan, Italy (June 5-9, 1999)
American Academy of Neurology (AAN)
51st Annual Meeting in Toronto, Canada (April 17-24, 1999)
British Society for Developmental Biology (BSDB)
BSCB/BSDB Joint Spring Meeting in Manchester, England (April 13-16, 1999)
Genetics Society of America (GSA)
40th Annual Drosophila Research Conference in Bellevue, Wash. (March 24-28, 1999)
European College of Neuropsychopharmacology (ECNP)
11th Congress in Paris, France (Oct. 31 - Nov. 4, 1998)
6th International Conference on Alzheimer's Disease and Related Disorders
Amsterdam, The Netherlands (July 18-23, 1998)
American Society of Hypertension (ASH)
13th Annual Meeting in New York, N.Y. (May 13-16, 1998)
5th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy
Geneva, Switzerland (April 15-18, 1998)
Genetics Society of America (GSA)
39th Annual Drosophila Research Conference in Washington, DC (March 25-29, 1998)
American Epilepsy Society (AES)
51st Annual Meeting in Boston, Mass. (Dec. 7-10, 1997)
International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
Brain 1997, 18th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Baltimore, Md. (June 15-19, 1997)
Aerospace Medical Association (AsMA)
68th Annual Meeting in Chicago, Ill. (May 11-15, 1997)
American Academy of Neurology (AAN)
49th Annual Meeting in Boston, Mass. (April 15-17, 1997)
American Heart Association
22nd International Joint Conference on Stroke and Cerebral Circulation in Anaheim, Calif. (Feb. 6-8, 1997)
American College of Neuropsychopharmacology (ACNP)
35th Annual Meeting in San Juan, Puerto Rico (Dec. 9-13, 1996)
Society for Neuroscience (SFN)
26th Annual Meeting in Washington, DC (Nov. 16-21, 1996)
Aerospace Medical Association (AsMA)
67th Annual Meeting in Atlanta, Ga. (May 5-9, 1996)
International Behavioral Neuroscience Society (ISBN)
5th Annual Meeting in Cancun, Mexico (May 2-5, 1996)
Undersea and Hyperbaric Medical Society (UHMS)
1996 Annual Scientific Meeting in Anchorage, Alaska (April 30 - May 5, 1996)
Genetics Society of America (GSA)
37th Annual Drosophila Research Conference in San Diego, Calif. (April 27 - May 1, 1996)
American Academy of Neurology (AAN)
48th Annual Meeting in San Francisco, Calif. (March 23-30, 1996)
International Neuropsychological Society (INS)
24th Annual Meeting in Chicago, Ill. (Feb. 14-17, 1996)
Gerontological Society of America (GSA)
50th Annual Meeting in Los Angeles, Calif. (Nov. 15-19, 1995)
American Neuropsychiatric Association (ANPA)
7th Annual Meeting in Pittsburgh, Penn. (Oct. 12-15, 1995)
Aerospace Medical Association (AsMA)
66th Annual Meeting in Anaheim, Calif. (May 7-11, 1995)
American Academy of Neurology (AAN)
47th Annual Meeting in Seattle, Wash. (May 6-13, 1995)
International Neuropsychological Society (INS)
23rd Annual Meeting in Seattle, Wash. (Feb. 8-11, 1995)
American Academy of Neurology (AAN)
46th Annual Meeting in Washington, DC (May 1-7, 1994)
International Neuropsychological Society (INS)
22nd Annual Meeting in Cincinnati, Ohio (Feb. 2-5, 1994)
American Neurological Association (ANA)
118th Annual Meeting in Boston, Mass. (Oct. 18-20, 1993)
American Society of Human Genetics (ASHG)
43rd Annual Meeting in New Orleans, La. (Oct. 5-9, 1993)
American Psychiatric Association (APA)
146th Annual Meeting in San Francisco, Calif. (May 22-27, 1993)
International Neuropsychological Society (INS)
21st Annual Meeting in Galveston , Texas (Feb. 24-27, 1993)
National Academy of Neuropsychology (NAN)
12th Annual Meeting in Pittsburgh, Penn. (Nov. 5-7, 1992)
American Anthropological Association (AAA)
90th Annual Meeting in Chicago, Ill. (Nov. 20-24, 1991)
American Neurological Association (ANA)
116th Annual Meeting in Seattle, Wash. (Sept. 28 - Oct. 2, 1991)
Aerospace Medical Association (AsMA)
62nd Annual Meeting in Cincinnati, Ohio (May 5-9, 1991)
American Academy of Neurology (AAN)
43rd Annual Meeting in Boston, Mass. (April 21-27, 1991)
American Anthropological Association (AAA)
89th Annual Meeting in New Orleans, La. (Nov. 27 - Dec. 2, 1990)
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
37th Annual Meeting in Chicago, Ill. (Sept. 7-8, 1990)
American Academy of Neurology (AAN)
42nd Annual Meeting in Miami, Fla. (April 2-4, 1990)
Society for Neuroscience (SFN)
13th Annual Meeting in Boston, Mass. (Nov. 6-11, 1983)
Society for Neuroscience (SFN)
12th Annual Meeting in Minneapolis, Minn. (Oct. 31 - Nov. 5, 1982)
American College of Cardiology (ACC)
31st Annual Scientific Session in Atlanta, Ga. (April 25-29, 1982)